<PAGE>
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 23, 1994
REGISTRATION NO. 33-
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
------------------------
REXENE CORPORATION
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
DELAWARE 2821 75-2104131
(State or other (Primary Standard (I.R.S. Employer
jurisdiction of Industrial Identification
incorporation or Classification Code Number)
organization) Number)
</TABLE>
5005 LBJ FREEWAY
OCCIDENTAL TOWER, SUITE 500
DALLAS, TEXAS 75244
(214) 450-9000
(Address, including zip code, and telephone number,
including area code, of registrant's principal executive offices)
------------------------
BERNARD J. MCNAMEE
VICE PRESIDENT, SECRETARY AND GENERAL COUNSEL
REXENE CORPORATION
5005 LBJ FREEWAY
OCCIDENTAL TOWER, SUITE 500
DALLAS, TEXAS 75244
(214) 450-9000
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
------------------------
COPIES TO:
<TABLE>
<S> <C>
PETER A. LODWICK KIRK A. DAVENPORT
THOMPSON & KNIGHT, LATHAM & WATKINS
A PROFESSIONAL CORPORATION 885 THIRD AVENUE, SUITE 1000
1700 PACIFIC AVENUE, SUITE 3300 NEW YORK, NEW YORK 10022
DALLAS, TEXAS 75201 (212) 906-1200
(214) 969-1700
</TABLE>
------------------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: As soon as
practicable after this registration statement becomes effective.
If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. / /
If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, check the following box. / /
------------------------
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
PROPOSED
PROPOSED MAXIMUM
MAXIMUM AGGREGATE AMOUNT OF
TITLE OF EACH CLASS OF AMOUNT TO OFFERING PRICE OFFERING REGISTRATION
SECURITIES TO BE REGISTERED BE REGISTERED PER UNIT (1) PRICE (1) FEE
<S> <C> <C> <C> <C>
% Senior Notes due 2004.... $175,000,000 100% $175,000,000 $60,345
<FN>
(1) Estimated solely for the purpose of calculating the registration fee.
</TABLE>
------------------------
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF
THE SECURITIES ACT OF 1933 OR UNTIL THIS REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A),
MAY DETERMINE.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A
REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION. THESE SECURITIES MAY NOT BE SOLD NOR MAY
OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT BECOMES
EFFECTIVE. THIS PROSPECTUS SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE
SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES
IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR
TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH STATE.
<PAGE>
SUBJECT TO COMPLETION, DATED SEPTEMBER 23, 1994
P R O S P E C T U S
$175,000,000
[LOGO]
% SENIOR NOTES DUE 2004
----------------
The % Senior Notes due 2004 (the "Senior Notes") are being offered hereby
(the "Notes Offering") by Rexene Corporation ("Rexene" or the "Company").
Concurrently with the Notes Offering and in connection with the Recapitalization
described herein, the Company is publicly offering 8,000,000 shares of common
stock of the Company ("Common Stock") pursuant to a separate prospectus (the
"Common Stock Offering" and, together with the Notes Offering, the "Offerings").
The Notes Offering is contingent upon the concurrent consummation of the Common
Stock Offering and the other elements of the Recapitalization, including the
establishment of the New Credit Agreement (as defined herein). See "The
Recapitalization."
Interest on the Senior Notes will be payable semiannually on
and , commencing , 1995. The
Senior Notes will mature on , 2004 and will not be redeemable,
in whole or in part, prior to , except that, at any time prior
to , the Company may redeem up to an aggregate of $ million
principal amount of Senior Notes, at a price equal to % of the principal
amount thereof plus accrued and unpaid interest, if any, to the redemption date
with the net cash proceeds of any future offering or offerings of Common Stock
of the Company; provided, however, that at least $ million aggregate
principal amount of Senior Notes must remain outstanding immediately following
each such redemption; and provided further that each such redemption shall occur
within 60 days of the date of the closing of the applicable offering. On or
after , the Senior Notes will be redeemable, at the Company's
option, in whole or in part, at the prices set forth herein plus accrued and
unpaid interest, if any, to the redemption date. In the event of a Change of
Control (as defined herein), the Company will be required to offer to purchase
all of the Senior Notes at a price equal to 101% of the principal amount
thereof, plus accrued and unpaid interest, if any, to the purchase date.
The Senior Notes will be senior unsecured obligations of the Company that
will rank senior in right of payment to all subordinated Indebtedness (as
defined herein) of the Company. The Senior Notes will rank PARI PASSU in right
of payment with all other existing and future Indebtedness of the Company,
including borrowings under the New Credit Agreement. However, the Senior Notes
will be effectively subordinated to secured Indebtedness of the Company to the
extent of the value of the assets securing such Indebtedness, including
borrowings under the New Credit Agreement which will be secured by substantially
all of the assets of the Company. As of June 30, 1994, on a pro forma basis
after giving effect to the Recapitalization, the Company would have had
outstanding approximately $275 million of senior Indebtedness, consisting of the
Senior Notes and $100 million aggregate principal amount of Indebtedness
pursuant to the New Credit Agreement.
The Company does not intend to list the Senior Notes on any securities
exchange or any automated quotation system. See "Investment Considerations --
Lack of a Public Market for the Senior Notes."
SEE "INVESTMENT CONSIDERATIONS" FOR A DISCUSSION OF CERTAIN FACTORS THAT
SHOULD BE CONSIDERED IN CONNECTION WITH AN INVESTMENT IN THE SENIOR NOTES
OFFERED HEREBY.
----------------
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE
SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION
PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY
REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
<TABLE>
<CAPTION>
UNDERWRITING PROCEEDS
PRICE TO THE DISCOUNTS AND TO THE
PUBLIC(1) COMMISSIONS(2) COMPANY(3)
<S> <C> <C> <C>
Per Senior Note....................... % % %
Total................................. $ $ $
<FN>
(1) Plus accrued interest, if any, from the date of issuance.
(2) See "Underwriting" for indemnification arrangements with the Underwriters.
(3) Before deducting expenses payable by the Company estimated at
$ .
</TABLE>
----------------
The Senior Notes are being offered by the Underwriters, subject to
acceptance by them and to their right to reject any order in whole or in part.
It is expected that delivery of the Senior Notes will be made against payment
therefor at the offices of Smith Barney Inc., 388 Greenwich Street, New York,
New York 10013, on or about , 1994.
----------------
SMITH BARNEY INC. WERTHEIM SCHRODER & CO.
INCORPORATED
November , 1994
<PAGE>
[CHART SHOWING FLOW OF RAW MATERIALS THROUGH THE COMPANY'S
PRODUCTION FACILITIES AND THE RESULTING END MARKET PRODUCTS.]
<PAGE>
[Photos of principal end market products to come]
<PAGE>
[Photos of principal end market products to come]
IN CONNECTION WITH THE OFFERINGS, THE UNDERWRITERS MAY OVER-ALLOT OR EFFECT
TRANSACTIONS WHICH STABILIZE OR MAINTAIN THE MARKET PRICE OF THE SENIOR NOTES,
THE COMMON STOCK OR BOTH AT LEVELS ABOVE THOSE WHICH MIGHT OTHERWISE PREVAIL IN
THE OPEN MARKET. SUCH TRANSACTIONS MAY BE EFFECTED ON THE NEW YORK STOCK
EXCHANGE, IN THE OVER-THE-COUNTER MARKET OR OTHERWISE. SUCH STABILIZING, IF
COMMENCED, MAY BE DISCONTINUED AT ANY TIME.
<PAGE>
PROSPECTUS SUMMARY
THE FOLLOWING SUMMARY SHOULD BE READ IN CONJUNCTION WITH, AND IS QUALIFIED
IN ITS ENTIRETY BY, THE MORE DETAILED INFORMATION AND FINANCIAL STATEMENTS,
INCLUDING THE NOTES THERETO, APPEARING ELSEWHERE IN THIS PROSPECTUS OR IN
DOCUMENTS INCORPORATED IN THIS PROSPECTUS BY REFERENCE. UNLESS OTHERWISE
INDICATED, ALL INFORMATION IN THIS PROSPECTUS ASSUMES THAT THE UNDERWRITERS'
OVER-ALLOTMENT OPTION TO PURCHASE A TOTAL OF 1,200,000 SHARES OF COMMON STOCK
FROM THE COMPANY IN CONNECTION WITH THE COMMON STOCK OFFERING WILL NOT BE
EXERCISED. UNLESS OTHERWISE INDICATED, ALL INDUSTRY DATA INCLUDED IN THIS
PROSPECTUS ARE DERIVED FROM INFORMATION AVAILABLE FROM OR PROVIDED BY CHEMICAL
MARKETING ASSOCIATES, INC. ("CMAI"), AN INDUSTRY CONSULTANT.
A GLOSSARY OF INDUSTRY TERMS APPEARS ON PAGE 9.
THE COMPANY
Rexene Corporation manufactures and markets a wide variety of products
ranging from value added specialty products, such as customized plastic films,
to commodity petrochemicals, such as styrene. These products are sold to a
diverse customer base and are used in a wide variety of industrial and consumer-
related applications. The Company's principal products are plastic film,
polyethylene, polypropylene and REXTAC-R- amorphous polyalphaolefin ("APAO")
resins and styrene. In addition, the Company manufactures, primarily for its own
consumption, ethylene and propylene, the two basic chemical building blocks of
the Company's principal products. The Company believes this captive olefins
source of supply provides it with an advantage over competitors that are not
backwardly integrated. The Company manufactures plastic film at five plants
located in the U.S. and England and polymers and petrochemicals at an integrated
facility in Odessa, Texas (the "Odessa Facility") which is located near supplies
of most of its feedstocks.
The Company believes that it has built a strong customer base and reputation
for quality primarily due to (i) its focus on a high degree of customer service
and the production of value added specialty products, (ii) its manufacturing and
marketing expertise, and (iii) the experience and commitment of its operating
management. In addition, the Company believes that it has developed a strategy
to allow it to compete effectively in its markets against larger competitors in
both periods of rising and declining product prices.
CT FILM. Through its Consolidated Thermoplastics division ("CT Film"), the
Company produces specialty grades of polyethylene films used in disposable
diapers, feminine hygiene products, medical products, tapes, packaging,
lamination and unsupported overwraps and greenhouse and agricultural
applications. CT Film's plants, located in Chippewa Falls, Wisconsin;
Clearfield, Utah; Dalton, Georgia; Harrington, Delaware; and Scunthorpe,
England, have a total rated annual production capacity of approximately 245
million pounds. CT Film's sales increased from $109 million in 1989 to
approximately $147 million in 1993, an increase of approximately 35%, while its
total rated annual production capacity expanded by 41%. In September 1994, CT
Film, through Rexene Corporation Limited, a wholly-owned subsidiary of the
Company, commenced operation of its first overseas plant in Scunthorpe, England,
which was built primarily to service a new U.K. facility of CT Film's major
customer, Kimberly-Clark Corporation. In 1993, CT Film had sales of
approximately $147 million, or 34% of the Company's net sales.
POLYETHYLENE. Polyethylene, the world's most widely produced polymer, is
used in the manufacture of packaging and nonpackaging films, coatings for paper
products, wire and cable applications, bottles and profile and foam extrusions.
The Company currently produces a variety of grades of high pressure, low density
polyethylene ("HPLDPE") for use in food packaging, industrial packaging, medical
bottles, produce films, laminated structures, paper coatings and other
applications. The Company seeks to compete with larger polyethylene producers by
targeting customers that require smaller lot sizes of specially tailored, high
quality products. This strategy generally affords the Company opportunities for
premium pricing relative to commodity grades of polyethylene. The Company
believes that the Odessa Facility, which has relatively small reactors and a
total rated annual production capacity for polyethylene of approximately 405
million pounds, is well positioned to compete in these markets. In 1993, the
Company had polyethylene sales of approximately $120 million, or 28% of the
Company's net sales.
3
<PAGE>
POLYPROPYLENE. Polypropylene is one of the fastest growing major polymers
in the world. The Company manufactures polypropylene for use in specialized
manufacturing applications in the medical, electrical and food packaging
markets. The Company seeks to compete with larger polypropylene producers by
focusing on specialty products that generally afford opportunities for premium
pricing relative to commodity grades of polypropylene. The Odessa Facility has a
total rated annual production capacity for polypropylene of approximately 180
million pounds. In 1993, the Company had polypropylene sales of approximately
$64 million, or 15% of the Company's net sales.
APAO. The Company is a major producer of APAO, a special purpose polymer
used in the production of adhesives, sealants, roofing materials, paper
lamination and wire and cable applications. The Company estimates that in 1993
Rexene accounted for approximately 30% of total U.S. market for APAO and atactic
polypropylene. The Odessa Facility has a total rated annual production capacity
for APAO of approximately 45 million pounds. In 1993, the Company had APAO sales
of approximately $15 million, or 4% of the Company's net sales.
STYRENE. Styrene is a raw material used principally in the production of
polymers used to manufacture products such as disposable cups and trays,
luggage, housewares, toys and building products. The Odessa Facility has a total
rated annual production capacity for styrene of approximately 320 million
pounds. In 1993, the Company had styrene sales of approximately $61 million, or
14% of the Company's net sales.
The corporate headquarters of Rexene, a Delaware corporation, are located at
5005 LBJ Freeway, Dallas, Texas 75244, and its telephone number is 214/450-9000.
BUSINESS STRATEGY
The Company's operating strategy to market value added specialty products
and to improve its operating costs is designed to allow it to compete
effectively against larger competitors in both periods of rising and declining
product prices. The Company believes that its operating strategy will enable it
to take advantage of improved market conditions in a strong economy and to
lessen the impact of depressed pricing and demand in market downturns. Over the
longer term, Rexene will seek to improve its profitability by (i) maintaining
its customer driven focus to provide value added specialty products and quality
service, (ii) focusing on niche markets which optimize the use of the Odessa
Facility, (iii) continuing to develop its plastic film business, (iv) developing
new products and applications through technological innovation, (v) continuing
to improve operating efficiencies, (vi) continuing to reinvest in its core
plastic film and polymer businesses and (vii) continuing to reduce its balance
sheet leverage.
RECENT INDUSTRY TRENDS
The polyethylene, polypropylene and styrene markets in which Rexene competes
are cyclical markets that are sensitive to relative changes in supply and
demand, which are in turn affected by general economic conditions. Historically,
these markets have experienced alternating periods of tight supply and rising
prices and profit margins, followed by periods of large capacity additions
resulting in oversupply and declining prices and margins. Following a
significant improvement in domestic economic growth since the second half of
1993, these markets experienced increased levels of demand which have resulted
in greater capacity utilization and higher domestic and export prices. According
to CMAI, during the first six months of 1994, domestic demand for low density
polyethylene ("LDPE"), polypropylene and styrene increased by approximately 9%,
16% and 5%, respectively, compared to the first six months of 1993. This
increase in demand has enabled the Company and the petrochemical industry in
general to increase selling prices significantly at a time when feedstock costs
have either not increased or only increased modestly compared to end product
prices. For example, from December 1993 to August 1994, the Company increased
the average selling prices of its polyethylene, polypropylene and styrene by
22%, 12% and 37% per pound, respectively. During the same period, prices for the
Company's feedstocks increased 34% for benzene and were relatively stable for
ethane and propane.
4
<PAGE>
THE RECAPITALIZATION
The Notes Offering is part of a recapitalization plan (the
"Recapitalization") designed to increase stockholders' equity, reduce
indebtedness and interest expense and improve the strategic, operating and
financial flexibility of the Company. The Company believes that the
Recapitalization should better position Rexene to continue to reduce its balance
sheet leverage through the use of cash flow from operations. The
Recapitalization includes (i) the Offerings, (ii) the establishment of a new
credit facility (the "New Credit Agreement"), providing the Company with a $100
million term loan (the "Term Loan"), which will be drawn down at the closing of
the Recapitalization, and an $80 million revolving line of credit (the
"Revolving Credit Facility"), which is not expected to be drawn down at such
closing, (iii) the call for redemption of the Company's Increasing Rate Senior
Notes Due 1999 (the "Old Senior Notes") and Increasing Rate Subordinated Notes
Due 2002 (the "Old Subordinated Notes" and, together with the Old Senior Notes,
the "Old Notes"), and (iv) the repayment in full of the outstanding indebtedness
under the Company's existing credit agreement with Transamerica Business Credit
Corporation (the "Old Credit Agreement").
The following table sets forth the estimated sources and uses of funds for
the Recapitalization, assuming consummation as of November 15, 1994. In the
event that the aggregate gross proceeds from the Offerings are less than $289
million, the Company may be required to arrange for alternative sources of cash,
which could include additional borrowings under the New Credit Agreement or
utilizing cash on hand, or a combination thereof. At June 30, 1994, the Company
had unrestricted cash on hand of approximately $35.6 million.
<TABLE>
<CAPTION>
(IN THOUSANDS)
<S> <C>
SOURCES:
Notes Offering (1).................................................................... $ 175,000
Common Stock Offering (1)............................................................. 114,000
Borrowings under New Credit Agreement................................................. 100,000
--------------
Total sources....................................................................... $ 389,000
--------------
--------------
USES:
Repay Old Senior Notes (2)(3)......................................................... $ 253,000
Repay Old Subordinated Notes(2)(3).................................................... 99,629
Repay borrowings under Old Credit Agreement........................................... 10,000
Estimated fees and expenses (4)....................................................... 16,336
Excess cash (5)....................................................................... 10,035
--------------
Total uses.......................................................................... $ 389,000
--------------
--------------
<FN>
- ------------------------
(1) Represents gross proceeds.
(2) Includes aggregate unamortized discount of approximately $59.9 million for
the Old Notes at November 15, 1994.
(3) Excludes accrued interest of approximately $11.6 million on the Old Senior
Notes and $5.1 million on the Old Subordinated Notes that will be paid from
the Company's existing cash balances on November 15, 1994.
(4) Includes estimated underwriting discounts and commissions and related
expenses of the Offerings; fees and expenses associated with the New Credit
Agreement and termination of the Old Credit Agreement; and other fees and
expenses payable or reimbursable by the Company in connection with the
Recapitalization.
(5) Any excess cash will be used for working capital purposes.
</TABLE>
5
<PAGE>
THE NOTES OFFERING(1)
<TABLE>
<S> <C>
Securities Offered........... $175 million aggregate principal amount of % Senior Notes
due , 2004.
Maturity Date................ , 2004.
Interest Payment Dates....... and , commencing , 1995.
Optional Redemption.......... The Senior Notes will not be redeemable, in whole or in
part, prior to , except that, at any time prior to
, the Company may redeem up to an aggregate of
$ million principal amount of Senior Notes, at a price
equal to % of the principal amount thereof, plus accrued
and unpaid interest, if any, to the redemption date with the
net cash proceeds of any future offering or offerings of
Common Stock of the Company; provided, however, that at
least $ million aggregate principal amount of Senior
Notes must remain outstanding immediately following each
such redemption; and provided further that each such
redemption shall occur within 60 days of the date of the
closing of the applicable offering. On or after ,
the Senior Notes will be redeemable, at the Company's
option, in whole or in part, at the prices set forth herein
plus accrued and unpaid interest, if any, to the date of
redemption. See "Description of Senior Notes -- Optional
Redemption".
Ranking...................... The Senior Notes will be senior unsecured obligations of the
Company that will rank senior in right of payment to all
subordinated Indebtedness of the Company. The Senior Notes
will rank PARI PASSU in right of payment with all other
Indebtedness of the Company. However, the Senior Notes will
be effectively subordinated to secured Indebtedness of the
Company to the extent of the value of the assets securing
such Indebtedness, including borrowings under the New Credit
Agreement entered into in connection with the
Recapitalization. Indebtedness incurred pursuant to the New
Credit Agreement will be secured by substantially all the
assets of the Company. See "Investment Considerations --
Secured Indebtedness" and "Description of New Credit
Agreement".
Change of Control............ Upon a Change of Control, the Company will be required to
make an offer to purchase all Senior Notes then outstanding
at a price equal to 101% of the principal amount thereof,
plus accrued and unpaid interest, if any, to the purchase
date. See "Description of Senior Notes -- Change of
Control".
Certain Covenants............ The indenture relating to the Senior Notes (the "Indenture")
will contain certain covenants that, among other things,
limit the ability of the Company and its Subsidiaries to
incur additional Indebtedness and issue Preferred Stock and
limit the ability of the Company and its Restricted
Subsidiaries to repurchase Capital Stock and subordinated
Indebtedness, engage in transactions with its affiliates,
engage in sale and leaseback transactions, incur or suffer
to exist certain liens, pay dividends and other
distributions, make investments, sell assets and engage in
mergers and consolidations. See "Description of Senior Notes
-- Certain Covenants."
Use of Proceeds.............. Repayment of indebtedness. See "Use of Proceeds."
<FN>
- ------------------------
(1) All capitalized terms used herein with respect to the Notes Offering and
not otherwise defined herein have the meanings assigned thereto under
"Description of Senior Notes -- Certain Definitions".
</TABLE>
INVESTMENT CONSIDERATIONS
Prospective purchasers of the Senior Notes offered hereby should consider
carefully the matters set forth herein under the caption "Investment
Considerations."
6
<PAGE>
SUMMARY SELECTED HISTORICAL AND PRO FORMA CONSOLIDATED FINANCIAL DATA
(IN THOUSANDS, EXCEPT PER SHARE DATA AND RATIOS)
The following table sets forth certain selected historical and pro forma
consolidated financial data for the Company for the periods indicated. In
October 1991, the predecessor corporation of the Company ("Old Rexene") filed a
petition for reorganization under the federal bankruptcy laws from which Old
Rexene emerged on September 18, 1992, pursuant to an amended plan of
reorganization (the "Amended Plan") which provided for the merger of Old Rexene
into a wholly owned subsidiary of Old Rexene to form the Company (the
"Reorganization"). The Company adopted fresh start reporting on September 30,
1992 following consummation of the Reorganization. As a result, results of
operations (other than net sales and EBITDA) for the periods after September 30,
1992 are not comparable to results of operations prior to that date.
<TABLE>
<CAPTION>
OLD REXENE
(PREDECESSOR) THE COMPANY
--------------------------------------- ------------------------------------------------
NINE SIX MONTHS
YEARS ENDED MONTHS THREE MONTHS ENDED
DECEMBER 31, ENDED ENDED YEAR ENDED JUNE 30,
---------------------------- SEPT. 30, DECEMBER 31, DECEMBER 31, ------------------
1989 1990 1991 1992 1992 1993 1993 1994
-------- -------- -------- --------- ------------ ------------ -------- --------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
HISTORICAL STATEMENT OF OPERATIONS
DATA:(1)
Net sales........................ $608,631 $502,186 $449,728 $316,106 $ 98,854 $429,353 $215,272 $243,216
Gross profit..................... 158,130 133,707 61,671 38,025 12,122 53,744 27,023 43,663
Operating income................. 99,938 81,100 12,028 9,392 1,418 14,504 7,505 23,726
Interest expense (2)............. 61,111 71,732 58,374 -- 12,660 49,834 24,398 25,152
Income (loss) before income taxes
and extraordinary items......... 53,956 18,360 (56,191) (28,840) (10,436) (34,183) (16,248) (838)
Income tax (expense) benefit..... (43,751) (15,655) 13,444 (2,636) 3,908 8,940 4,439 177
Net income (loss) before
extraordinary items............. 10,205 2,705 (42,747) (31,476) (6,528) (25,243) (11,809) (661)
Ratio of earnings to fixed
charges (3) (4)................. -- -- -- --
OTHER DATA:
Depreciation and amortization.... $ 25,381 $ 22,451 $ 23,852 $ 20,062 $ 4,315 $ 17,446 $ 8,560 $ 9,194
Capital expenditures............. 18,596 28,855 33,464 11,136 3,961 17,008 7,062 15,462
EBITDA (5)....................... 125,319 103,551 35,880 29,454 5,733 31,950 16,065 32,920
Ratio of EBITDA to interest
expense (3) (5)................. -- -- -- 1.31x
PRO FORMA STATEMENT OF OPERATIONS
DATA:(6)
Operating income................. $ 14,504 $ 23,726
Interest expense................. $ 27,892 $ 13,894
Net income (loss)................ $(11,639) $ 6,319
EBITDA (5)....................... $ 31,950 $ 32,920
Ratio of EBITDA to interest
expense (5)..................... 1.15x 2.37x
Ratio of earnings to fixed
charges (4)..................... -- 1.64x
<CAPTION>
AT JUNE 30, 1994
------------------------
AS ADJUSTED
ACTUAL (6)
--------- ------------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
BALANCE SHEET DATA:
Cash and cash equivalents (7).... $ 37,892 $ 44,653
Working capital.................. 115,299 117,946
Total assets..................... 449,861 464,785
Long-term debt (including current
portion):
Face amount.................... 361,629 275,000
Unamortized discount (8)....... (63,606) --
--------- ------------
Net balance.................... 298,023 275,000
Stockholders' equity (deficit)... (5,765) 70,898
</TABLE>
7
<PAGE>
<TABLE>
<S> <C> <C> <C> <C> <C> <C> <C> <C>
<FN>
- ------------------------------
(1) The financial results of a manufacturing facility in Bayport, Texas, which
the Company sold in February 1990, are included in the historical statement
of operations data for the years ended December 31, 1989 and 1990. Net
sales and operating income for 1989 were $124.7 million and $4.1 million,
respectively. Net sales and operating income of the Bayport manufacturing
facility for 1990 were $16.3 million and $1.8 million, respectively.
(2) Interest expense on the indebtedness of Old Rexene accrued through October
16, 1991. In addition, interest expense on such indebtedness accrued from
October 16, 1991 to December 31, 1991 in accordance with terms of an
agreement with a noteholders' committee formed as part of the
Reorganization. If the interest expense from October 16, 1991 to December
31, 1991 had been calculated under the term of the indebtedness of Old
Rexene, the interest expense for the year ended December 31, 1991 would
have aggregated $73.8 million. The Amended Plan eliminated post petition
interest requirements through June 30, 1992. Interest expense from July 1,
1992 through September 30, 1992 was not classified as interest expense but
reflected in reorganization expense. See Note 3 of the Notes to the
Consolidated Financial Statements. Non-cash interest expense (income) was
$10.8 million for the year ended December 31, 1989, ($4.6 million) for the
year ended December 31, 1990 (due to the reversal of interest previously
accrued in accordance with Emerging Issues Task Force ("EITF") Issue No.
86-15, "Increasing Rate Debt"), $3.3 million for the year ended December
31, 1991, zero for the nine months ended September 30, 1992 (due to the
Amended Plan previously noted) $6.4 million for the three months ended
December 31, 1992 and $25.4 million for the year ended December 31, 1993.
Non-cash interest expense for the six months ended June 30, 1993 and 1994
was $12.3 million and $13.0 million, respectively.
(3) The ratio of earnings to fixed charges and the ratio of EBITDA to interest
expense for the periods prior to September 30, 1992 are not presented
because such information is not comparable to the similar information for
the periods after September 30, 1992, the date of the Company's adoption of
"fresh start" reporting.
(4) For the purposes of determining the ratio of earnings to fixed charges,
earnings consist of income before income taxes, extraordinary items and
fixed charges. Fixed charges consist of interest on indebtedness,
including, if any, the amortization of debt issue costs, accretion of debt
discount, interest expense accrued in accordance with EITF Issue No. 86-15
(See Note 10 to the Consolidated Financial Statements) and one-third of
rental expense (which is deemed representative of the interest factor
therein). Earnings were insufficient to cover fixed charges in the
historical periods ended December 31, 1992, December 31, 1993, June 30,
1993, and June 30, 1994 by $10.7 million, $35.4 million, $17.3 million, and
$1.6 million, respectively. Earnings were insufficient to cover fixed
charges for the pro forma period ended December 31, 1993 by $12.9 million.
(5) EBITDA means operating income before depreciation and amortization. EBITDA
has been included solely to facilitate consideration of the covenants in
the Indenture that are based, in part, on EBITDA and because the Company
understands that it is used by certain investors as one measure of a
company's historical ability to service its debt. EBITDA is not intended to
represent cash flows for the period nor has it been presented as an
alternative to earnings from operations as an indicator of operating
performance and should not be considered in isolation or as a substitute
for measures of performance prepared in accordance with generally accepted
accounting principles. EBITDA for the periods ended December 31, 1992,
December 31, 1993 and June 30, 1993 was insufficient to cover interest
expense by $6.9 million, $17.9 million and $8.3 million, respectively.
Interest expense for such periods included non-cash interest expense as
described in Note 2 above.
(6) Gives effect to the Recapitalization as described under the caption "Pro
Forma Unaudited Condensed Consolidated Financial Data". See "Management's
Discussion and Analysis of Financial Condition and Results of Operations."
(7) Includes restricted cash of $2.3 million.
(8) Represents the unamortized discount on the Old Notes.
</TABLE>
8
<PAGE>
GLOSSARY OF INDUSTRY TERMS
<TABLE>
<S> <C>
"APAO" -- amorphous polyalphaolefins, a special purpose polymer used
primarily in roofing materials and adhesives, manufactured
principally to replace APP.
"APP" -- atactic polypropylene, a by-product of isotatic polypropylene
manufacturing.
"benzene" -- a petrochemical produced primarily from petroleum and used in
the production of styrene.
"CMAI" -- Chemical Marketing Associates, Inc., a Houston, Texas based
industry consultant.
"copolymers" -- a polymer formed from two different chemical building blocks
(monomers).
"CT Film" -- the Company's Consolidated Thermoplastics division, which
produces specialty grades of polyethylene films.
"ethane" -- an NGL component from which ethylene is produced.
"ethylene" -- a principal raw material used by the Company to make
polyethylene and styrene.
"feedstocks" -- ethane, propane and benzene, raw materials used in the
production of ethylene, propylene and styrene.
"film" -- a thin sheet of plastic.
"FPO" -- a flexible polyolefin polymer made from propylene.
"HDPE" -- high density polyethylene resin, a homopolymer produced from
ethylene in a low pressure process.
"homopolymer" -- a polymer produced from a single monomer.
"HPLDPE" -- high pressure low density polyethylene resin.
"LDPE" -- low density polyethylene, resin including HPLDPE and LLDPE.
"liner grade" -- a multi-purpose commodity grade of polyethylene.
"LLDPE" -- linear low density polyethylene resin.
"monomer" -- a chemical building block from which a polymer is formed.
"NGL" -- natural gas liquids which are condensed from "wet" natural gas.
"olefins" -- a particular class of petrochemicals, including ethylene and
propylene.
"operating/utilization -- derived by dividing production by total rated annual production
rate" capacity.
"petrochemicals" -- organic chemicals produced from petroleum or natural gas,
including olefins, benzene and styrene.
"polyethylene" -- a polymer formed from the polymerization of mainly ethylene.
"polymer" -- products, such as polyethylene, polypropylene and APAO, made
from the polymerization of monomers, such as ethylene and
propylene.
"polypropylene" -- a polymer formed from the polymerization of mainly propylene.
"propane" -- an NGL component from which ethylene and propylene are produced.
"propylene" -- a principal raw material used by the Company to make
polypropylene and APAO.
"SPI" -- Society of the Plastics Industry Inc., an industry trade
association.
"styrene" -- a commodity petrochemical produced from ethylene and benzene.
"thermoplastic" -- a polymer which after shaping can be reshaped (within
limitations) by the application of heat.
"total rated annual -- official design capacity of plants at continuous use all year.
production capacity"
</TABLE>
9
<PAGE>
INVESTMENT CONSIDERATIONS
The following factors, as well as the other information contained elsewhere
in this Prospectus, should be carefully considered before investing in the
securities being offered hereby.
INDUSTRY CYCLICALITY
The polyethylene, polypropylene and styrene markets in which the Company
competes are cyclical markets that are sensitive to relative changes in supply
and demand, which are in turn affected by general economic conditions.
Historically, these markets have experienced alternating periods of tight
supply, causing prices and profit margins to increase, followed by periods of
large capacity additions, resulting in oversupply and declining prices and
profit margins. In the early 1980's, overcapacity in the polyethylene and
polypropylene markets and weakened demand for styrene due to general economic
conditions led to poor operating results for the Company and the industry in
general. In the mid 1980's, construction of new production facilities slowed and
increases in production capacities due to technology improvements moderated. At
the same time, domestic demand grew significantly as a result of a stronger U.S.
economy and export sales strengthened due in part to a weaker U.S. dollar. As a
result, during fiscal years 1987 to 1989, the industry experienced increased
levels of demand for its products which resulted in near full capacity
utilization rates, higher domestic and export prices and record earnings.
Feedstock prices were also favorable during this period. In response to this
rapid increase in demand and profits, the U.S. LDPE, polypropylene and styrene
industries increased total rated annual production capacity by approximately
22%, 31% and 34%, respectively, from 1988 to 1993. From 1990 to 1993, the rate
in U.S. demand slowed as a result of general economic conditions, and
significant production capacity was added in some of the traditional export
markets in the Far East. As a consequence, the industry, including the Company,
experienced during this period an overcapacity condition that resulted in a
decline in utilization rates and substantially lower average selling prices and
profit margins.
Economic growth in the United States in late 1993 and 1994 resulted in
significantly increased demand in the petrochemical and polymer markets in which
the Company participates and higher average selling prices and higher profit
margins during 1994. However, Rexene believes that, from late 1994 to 1995,
additional total rated annual production capacity of approximately 1.7 billion
pounds in LDPE (all of which is LLDPE), 100 million pounds in polypropylene and
200 million pounds in styrene could be added to the industry by the Company's
competitors. An additional 670 million pounds of polypropylene capacity has been
announced to be added by the Company's competitors during 1996. During 1993, the
United States industry had total rated annual production capacity of
approximately 13.7 billion pounds of LDPE, 9.8 billion pounds of polypropylene
and 11.6 billion pounds of styrene. There can be no assurance that the current
growth in demand for the Company's products will be sustained or that it will
keep pace with anticipated or unanticipated capacity additions or other events.
See "-- Competition."
PRICE VOLATILITY OF PETROCHEMICAL FEEDSTOCKS
The Company uses large amounts of petrochemical feedstocks in the
manufacturing of its chemical products. The prices of feedstocks fluctuate
widely based upon the prices of natural gas and oil. During the past four years,
feedstocks accounted for between approximately 24% and 32% of the Company's
total cost of sales. While the Company tries to match cost increases with
corresponding price increases, large increases in the prices of petrochemical
feedstocks could adversely affect the Company's operating margins. There may be
periods of time during which the Company is unable to pass through to customers
increases in feedstock costs because of weakness in demand for, or oversupply
of, the Company's products. See "Management's Discussion and Analysis of
Financial Condition and Results of Operations."
HIGH LEVERAGE AND SUBSTANTIAL DEBT SERVICE REQUIREMENTS
Following the Recapitalization, the Company will continue to be highly
leveraged and have substantial debt service obligations. As of June 30, 1994, on
a pro forma basis after giving effect to the Recapitalization, the Company's
long-term debt would have been $265 million and the Company's stockholders'
equity would have been approximately $71 million. On such a pro forma basis,
this long-term debt would have included $90 million of borrowings under the Term
Loan and $175 million of Senior Notes. In addition, $10 million of
10
<PAGE>
borrowings under the Term Loan would be reflected as the current portion of
long-term debt. See "Capitalization." The Company may incur additional
indebtedness in the future, subject to certain limitations contained in the
instruments governing its indebtedness. For a description of the Senior Notes
and the New Credit Agreement, see "Description of New Credit Agreement" and
"Description of Senior Notes."
The degree to which the Company is leveraged could have important
consequences to holders of the Senior Notes of the Company, including but not
limited to, the following: (i) the Company's ability to obtain additional
financing in the future for working capital, capital expenditures, acquisitions,
general corporate purposes or other purposes may be impaired; (ii) a significant
portion of the Company's cash flow from operations must be dedicated to the
payment of principal and interest on its indebtedness, thereby reducing the
funds available to the Company; (iii) certain of the Company's borrowings are
and will continue to be at variable rates of interest, which could result in
higher interest expense in the event of increases in interest rates; and (iv)
such indebtedness contains and will contain financial and restrictive covenants,
the failure to comply with which may result in an event of default which, if not
cured or waived, could have a material adverse effect on the Company.
After the Recapitalization, the Company will have substantial principal
repayment obligations. The Company will be required to repay a portion of its
borrowings under the Term Loan each year, commencing in 1995, so as to retire
such indebtedness in its entirety by November 1999. The Senior Notes will mature
on , 2004. The Company believes that following the consummation of
the Offerings, based on current levels of operations and anticipated growth, its
cash flow from operations, together with other available sources of liquidity,
including borrowings under the Revolving Credit Facility, will be adequate for
the foreseeable future to make scheduled payments of principal and interest
under the New Credit Agreement and interest payments on the Senior Notes, to
permit anticipated capital expenditures and to fund working capital
requirements. However, the ability of the Company to satisfy these obligations
depends on a number of significant assumptions, including, among other things,
that (i) demand for the Company's polymers and styrene products will continue at
historical levels and demand for the Company's plastic film products will
continue to grow at historical rates, (ii) the Company will be able to recover
any long-term raw material cost increases through higher selling prices, (iii)
the Company will be able to obtain supplies of key raw materials and retain key
material suppliers and key customers, and (iv) the Company will succeed in
implementing its business strategy. If Rexene is unable to generate sufficient
cash flow to service its indebtedness, it will have to adopt one or more
alternatives, such as reducing or delaying planned capital expenditures, selling
assets, restructuring or refinancing its indebtedness or seeking additional
equity capital. There can be no assurance that any of these strategies could be
effected on satisfactory terms, if at all, particularly in light of the
Company's high levels of indebtedness, the pledge of substantially all of its
assets as security for the New Credit Agreement and the restrictive covenants in
the New Credit Agreement and the Indenture.
In the event that Rexene is unable to generate sufficient cash flow and is
otherwise unable to obtain funds necessary to meet required payments of
principal, premium, if any, and interest on its indebtedness, Rexene would be in
default under the terms of the agreements governing such indebtedness, including
the Indenture and the New Credit Agreement. In the event of such default, the
holders of such indebtedness could elect to declare all of the funds borrowed
thereunder to be due and payable together with accrued and unpaid interest, and
the lenders under the New Credit Agreement could elect to terminate their
commitments thereunder, which could result in the Company being forced to seek
protection under applicable bankruptcy laws or in an involuntary bankruptcy
proceeding being brought against the Company. Under such circumstances, the
holders of the Senior Notes would be adversely affected. See "-- Secured
Indebtedness," "Use of Proceeds," "Description of New Credit Agreement" and
"Description of Senior Notes."
RANKING OF THE SENIOR NOTES
The Senior Notes will be unsecured obligations of the Company ranking PARI
PASSU in right of payment with all other senior indebtedness of Rexene, and will
be senior in right of payment to all existing and future subordinated
indebtedness of Rexene. However, the Senior Notes will be effectively
subordinated to secured indebtedness of the Company, including borrowings under
the New Credit Agreement, to the extent of the
11
<PAGE>
value of the assets securing such indebtedness. In the event of the dissolution,
liquidation or reorganization of, or similar proceedings relating to, Rexene,
secured lenders would be entitled to receive payment at least equal to the value
of their collateral, which could exceed the amount recoverable by unsecured
creditors, including the holders of the Senior Notes. At June 30, 1994, on a pro
forma basis after giving effect to the Recapitalization, Rexene would have had
outstanding $100 million of secured indebtedness, all of which would have been
outstanding pursuant to the New Credit Agreement. See "Use of Proceeds,"
"Capitalization," "Description of New Credit Agreement" and "Description of
Senior Notes."
HISTORY OF NET LOSSES
Excluding the effect of an extraordinary gain in 1992, the Company has
experienced net losses in each of the past three fiscal years. Such net losses
were in part due to the interest expense arising from the substantial
indebtedness incurred by the Company in 1989 to fund a special dividend
aggregating approximately $216 million and the payment of approximately $105
million in settlement, including expenses, of certain litigation arising from
the acquisition of Old Rexene by an investor group in 1988. The Company's
interest expense was substantially reduced as a result of the Reorganization and
will be further reduced as a result of the Recapitalization. There can be no
assurance, however, that the Company will not incur net losses in the future.
See "Pro Forma Unaudited Condensed Consolidated Financial Data" and
"Management's Discussion and Analysis of Financial Condition and Results of
Operations".
COMPETITION
The industries in which the Company operates are highly competitive. Many of
the Company's competitors, particularly in the petrochemical industry, are
larger and have substantially greater financial resources than the Company.
Among the Company's competitors are some of the world's largest chemical
companies and major integrated petroleum companies that have their own raw
material resources. In addition, a significant portion of the Company's business
is based upon widely available technology. The entrance of new competitors into
the industry and the addition by existing competitors of additional capacity may
reduce the Company's ability to maintain profit margins in circumstances where
overcapacity develops in the industry or preserve market share in circumstances
where oversupply develops in the industry. Any of these developments would have
a negative impact on the Company's ability to obtain higher profit margins
during periods of increased demand. See "-- Industry Cyclicality."
DEPENDENCE ON MANUFACTURING FACILITY
All of the Company's olefins, polymers and styrene are manufactured at the
Odessa Facility. Any significant interruption of operations at the olefins plant
at the Odessa Facility could disrupt or eliminate the supply of ethylene and
propylene to other operations at the Odessa Facility, which could have a
material and adverse effect on the Company's business. See "Business --
Properties."
ENVIRONMENTAL CONSIDERATIONS
The Company and its operations are subject to extensive federal, state,
local and foreign environmental laws, rules, regulations and ordinances relating
to pollution, the protection of the environment or the release or disposal of
materials ("Environmental Laws") and are also subject to other federal, state,
local and foreign laws and regulations regarding health and safety matters. The
operation of any chemical manufacturing plant and the distribution of chemical
products entail risks under Environmental Laws, many of which provide for
substantial fines and criminal sanctions for violations, and there can be no
assurance that material costs or liabilities will not be incurred. In addition,
future developments, such as increasingly strict requirements of environmental
and health and safety laws and regulations and enforcement policies thereunder,
could bring into question the handling, manufacture, use, emission or disposal
of substances or pollutants at the Company's facilities or the manufacture, use
or disposal of certain products made from styrene or plastic resins. Potentially
significant expenditures could be required in order to comply with evolving
Environmental Laws that may be adopted or imposed in the future. To meet
changing licensing and regulatory standards, the Company may be required to make
additional significant site or operational modifications, potentially involving
substantial expenditures and reduction or suspension of certain operations. See
"Management's Discussion and Analysis of Financial Condition and Results of
Operations -- Liquidity and Capital Resources."
12
<PAGE>
The Company's operating expenditures for environmental remediation and waste
disposal were approximately $6.4 million in 1993 and are expected to be
approximately $6.0 million in 1994. In 1993, the Company also expended
approximately $5.1 million relating to environmental capital expenditures. In
1994, the Company expects to spend approximately $3.2 million for
environmentally-related capital expenditures, which is lower than historical
levels due to timing of expenditures pertaining to several projects. Thereafter
for the foreseeable future, the Company expects to incur approximately $4.0 to
$5.0 million per year in capital spending to address the requirements of
Environmental Laws. Annual amounts could vary depending on a variety of factors,
such as the control measures or remedial technologies ultimately required and
the time allowed to meet such requirements. See "Management's Discussion and
Analysis of Financial Condition and Results of Operations -- Liquidity and
Capital Resources" and "Business -- Environmental and Related Regulation."
LEGAL MATTERS
The Company is the defendant in a number of pending lawsuits. Although there
can be no assurance of the final resolution of any of these matters, the Company
believes that it has meritorious defenses to the various claims made and intends
to defend each suit vigorously. If, however, any of these litigation matters is
adversely resolved, it could have a material adverse effect on the Company's
financial position or results of operations. See "Business -- Litigation."
LACK OF A PUBLIC MARKET FOR THE SENIOR NOTES
The Senior Notes are a new issue of securities, have no established trading
market and may not be widely distributed. Rexene does not intend to have the
Senior Notes listed for trading on any securities exchange or to seek their
admission to trading in any automated quotation system. If the Senior Notes are
traded after their initial issuance, they may trade at a discount from their
initial public offering price depending upon many factors, including among other
things, the Company's results of operations, prevailing interest rates and the
market for similar securities. No assurance can be given that any market for the
Senior Notes will develop, or, if any such market develops, as to the liquidity
of such market. The Company has been informed by Smith Barney Inc. and Wertheim
Schroder & Co. Incorporated that they currently intend to make a market in the
Senior Notes, as permitted by applicable laws and regulations; however, they are
not obligated to make such a market and may discontinue market making at any
time without notice. Accordingly, no assurance can be given as to the liquidity
of, or trading market for, the Senior Notes. See "Underwriting."
13
<PAGE>
THE RECAPITALIZATION
BACKGROUND. Following a period of high industry profitability in the late
1980's, Old Rexene in 1989 paid a special dividend aggregating approximately
$216 million and paid approximately $105 million in settlement, including
expenses, of certain litigation arising from the acquisition of Old Rexene by an
investor group in 1988. The dividend and the settlement payments were financed
through the issuance of approximately $500 million of increasing rate notes due
in July 1992. In 1990, a cyclical downturn in the chemical industry began,
reducing industry prices and resulting in a substantial decline in the Company's
operating results and liquidity. Due to a variety of factors, including the then
near-term unfavorable outlook for business conditions in the chemical industry
and the significant contraction of the market for high-yield debt, Old Rexene
was unable to arrange a refinancing of its outstanding indebtedness.
In response to these conditions and the pending maturity of its notes, Old
Rexene met with certain large institutional investors and discussed a voluntary
plan of reorganization. In October 1991, Old Rexene filed a petition for
reorganization under the federal bankruptcy laws. On September 18, 1992, Old
Rexene emerged from bankruptcy in accordance with a plan of reorganization
providing for the merger of Old Rexene into a wholly owned subsidiary of Old
Rexene to form the Company. As a result of the Reorganization, the Company,
among other things, (i) reduced the principal amount of its long-term debt by
approximately $66 million by replacing $403 million of debt, which was scheduled
to mature in July 1992, with $337 million face amount of the Old Notes, (ii)
reduced its annual cash interest requirements from approximately $74 million to
a minimum amount of approximately $24 million through 1994 and (iii) issued
92.5% of the outstanding shares of Common Stock of Rexene to the holders of the
Old Notes.
RECAPITALIZATION. The Notes Offering is part of the Recapitalization, which
is designed to increase stockholders' equity, reduce indebtedness and interest
expense and improve the strategic, operating and financial flexibility of the
Company. The Company believes that the Recapitalization should better position
the Company to continue to reduce its balance sheet leverage through the use of
cash flow from operations.
The principal elements of the Recapitalization, each of which is contingent
upon the concurrent consummation of the others, are:
(i) the issuance and sale by the Company of $175 million aggregate
principal amount of the Senior Notes pursuant to the Notes Offering;
(ii) the issuance and sale by the Company of 8,000,000 shares of Common
Stock pursuant to the Common Stock Offering (the gross proceeds of
which are estimated to be $114 million based on an assumed offering
price of $14.25 per share, the closing price of the Common Stock on
September 14, 1994);
(iii) the establishment of the New Credit Agreement providing the Company
with the Term Loan of up to $100 million, which will be drawn down at
the closing of the Recapitalization, and the $80 million Revolving
Credit Facility, which is not expected to be drawn down at the closing
of the Recapitalization, pursuant to a commitment letter (the
"Commitment Letter") received from a bank (the "Bank"); and
(iv) the call for the redemption of the Old Senior Notes and the Old
Subordinated Notes and the repayment in full of the outstanding
indebtedness under the Old Credit Agreement.
Contemporaneously with the closing of the Offerings, the Company will
terminate its obligations under the Old Notes and the indentures (the "Old
Indentures") which govern the Old Notes pursuant to the terms thereof by
irrevocably depositing with the trustee under each of the Old Indentures that
amount necessary to redeem the Old Notes. Concurrently with such deposit,
redemption notices will be issued to the trustee under each of the Old
Indentures and to the holders of the Old Notes. These redemption notices will
set the date of redemption at the earliest allowable date, which is 30 days
after such notice.
14
<PAGE>
USE OF PROCEEDS
The net proceeds to the Company from the Notes Offering are estimated to be
approximately $170 million, after deducting underwriting discounts and
commissions and estimated expenses of the Notes Offering. The net proceeds to
the Company from the Common Stock Offering, after deducting underwriting
discounts and commissions and estimated expenses, are estimated (based on an
assumed offering price of $14.25 per share, the closing price of the Common
Stock on September 14, 1994) to be approximately $108 million ($124 million if
the Underwriters' over-allotment option in connection with the Common Stock
Offering is exercised in full).
The net proceeds of the Offerings, together with approximately $100 million
of borrowings under the Term Loan, will be used by the Company to redeem the Old
Notes and to repay in full the outstanding indebtedness under the Old Credit
Agreement. Any excess proceeds will be used by the Company for working capital
purposes. In the event that the gross proceeds from the Offerings are less than
$289 million, the Company may be required to arrange for alternative sources of
cash, which could include additional borrowings under the New Credit Agreement
or utilizing cash on hand, or a combination thereof. At June 30, 1994, the
Company had unrestricted cash on hand of approximately $35.6 million.
Interest rates on the Old Senior Notes and Old Subordinated Notes increase
beginning in 1995 and 1996, respectively. The annual interest rate on the Old
Senior Notes is 9% through November 14, 1995, 12% from November 15, 1995 through
November 14, 1996 and 14% thereafter. The annual interest rate on the Old
Subordinated Notes is 10% through November 14, 1996, 12% from November 15, 1996
to November 14, 1997, and 14% thereafter. For each interest period ending on or
prior to November 15, 1994, the Company may pay up to 90% of the interest due on
the Old Subordinated Notes by delivering additional Old Subordinated Notes in
lieu of cash through a pay-in-kind feature. To date, the Company has issued an
aggregate principal amount of $15.2 million in additional Old Subordinated Notes
in lieu of paying interest. Upon the expiration of the pay-in-kind feature on
November 15, 1994, and absent the completion of the Recapitalization, the
Company's annual cash interest obligations on the Old Subordinated Notes will
increase approximately $9.5 million, commencing with the semi-annual interest
payment due on May 15, 1995. The Company has elected not to exercise the
pay-in-kind feature for its November 15, 1994 interest payment. Interest accrues
on amounts outstanding under the Old Credit Agreement at an annual rate equal to
the lender's prime rate plus 1.5% (9.25% at September 1, 1994).
15
<PAGE>
CAPITALIZATION
The following table sets forth the cash and cash equivalents, the current
portion of long-term debt and the total capitalization of the Company as of June
30, 1994, and as adjusted to give effect to the Recapitalization. See "Use of
Proceeds," "Selected Historical Consolidated Financial Data" and "Pro Forma
Unaudited Condensed Consolidated Financial Data."
<TABLE>
<CAPTION>
JUNE 30, 1994
----------------------------
ACTUAL AS ADJUSTED
------------- -------------
(IN THOUSANDS)
<S> <C> <C>
Cash and cash equivalents............................................................ $ 37,892 $ 44,653
------------- -------------
------------- -------------
Current portion of long-term debt.................................................... $ -- $ 10,000(1)
------------- -------------
------------- -------------
Long-term debt:
Old Credit Agreement............................................................... $ 9,000 $ --
Term Loan.......................................................................... -- 90,000
Old Senior Notes................................................................... 253,000 --
Old Subordinated Notes............................................................. 99,629 --
Senior Notes....................................................................... -- 175,000
Less: unamortized discount......................................................... (63,606)(2) --
------------- -------------
Total long-term debt............................................................. 298,023 265,000
------------- -------------
Stockholders' equity (deficit):
Common stock....................................................................... 105 185
Paid-in capital.................................................................... 26,562 134,147
Accumulated deficit (3)............................................................ (32,432) (63,434)
------------- -------------
Total stockholders' equity (deficit)............................................. (5,765) 70,898
------------- -------------
Total capitalization............................................................. $ 292,258 $ 335,898
------------- -------------
------------- -------------
<FN>
- ------------------------
(1) Represents current portion of the Term Loan.
(2) Represents the unamortized discount on the Old Notes.
(3) The change in accumulated deficit is due to recording the extraordinary
loss of approximately $29.9 million (net of income tax benefits) and other
costs (approximately $1.1 million net of income tax benefits) resulting
from the redemption of the Old Notes. Such losses will be recognized upon
consummation of the Recapitalization.
</TABLE>
16
<PAGE>
SELECTED HISTORICAL CONSOLIDATED FINANCIAL DATA
(IN THOUSANDS, EXCEPT PER SHARE DATA AND RATIOS)
The following table sets forth certain selected historical consolidated
financial data for the Company for the periods indicated. Information should be
read in conjunction with the Company's Consolidated Financial Statements and
Notes thereto included elsewhere in this Prospectus. The historical data
presented below as of June 30, 1993 and June 30, 1994 and for the six months
then ended have been derived from the interim Condensed Consolidated Financial
Statements of the Company as of such dates, and the historical consolidated
financial data presented below for the periods ended December 31, 1989, 1990,
1991, 1992 and 1993, and the nine months ended September 30, 1992, were derived
from the Consolidated Financial Statements of the Company and Old Rexene. The
Company adopted fresh start reporting on September 30, 1992 following
consummation of the Reorganization. As a result, results of operations (other
than net sales and EBITDA) for the periods after September 30, 1992 are not
comparable to results of operations prior to that date.
<TABLE>
<CAPTION>
OLD REXENE
(PREDECESSOR) THE COMPANY
--------------------------------------- ------------------------------------------------
NINE THREE SIX MONTHS
YEAR ENDED MONTHS MONTHS YEAR ENDED ENDED
DECEMBER 31, ENDED ENDED DECEMBER 31, JUNE 30,
---------------------------- SEPT. 30, DECEMBER 31, ------------ ------------------
1989 1990 1991 1992 1992 1993 1993 1994
-------- -------- -------- --------- ------------ ------------ -------- --------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
STATEMENT OF OPERATIONS DATA: (1)
Net sales........................ $608,631 $502,186 $449,728 $316,106 $ 98,854 $429,353 $215,272 $243,216
Gross profit..................... 158,130 133,707 61,671 38,025 12,122 53,744 27,023 43,663
Operating income................. 99,938 81,100 12,028 9,392 1,418 14,504 7,505 23,726
Interest expense (2)............. 61,111 71,732 58,374 -- 12,660 49,834 24,398 25,152
Income (loss) before income taxes
and extraordinary items......... 53,956 18,360 (56,191) (28,840) (10,436) (34,183) (16,248) (838)
Income tax (expense) benefit..... (43,751) (15,655) 13,444 (2,636) 3,908 8,940 4,439 177
Net income (loss) before
extraordinary items............. 10,205 2,705 (42,747) (31,476) (6,528) (25,243) (11,809) (661)
Ratio of earnings to fixed
charges (3)(4).................. -- -- -- --
OTHER DATA:
Depreciation and amortization.... $ 25,381 $ 22,451 $ 23,852 $ 20,062 $ 4,315 $ 17,446 $ 8,560 $ 9,194
Capital expenditures............. 18,596 28,855 33,464 11,136 3,961 17,008 7,062 15,462
EBITDA (5)....................... 125,319 103,551 35,880 29,454 5,733 31,950 16,065 32,920
Ratio of EBITDA to interest
expense (3)(5).................. -- -- -- 1.31x
NET SALES DATA:
Plastic film..................... $108,660 $125,506 $135,923 $104,264 $ 34,140 $147,468 $ 70,276 $ 78,346
Polyethylene (1)................. 169,483 141,795 131,044 90,799 32,250 120,060 64,297 65,544
Polypropylene (1)................ 167,593 83,353 73,625 51,989 13,213 64,459 32,997 37,301
APAO............................. 9,292 10,590 13,001 10,997 2,649 15,084 7,649 10,132
Styrene.......................... 132,140 126,019 80,409 49,392 13,705 61,372 30,736 38,299
Other............................ 21,463 14,923 15,726 8,665 2,897 20,910 9,317 13,594
-------- -------- -------- --------- ------------ ------------ -------- --------
Total........................ $608,631 $502,186 $449,728 $316,106 $ 98,854 $429,353 $215,272 $243,216
-------- -------- -------- --------- ------------ ------------ -------- --------
-------- -------- -------- --------- ------------ ------------ -------- --------
</TABLE>
<TABLE>
<CAPTION>
AT DECEMBER 31,
----------------------------------------------------- AT JUNE 30,
1989 1990 1991 1992 1993 1994
--------- --------- --------- --------- --------- -----------
<S> <C> <C> <C> <C> <C> <C>
BALANCE SHEET DATA:
Cash and cash equivalents (6)....................... $ 61,744 $ 64,294 $ 48,169 $ 34,202 $ 30,535 $ 37,892
Working capital..................................... 119,053 133,051 109,777 104,824 105,110 115,299
Total assets........................................ 555,679 461,152 440,665 423,591 430,036 449,861
Long-term debt (including current portion)
Face amount....................................... 416,000 403,000 -- 340,249 350,342 361,629
Unamortized discount (7).......................... -- -- -- (78,523) (68,578) (63,606)
Net amount........................................ 416,000 403,000 -- 261,726 281,764 298,023
Liabilities subject to compromise................... -- -- 428,297 -- -- --
Other noncurrent liabilities........................ 48,418 51,096 57,410 105,601 111,056 113,486
Stockholders' equity (deficit)...................... (81,376) (55,936) (94,813) 20,106 (5,137) (5,765)
</TABLE>
17
<PAGE>
<TABLE>
<S> <C> <C> <C> <C> <C> <C>
<FN>
- ------------------------------
(1) The financial results of a manufacturing facility in Bayport, Texas, which
the Company sold in February 1990, are included in the statement of
operations data for the years ended December 31, 1989 and 1990. Net sales
and operating income for 1989 were $124.7 million and $4.1 million,
respectively. In addition, the assets and liabilities of this facility are
included in the Balance Sheet Data at December 31, 1989. Net sales and
operating income of the Bayport manufacturing facility for 1990 were $16.3
million and $1.8 million, respectively.
(2) Interest expense on the indebtedness of Old Rexene accrued through October
16, 1991. In addition, interest expense on such indebtedness accrued from
October 16, 1991 to December 31, 1991 in accordance with terms of an
agreement with a noteholders' committee formed as part of the
Reorganization. If the interest expense from October 16, 1991 to December
31, 1991 had been calculated under the term of the indebtedness of Old
Rexene, the interest expense for the year ended December 31, 1991 would
have aggregated $73.8 million. The Amended Plan eliminated post petition
interest requirements through June 30, 1992. Interest expense from July 1,
1992 through September 30, 1992 was not classified as interest expense but
reflected as a reorganization expense. See Note 3 to the Consolidated
Financial Statements. Non-cash interest expense (income) was $10.8 million
for the year ended December 31, 1989, ($4.6 million) for the year ended
December 31, 1990 (due to the reversal of interest previously accrued in
accordance with EITF Issue No. 86-15, "Increasing Rate Debt"), $3.3 million
for the year ended December 31, 1991, zero for the nine months ended
September 30, 1992 (due to the Amended Plan previously noted), $6.4 million
for the three months ended December 31, 1992 and $25.4 million for the year
ended December 31, 1993. Non-cash interest expense for the six months ended
June 30, 1993 and 1994 was $12.3 million and $13.0 million, respectively.
(3) The ratio of earnings to fixed charges and the ratio of EBITDA to interest
expense for the periods prior to September 30, 1992 are not presented
because such information is not comparable to the similar information for
the periods after September 30, 1992, the date of the Company's adoption of
"fresh start" reporting.
(4) For the purposes of determining the ratio of earnings to fixed charges,
earnings consist of income before income taxes, extraordinary items and
fixed charges. Fixed charges consist of interest on indebtedness,
including, if any, the amortization of debt issue costs, accretion of debt
discount, interest expense accrued in accordance with EITF Issue No. 86-15,
"Increasing Rate Debt" (See Note 10 to the Consolidated Financial
Statements) and one-third of rental expense (which is deemed representative
of the interest factor therein). Earnings were insufficient to cover fixed
charges in the periods ended December 31, 1992, December 31, 1993, June 30,
1993 and June 30, 1994 by $10.7 million, $35.4 million, $17.3 million, and
$1.6 million, respectively.
(5) EBITDA means operating income before depreciation and amortization. EBITDA
has been included solely to facilitate consideration of the covenants in
the Indenture that are based, in part, on EBITDA and because the Company
understands that it is used by certain investors as one measure of a
company's historical ability to service its debt. EBITDA is not intended to
represent cash flows for the period nor has it been presented as an
alternative to earnings from operations as an indicator of operating
performance and should not be considered in isolation or as a substitute
for measures of performance prepared in accordance with generally accepted
accounting principles. EBITDA for the periods ended December 31, 1992,
December 31, 1993 and June 30, 1993 were insufficient to cover interest
expense by $6.9 million, $17.9 million and $8.3 million, respectively.
Interest expense for such periods included non-cash interest expense as
described in Note 2 above.
(6) Includes restricted cash of $3.7 million, $2.2 million and $2.3 million at
December 31, 1992, December 31, 1993 and June 30, 1994, respectively.
(7) Represents the unamortized discount on the Old Notes.
</TABLE>
18
<PAGE>
PRO FORMA UNAUDITED CONDENSED CONSOLIDATED FINANCIAL DATA
The following Pro Forma Unaudited Condensed Consolidated Statements of
Operations for the six months ended June 30, 1994 and the year ended December
31, 1993 present pro forma operating results as if the Recapitalization had
occurred as of January 1, 1993. The Pro Forma Unaudited Consolidated Balance
Sheet as of June 30, 1994 gives effect to the Recapitalization as if it had
occurred on that date. The pro forma adjustments are described in the notes
thereto.
The Pro Forma Unaudited Condensed Consolidated Financial Data should be read
in conjunction with the Company's Consolidated Financial Statements and Notes
thereto included elsewhere in this Prospectus. The Pro Forma Unaudited Condensed
Consolidated Financial Data does not purport to represent either future results
or the results that would have occurred if the Recapitalization had occurred on
the dates indicated, nor does it give effect to any matters other than those
described in the notes thereto.
PRO FORMA UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 1993
<TABLE>
<CAPTION>
HISTORICAL ADJUSTMENTS PRO FORMA
---------- ------------- -----------
(IN THOUSANDS, EXCEPT PER SHARE DATA)
<S> <C> <C> <C>
Net sales....................................................................... $ 429,353 $ 429,353
Operating expense............................................................... 414,849 414,849
---------- -----------
Operating income................................................................ 14,504 14,504
Interest expense................................................................ (49,834) $ 21,942(1) (27,892)
Interest income................................................................. 1,392 1,392
Other, net...................................................................... (245) (245)
---------- ------------- -----------
Income (loss) before income taxes............................................... (34,183) 21,942 (12,241)
Income tax (expense) benefit.................................................... 8,940 (8,338)(2) 602
---------- ------------- -----------
Net loss(3)..................................................................... $ (25,243) $ 13,604 $ (11,639)
---------- ------------- -----------
---------- ------------- -----------
</TABLE>
FOR THE SIX MONTHS ENDED JUNE 30, 1994
<TABLE>
<CAPTION>
HISTORICAL ADJUSTMENTS PRO FORMA
---------- ------------- -----------
(IN THOUSANDS, EXCEPT PER SHARE DATA)
<S> <C> <C> <C>
Net sales....................................................................... $ 243,216 $ 243,216
Operating expense............................................................... 219,490 219,490
---------- -----------
Operating income................................................................ 23,726 23,726
Interest expense................................................................ (25,152) $ 11,258(1) (13,894)
Interest income................................................................. 856 856
Other, net...................................................................... (268) (268)
---------- ------------- -----------
Income (loss) before income taxes............................................... (838) 11,258 10,420
Income tax (expense) benefit.................................................... 177 (4,278)(2) (4,101)
---------- ------------- -----------
Net income (loss)(3)............................................................ $ (661) $ 6,980 $ 6,319
---------- ------------- -----------
---------- ------------- -----------
</TABLE>
19
<PAGE>
PRO FORMA UNAUDITED CONSOLIDATED BALANCE SHEET
AS OF JUNE 30, 1994
ASSETS
<TABLE>
<CAPTION>
HISTORICAL ADJUSTMENTS PRO FORMA
---------- -------------- -----------
(IN THOUSANDS)
<S> <C> <C> <C>
Cash and cash equivalents...................................................... $ 37,892 $ 107,665(4) $ 44,653
100,000(5)
175,000(6)
(365,903)(7)
(8,163)(8)
(1,838)(9)
Accounts receivable, net....................................................... 66,386 66,386
Inventories.................................................................... 53,350 53,350
Prepaid expenses and other..................................................... 1,788 1,788
---------- -------------- -----------
Total current assets......................................................... 159,416 6,761 166,177
Property, plant and equipment, net............................................. 251,307 251,307
Reorganization value in excess of amounts allocable to identifiable assets,
net........................................................................... 3,527 3,527
Intangible assets, net......................................................... 3,638 8,163(8) 11,801
Other noncurrent assets........................................................ 31,973 31,973
---------- -------------- -----------
$ 449,861 $ 14,924 $ 464,785
---------- -------------- -----------
---------- -------------- -----------
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current portion of long-term debt.............................................. $ 10,000(5) $ 10,000
Accounts payable............................................................... $ 26,814 26,814
Accrued liabilities............................................................ 6,647 6,647
Accrued interest............................................................... 3,103 (3,103)(7)
Income taxes payable........................................................... 2,783 (2,783)(3)
Employee benefits payable...................................................... 4,770 4,770
---------- -------------- -----------
Total current liabilities.................................................... 44,117 4,114 48,231
Long-term debt................................................................. 298,023 90,000(5) 265,000
175,000(6)
(361,629)(7)
63,606(3)
Other noncurrent liabilities................................................... 70,536 (1,171)(7) 54,404
(14,961)(3)
Deferred income taxes.......................................................... 42,950 (16,000)(3) 26,252
(698)(9)
---------- -------------- -----------
Total liabilities............................................................ 455,626 (61,739) 393,887
Commitments and contingencies.................................................. -- --
Stockholders' equity (deficit)................................................. (5,765) 107,665(4) 70,898
(29,862)(3)
(1,140)(9)
---------- -------------- -----------
$ 449,861 $ 14,924 $ 464,785
---------- -------------- -----------
---------- -------------- -----------
</TABLE>
20
<PAGE>
<TABLE>
<S> <C> <C> <C>
<FN>
NOTES TO PRO FORMA UNAUDITED CONDENSED CONSOLIDATED FINANCIAL DATA
(1) Adjustment to eliminate cash and non-cash interest expense on the Old Notes
and to record (i) interest expense associated with the Senior Notes and
Term Loan, (ii) fees under the New Credit Agreement, and (iii) amortization
of debt issue costs resulting from the Recapitalization, net of pro forma
capitalized interest. Each one half of one percent change in the assumed
interest rates for both the Senior Notes and the Term Loan changes pro
forma annual interest expense by $1.4 million.
(2) Adjustment to reflect the federal and state income tax impact related to
the changes in interest expenses discussed above.
(3) Pro forma net income (loss) does not include the extraordinary loss that
will result from the redemption of the Old Notes. This extraordinary loss
is $29.9 million (net of income tax benefits) if the Recapitalization had
occurred as of June 30, 1994. Such loss has been reflected in the pro forma
stockholders' equity and will be reflected in the Company's historical
income statement in the period during which the Old Notes are redeemed. The
pro forma balance sheet adjustments also reflect the recognition of
unamortized discount on the Old Notes and the reversal of non-cash interest
accrued in accordance with EITF Issue No. 86-15, "Increasing Rate Debt"
resulting from the redemption of the Old Notes and the recording of related
income tax benefits.
(4) Adjustment giving effect to the issuance of 8 million shares of Common
Stock pursuant to the Common Stock Offering at an assumed offering price
per share of $14.25 (the closing price on the New York Stock Exchange on
September 14, 1994), net of estimated issuance costs of $6.3 million.
(5) Adjustment giving effect to the proceeds from the New Credit Agreement.
(6) Adjustment giving effect to the issuance of the Senior Notes.
(7) Adjustment giving effect to the repayment of the Old Notes and related
accrued interest and borrowings under the Old Credit Agreement.
(8) Adjustment to reflect the financing fees related to the New Credit
Agreement and the Senior Notes.
(9) Adjustment to reflect the payment of net interest expense on the Old Notes
during the redemption notice period of 30 days in compliance with the Old
Indentures and payment of the termination fee related to the Old Credit
Agreement. This non-recurring adjustment has not been reflected in pro
forma net income and has been reflected in pro forma stockholders' equity.
</TABLE>
21
<PAGE>
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
OVERVIEW
The polyethylene, polypropylene and styrene markets in which Rexene competes
are cyclical markets that are sensitive to relative changes in supply and
demand, which are in turn affected by general economic conditions. Rexene's
plastic film and APAO businesses are generally less sensitive to the economic
cycles. Historically, the cyclical segments have experienced alternating periods
of tight supply and rising prices and profit margins, followed by periods of
large capacity additions resulting in oversupply and declining prices and profit
margins. Following a significant improvement in domestic economic growth since
the second half of 1993, these markets experienced increased levels of demand
which have resulted in greater capacity utilization and higher domestic and
export prices. According to CMAI, during the first six months of 1994, domestic
demand for LDPE, polypropylene and styrene increased by approximately 9%, 16%
and 5%, respectively, compared to the first six months of 1993. This increase in
demand has enabled the Company and the petrochemical industry in general to
increase selling prices significantly at a time when feedstock costs have either
not increased or only increased modestly compared to end product prices. For
example, from December 1993 to August 1994, the Company increased the average
selling prices of its polyethylene, polypropylene and styrene by 22%, 12% and
37% per pound, respectively. During the same period, prices for the Company's
feedstocks increased 34% for benzene and were relatively stable for ethane and
propane.
Principal raw materials purchased by the Company consist of ethane, propane
(extracted from natural gas liquids), propylene and benzene for the polymer and
styrene businesses and polyethylene resins for the film business. The prices of
feedstocks fluctuate widely based on the prices of natural gas and oil. During
the past four years, feedstocks accounted for between approximately 24% and 32%
of the Company's total cost of sales. As a result, the Company's ability to pass
on increases in raw material costs to customers has a significant impact on
operating results. Current market conditions for the Company's products indicate
that increases in feedstock costs may be passed on to customers, but an adverse
change in market conditions for such products could reduce pricing flexibility,
including the ability to pass on any such increase.
RESULTS OF OPERATIONS
In connection with the Reorganization, the Company adopted as of September
30, 1992, the American Institute of Certified Public Accountants' Statement of
Position No. 90-7, "Financial Reporting by Entities in Reorganization Under the
Bankruptcy Code" (the "Reorganization SOP"). The Company's basis of accounting
for financial reporting purposes changed as a result of adopting the
Reorganization SOP. Specifically, the Reorganization SOP required (i) the
adjustment of the Company's assets and liabilities to reflect a reorganization
value generally approximating the fair value of the Company as a going concern
on an unleveraged basis, (ii) the elimination of its accumulated deficit, and
(iii) adjustments to its capital structure to reflect consummation of the
Amended Plan. Accordingly, the results of operations (other than net sales)
after September 30, 1992 are not comparable to results of operations prior to
such date, and the results of operations for the nine months ended September 30,
1992 and the three months ended December 31, 1992 have not been aggregated.
The Company will record an extraordinary non-cash loss from the redemption
of the Old Notes. Such loss will be recognized in the period during which the
Old Notes are redeemed. See Note 3 of the Notes to the Pro Forma Unaudited
Condensed Consolidated Financial Data appearing elsewhere herein.
22
<PAGE>
SIX MONTHS ENDED JUNE 30, 1994 COMPARED TO SIX MONTHS ENDED JUNE 30, 1993
Results of operations for the six months ended June 30, 1993 and June 30,
1994 are as follows (in thousands):
<TABLE>
<CAPTION>
SIX MONTHS ENDED
JUNE 30,
----------------------
1993 1994
---------- ----------
<S> <C> <C>
Net sales............................................................. $ 215,272 $ 243,216
Operating expenses:
Cost of sales....................................................... 188,249 199,553
Marketing, general and administrative............................... 16,346 16,787
Research and development............................................ 3,172 3,150
---------- ----------
207,767 219,490
---------- ----------
Operating income...................................................... 7,505 23,726
Interest expense...................................................... (24,398) (25,152)
Interest income....................................................... 696 856
Other, net............................................................ (51) (268)
---------- ----------
Loss before income taxes.............................................. (16,248) (838)
Income tax benefit.................................................... 4,439 177
---------- ----------
Net loss.............................................................. $ (11,809) $ (661)
---------- ----------
---------- ----------
</TABLE>
Net sales increased $27.9 million (or 13%) from $215.3 million for the six
months ended June 30, 1993 to $243.2 million for the six months ended June 30,
1994 due to increases in all product lines. Plastic film sales increased $8.1
million (or 11%) in the first six months of 1994 as compared to the first six
months of 1993 principally due to a volume increase of 9.9 million pounds (or
12%) partially offset by a price decrease of 3 cents per pound (or 3%). Styrene
sales increased $7.6 million (or 25%) in the first six months of 1994 as
compared to the first six months of 1993 due to a volume increase of 26.3
million pounds (or 20%) and a price increase of 1 cent per pound (or 5%).
Polypropylene sales increased $4.3 million (or 13%) in the first six months of
1994 as compared to the first six months of 1993 due to a volume increase of 6.1
million pounds (or 8%) and a price increase of 2 cents per pound (or 5%).
Polyethylene sales increased $1.2 million (or 2%) in the first six months of
1994 as compared to the first six months of 1993, principally due to a volume
increase of 13.8 million pounds (or 8%), partially offset by a price decrease of
2 cents per pound (or 6%). APAO sales increased $2.5 million (or 32%) in the
first six months of 1994 as compared to the first six months of 1993,
principally due to a volume increase of 5.4 million pounds (or 37%). Excess
ethylene and propane sales increased $4.3 million (or 29%) in the first six
months of 1994 as compared to the first six months of 1993.
The Company's gross profit percentage increased from 13% for the six months
ended June 30, 1993 to 18% for the same period in 1994. The gross profits in all
product lines increased in the first half of 1994 as compared to the same period
last year principally due to lower raw material prices, manufacturing
efficiencies due to higher production volumes and higher selling prices
discussed above. These increases were partially offset by lower polyethylene
selling prices.
Marketing, general and administrative expenses increased $.4 million (or 3%)
for the first six months of 1994 as compared to the same period in 1993
principally due to higher employee benefits that are related to the Company's
improved operating performance, partially offset by lower marketing and bad debt
expenses. Research and development expenses for the first six months of 1994
remained relatively stable compared to the first six months of 1993.
Due primarily to the factors described above, operating income increased
$16.2 million (or 216%) for the six months ended June 30, 1994 as compared to
the corresponding period in 1993.
23
<PAGE>
The income tax benefit decreased $4.3 million (or 96%) for the first six
months of 1994 as compared to the same period in 1993 due to an increase in
current income taxes payable of $2.2 million and a decrease in deferred tax
benefits of $2.1 million.
Due primarily to the factors discussed above, net loss decreased $11.1
million (or 94%) for the first six months of 1994 as compared to the first six
months of 1993.
1993 COMPARED TO 1992 (PRO FORMA)
As previously discussed, as a result of the Reorganization and the Company's
adoption of "fresh start" accounting principles in connection therewith, the
Company's results of operations (other than net sales) subsequent to September
30, 1992 are not comparable to those of prior periods. Therefore, the following
analysis compares the results for the year ended December 31, 1993 to the pro
forma results for the year ended December 31, 1992. The pro forma information
gives effect to the Reorganization as though it had occurred on September 30,
1991. The adjustments relate primarily to (i) the recording of interest expense
in accordance with the terms of the Old Notes, (ii) the recording of
depreciation of property, plant and equipment in accordance with their restated
values, (iii) the recording of amortization of reorganization value in excess of
amounts allocable to identifiable assets, (iv) the elimination of goodwill
amortization, reorganization items and the extraordinary gain, and (v) the
income tax effects for adjustments (i) through (iv) above.
Results of operations for the year ended December 31, 1993 and the year
ended December 31, 1992 (pro forma) are as follows (in thousands):
<TABLE>
<CAPTION>
YEAR ENDED DECEMBER 31,
------------------------
1992 1993
----------- --------
(PRO FORMA)
<S> <C> <C>
Net sales..................................................... $414,960 $429,353
Operating expenses:
Cost of sales............................................... 360,257 375,609
Marketing, general and administrative....................... 30,629 32,641
Research and development.................................... 6,374 6,599
----------- --------
397,260 414,849
----------- --------
Operating income.............................................. 17,700 14,504
Interest expense.............................................. (49,572) (49,834)
Interest income............................................... 1,377 1,392
Other, net.................................................... (6,818) (245)
----------- --------
Loss before income taxes...................................... (37,313) (34,183)
----------- --------
Income tax benefit............................................ 8,116 8,940
----------- --------
Net loss...................................................... $(29,197) $(25,243)
----------- --------
----------- --------
</TABLE>
Net sales increased $14.4 million (or 3%) for the year ended December 31,
1993 as compared to 1992 principally due to an increase in plastic film sales.
Plastic film sales increased $11.8 million (or 9%) primarily due to a volume
increase of 11.2 million pounds (or 7%) principally due to higher sales to the
disposable diaper market and the blown coextrusion film market. APAO and excess
propane and ethylene sales also contributed to the increase in sales. APAO sales
increased $3.3 million (or 20%) from 1992 to 1993 principally due to an increase
in sales of product purchased from the Ube Rexene Corporation joint venture
located in Japan. Excess ethylene and propane sales increased $5 million due to
changes in the feedstock mix at the olefin plant. These increases were partially
offset by a $3 million (or 2%) decrease in polyethylene sales and a $3.1 million
(or 5%) decrease in styrene sales. Polyethylene and styrene sales declined in
1993 as compared to 1992 primarily as a result of continuous pricing pressure
due to an overcapacity in the industry.
The Company's gross profit percentage remained constant at 13% in 1993 as
compared to 1992. Gross profit for 1993 decreased $1.0 million (or 2%) as
compared to 1992 principally due to a decrease in polyethylene gross profits of
$4.4 million as a result of lower margins, partially offset by lower
environmental
24
<PAGE>
remediation charges in 1993. Gross profit for 1992 reflected a charge to
increase the Company's environmental remediation accrual. Polyethylene margins
for 1993 were lower than 1992 margins principally as a result of higher ethylene
transfer prices and lower selling prices for polyethylene.
Marketing, general and administrative expenses increased $2.0 million (or
7%) from $30.6 million in 1992 to $32.6 million in 1993 principally due to an
increase in marketing and related expenditures incurred to address growth
opportunities for plastic film and APAO. In addition, the increase in 1993 is
due to unusually low expenses in 1992 as a result of changes in estimates of
incentive and benefit plan expenses and lower legal fees for general litigation
resulting from the automatic stay provision of the Bankruptcy Code.
Due primarily to the factors described above, operating income decreased
$3.2 million (or 18%) from $17.7 million in 1992 to $14.5 million in 1993.
Other, net decreased $6.6 million (or 96%) from $6.8 million in 1992 to $.2
million in 1993 principally due to a $7.4 million accrual in 1992 relating to
the adverse judgment (including estimated attorneys' fees) on the Izzarelli
class action lawsuit, partially offset by $1.5 million of business interruption
insurance proceeds received in 1992 for an electrical outage at the Odessa
Facility in May 1991. See "Business -- Litigation."
The 1993 results include an income tax benefit of $8.9 million as compared
to a benefit of $8.1 million for 1992. As a result of adoption of Statement of
Financial Accounting Standards 109, "Accounting for Income Taxes" on September
30, 1992, the income tax benefit for 1993 is not comparable to the income tax
benefit for 1992.
Due primarily to the factors described above, the net loss decreased $4.0
million (or 14%) from $29.2 million in 1992 to $25.2 million in 1993.
1992 COMPARED TO 1991
As previously discussed, as a result of the Reorganization and the Company's
adoption of "fresh start" accounting principles in connection therewith, the
Company's results of operations (other than net sales) subsequent to September
30, 1992 are not comparable to those of prior periods. Therefore, the following
analysis compares the results for the three months ended December 31, 1992 to
the results for the three months ended December 31, 1991 on a pro forma basis as
described in the following sentence, and compares the results for the nine
months ended September 30, 1992 to the nine months ended September 30, 1991. The
pro forma information for the three months ended December 31, 1991 gives effect
to the Reorganization as though it had occurred on September 30, 1991. The
adjustments relate primarily to (i) the recording of interest expense in
accordance with the terms of the Old Notes, (ii) the recording of depreciation
of property, plant and equipment in accordance with their restated values, (iii)
the recording of amortization of reorganization value in excess of amounts
allocable to identifiable assets, and (iv) the income tax effects for
adjustments (i) through (iii) above.
25
<PAGE>
Results of operations for the three months ended December 31, 1992 and the
three months ended December 31, 1991 (pro forma), and the results of operations
for the nine months ended September 30, 1992 and the nine months ended September
30, 1991 are as follows (in thousands):
<TABLE>
<CAPTION>
NINE MONTHS ENDED THREE MONTHS ENDED
SEPTEMBER 30, DECEMBER 31,
-------------------- ----------------------
1991 1992 1991 1992
--------- --------- ----------- ---------
(PRO FORMA)
<S> <C> <C> <C> <C>
Net sales................................... $ 350,902 $ 316,106 $ 98,826 $ 98,854
Operating expenses:
Cost of sales............................. 299,356 278,081 87,523 86,732
Marketing, general and administrative..... 32,446 23,918 10,132 9,045
Research and development.................. 4,546 4,715 1,709 1,659
--------- --------- ----------- ---------
336,348 306,714 99,364 97,436
--------- --------- ----------- ---------
Operating income (loss)..................... 14,554 9,392 (538) 1,418
Interest expense............................ (49,397) -- (12,660) (12,660)
Other, net.................................. 4,402 282 (651) 806
Debt restructuring costs.................... (9,786) -- -- --
Reorganization items........................ -- (38,514) -- --
--------- --------- ----------- ---------
Loss before income taxes and extraordinary
gain....................................... (40,227) (28,840) (13,849) (10,436)
--------- --------- ----------- ---------
Income tax (expense) benefit................ 8,567 (2,636) 3,352 3,908
--------- --------- ----------- ---------
Loss before extraordinary gain.............. (31,660) (31,476) (10,497) (6,528)
Extraordinary gain.......................... -- 123,672 -- --
--------- --------- ----------- ---------
Net income (loss)........................... $ (31,660) $ 92,196 $ (10,497) $ (6,528)
--------- --------- ----------- ---------
--------- --------- ----------- ---------
</TABLE>
THREE MONTHS ENDED DECEMBER 31, 1992 COMPARED TO THREE MONTHS ENDED DECEMBER
31, 1991
(PRO FORMA)
Net sales remained constant for the three months ended December 31, 1992 as
compared to the three months ended December 31, 1991. Polyethylene sales
increased $2.7 million (or 9%) principally due to an increase in average selling
prices of 4 cents per pound (or 12%). The increase in average selling prices was
due to high capacity utilization in the HPLDPE resin industry. The polyethylene
sales increase was offset by a decrease in polypropylene sales of $2.7 million
(or 17%) for the three months ended December 31, 1992 compared to the same
period in 1991 principally due to a decrease in sales volumes of 3.1 million
pounds (or 9%) and a decrease in average selling prices of 4 cents per pound (or
9%). The decreased polypropylene sales volume was primarily due to lower demand
resulting from overall economic conditions and oversupply in the global
polypropylene markets.
The Company's gross profit percentage increased from 11% in the three months
ended December 31, 1991 to 12% in the 1992 period principally due to the 4 cents
per pound polyethylene price increase.
Marketing, general and administrative expenses decreased $1.1 million (or
11%) from $10.1 million for the three months ended December 31, 1991 to $9.0
million for the three months ended December 31, 1992 principally due to cost
reduction and containment efforts.
Due primarily to the factors described above, operating income was $1.4
million for the three months ended December 31, 1992 as compared, on a pro forma
basis, to an operating loss of $.5 million for the corresponding period in 1991.
Other, net increased $1.5 million for the three months ended December 31,
1992 as compared to the same period in 1991 principally because of a
reimbursement from an escrow account established during a merger of the Company
in 1988 of approximately $1.0 million for the net cost, plus interest thereon,
of defending certain lawsuits.
26
<PAGE>
Due primarily to the factors described above, the net loss for the three
months ended December 31, 1992 decreased by $4.0 million (or 38%) to $6.5
million, as compared, on a pro forma basis, to $10.5 million for the
corresponding period in 1991.
NINE MONTHS ENDED SEPTEMBER 30, 1992 COMPARED TO NINE MONTHS ENDED SEPTEMBER
30, 1991
Net sales decreased $34.8 million (or 10%) from $350.9 million for the nine
months ended September 30, 1991 to $316.1 million for the nine months ended
September 30, 1992 principally due to lower styrene, polyethylene and
polypropylene sales. Styrene sales decreased $16.1 million (or 25%) in the first
nine months of 1992 as compared to the first nine months of 1991 due to a volume
decrease of 20.3 million pounds (or 9%) and a price decrease of 4.9 cents per
pound (or 17%). The decrease in styrene volumes was primarily due to lower plant
utilization rates which were implemented to minimize operating losses and to
focus on key customers. Polyethylene sales decreased $10.6 million (or 10%) in
the first nine months of 1992 as compared to the first nine months of 1991 due
to a volume decrease of 22.1 million pounds (or 8%) and a price decrease of 1.0
cent per pound (or 3%). The polyethylene volume decrease was primarily due to
lower demand resulting from sluggish economic conditions during the early part
of the year. Polypropylene sales decreased $5.5 million (or 10%) in the first
nine months of 1992 as compared to the first nine months of 1991 due to a price
decrease of 2.1 cents per pound (or 5%) and a volume decrease of 6.5 million
pounds (or 5%). The decrease in polypropylene volumes was due to a variety of
factors including lower plant utilization rates and overall economic conditions.
Plastic film sales for the first nine months of 1992 remained relatively stable
as compared to the comparable period in 1991.
The Company's gross profit percentage decreased from 15% for the nine months
ended September 30, 1991 to 12% for the same period in 1992 principally due to
the lower average selling prices discussed above and due to an increase to the
Company's environmental remediation accrual.
Marketing, general and administrative expenses decreased $8.5 million (or
26%) from $32.4 million for the nine months ended September 30, 1991 to $23.9
million for the nine months ended September 30, 1992 principally due to cost
containment efforts and lower legal fees for general litigation because of the
automatic stay provision of the federal bankruptcy laws. (Also see professional
fees associated with the Reorganization discussed below). Due primarily to the
factors described above, operating income for the nine months ended September
30, 1992 decreased $5.2 million (or 35%) to $9.4 million, as compared to $14.6
million for the corresponding period in 1991.
Interest expense on the senior and subordinated notes of Old Rexene was
accrued through October 18, 1991. In addition, interest expense was accrued from
October 18, 1991 to December 31, 1991 in accordance with an agreement in
principle between the Company and the holders of senior and subordinated notes
of Old Rexene prior to the approval of the Amended Plan. The Amended Plan
eliminated postpetition interest requirements through June 30, 1992. Therefore,
postpetition interest of $6.8 million accrued as of December 31, 1991 was
reversed in the first quarter of 1992 and is included in other, net on the
condensed consolidated statement of operations for the nine months ended
September 30, 1992. Interest expense from July 1, 1992 through September 30,
1992 is included in reorganization items.
Other, net for the nine months ended September 30, 1992, includes a $7.4
million accrual relating to the adverse judgment (including estimated attorneys'
fees) on the Izzarelli class action lawsuit, partially offset by the reversal of
postpetition interest of $6.8 million accrued as of December 31, 1991 discussed
above, and $1.5 million of business interruption insurance proceeds received for
an electrical outage at the Odessa Facility in May 1991. See "Business --
Litigation."
The Reorganization items for the nine months ended September 30, 1992 are
described in Note 3 to the Consolidated Financial Statements. In the first nine
months of 1992, the Company incurred $12.6 million of professional fees
associated with the Reorganization. In the first nine months of 1991, the
Company incurred $9.8 million of debt restructuring costs.
The Company recorded income tax expense of $2.6 million on a loss before
income taxes of $28.8 million for the nine months ended September 30, 1992.
There are permanent differences between the Company's income for financial
reporting purposes and tax purposes resulting principally from the lower tax
basis
27
<PAGE>
for assets purchased when the Company was sold in 1988. These permanent
differences cause the effective income tax rate to be higher than the statutory
income tax rate for federal and state income taxes with the effective rate being
greater in periods of lower taxable income.
In the third quarter of 1992, the Company recorded an extraordinary gain of
$123.7 million as a result of exchanging the senior and subordinated notes of
Old Rexene for the Old Notes and Common Stock under the Amended Plan.
Due primarily to the factors described above, the Company had net income of
$92.2 million for the nine months ended September 30, 1992 (or a net loss before
extraordinary gain of $31.5 million) compared to a net loss of $31.7 million for
the corresponding period in 1991.
LIQUIDITY AND CAPITAL RESOURCES
During the six months ended June 30, 1994, net cash provided by operating
activities was $15.8 million, compared with $4.3 million of net cash used for
operating activities during the comparable period in 1993. Net cash provided by
operating activities for the six months ended June 30, 1994 increased
principally due to higher operating income and $5.5 million of federal income
tax refunds, partially offset by the effect of increased accounts receivable
resulting principally from higher sales volumes.
The New Credit Agreement provides for up to $100 million of term loans and
up to $80 million of revolving credit loans for working capital and for letters
of credit. The Company will be required to repay a portion of its borrowings
under the Term Loan each year, commencing in 1995, so as to retire such
indebtedness in its entirety by November 1999. Availability of borrowings under
the Revolving Credit Facility will be based upon a formula related to inventory
and accounts receivable and is contingent upon the receipt by the Company of
gross proceeds from the Common Stock Offering of at least $85 million and of
aggregate gross proceeds from the Offerings of at least $275 million. See
"Description of New Credit Agreement."
After the Recapitalization, the Company will have substantial principal
repayment obligations. The Company will be required to repay a portion of its
borrowings under the Term Loan each year, commencing in 1995, so as to retire
such indebtedness in its entirety by November 1999. The Senior Notes will mature
on , 2004. The Company believes that following the consummation of
the Offerings, based on current levels of operations and anticipated growth, its
cash flow from operations, together with other available sources of liquidity,
including borrowings under the Revolving Credit Facility, will be adequate for
the foreseeable future to make scheduled payments of principal and interest
under the New Credit Agreement and interest payments on the Senior Notes, to
permit anticipated capital expenditures and to fund working capital
requirements. However, the ability of the Company to satisfy these obligations
depends on a number of significant assumptions regarding the demand for the
Company's products, raw material costs and other factors. See "Investment
Considerations -- High Leverage and Substantial Debt Service Requirements."
The Indenture and the New Credit Agreement will contain covenants which,
among other things, restrict the ability of the Company to incur additional
indebtedness, create or permit liens, effect certain asset sales and engage in
certain mergers or similar transactions. The New Credit Agreement is also
expected to contain covenants which require the Company to meet certain
financial ratios and tests. These covenants could limit the Company's ability to
obtain additional financing and engage in certain corporate activities.
Continued compliance with such covenants will depend upon a variety of factors,
including general economic conditions and other factors beyond the control of
the Company. See "Investment Considerations," "Description of New Credit
Agreement" and "Description of Senior Notes."
During 1992 and 1993, the Company expended approximately $15.1 and $17.0
million, respectively, for capital expenditures. For 1994, the Company has
budgeted $31.0 million for capital expenditures, of which $19.0 million had been
spent through August 1994. For 1995, the Company has budgeted approximately
$30.0 million for proposed capital expenditures. In addition, the Company is
exploring a number of possible product development opportunities which would
require additional capital expenditures. For example, the Company has announced
the development of a new polyolefin polymer, REXFLEX-TM- FPO. The Company is
28
<PAGE>
currently producing experimental quantities of this product in a small-scale
pilot plant at the Odessa Facility and is in the process of developing process
technology for a commercial plant. At this time, however, no budgeting decision
has been made regarding this or other similar projects.
A number of potential environmental liabilities exist which relate to
contaminated property. In addition, a number of potential environmental costs
relate to pending or proposed environmental regulations. No assurance can be
given that all of the potential liabilities arising out of the Company's present
or past operations have been identified or that the amounts that might be
required to remediate such sites or comply with pending or proposed
environmental regulations can be accurately estimated; however, on the basis of
reasonable investigation and analysis, management believes that the
approximately $23.3 million accrued in the June 30, 1994 balance sheet is
adequate for the total potential environmental liability of the Company with
respect to contaminated sites. If, however, additional liabilities with respect
to environmental contamination are identified, there is no assurance that
additional amounts that might be required to remediate such potential sites
would not have a material adverse effect on the financial condition of the
Company. In addition, future regulatory developments could restrict or possibly
prohibit existing methods of environmental compliance, such as the disposal of
waste water in deep injection wells. At this time, the Company is unable to
determine the potential consequences such possible future regulatory
developments would have on its financial condition. Management continually
reviews on an on-going basis its estimates of potential environmental
liabilities. The Company does not currently carry environmental impairment
liability insurance to protect it against such contingencies because such
coverage is available only at great cost and with broad exclusions. As part of
its financial assurance requirements under the Resource Conservation and
Recovery Act ("RCRA") and equivalent Texas law, the Company has deposited $10.6
million in trust to cover closure and post-closure costs and liability for
bodily injury and certain types of property damage arising from sudden and
non-sudden accidental occurrences at certain of the Odessa Facility's hazardous
waste management units. This deposit is included in other noncurrent assets in
the June 30, 1994 balance sheet. This amount deposited in trust does not cover
the costs of addressing existing contamination at the Odessa Facility.
The Company's operating expenditures for environmental remediation and waste
disposal were approximately $6.4 million in 1993 and are expected to be
approximately $6.0 million in 1994. In 1993 the Company also expended
approximately $5.1 million relating to environmental capital expenditures. In
1994, the Company expects to spend approximately $3.2 million for
environmentally-related capital expenditures, which is lower than historical
levels due to timing of expenditures pertaining to several projects. Thereafter
for the foreseeable future, the Company expects to incur approximately $4.0 to
$5.0 million per year in capital spending to address the requirements of
Environmental Laws. Annual amounts could vary depending on a variety of factors,
such as the control measures or remedial technologies ultimately required and
the time allowed to meet such requirements.
29
<PAGE>
BUSINESS
INDUSTRY
The polyethylene, polypropylene and styrene markets in which Rexene competes
are cyclical markets that are sensitive to relative changes in supply and
demand, which are in turn affected by general economic conditions. Rexene's
plastic film and APAO businesses are generally less sensitive to economic
cycles. Historically, the cyclical segments have experienced alternating periods
of tight supply and rising prices and profit margins, followed by periods of
large capacity additions resulting in oversupply and declining prices and profit
margins. In the early 1980's, overcapacity in the polyethylene and polypropylene
markets and weakened demand for styrene due to general economic conditions led
to poor operating results for the Company and the industry in general. In the
mid 1980's, construction of new production facilities slowed and increases in
production capacities due to technology improvements moderated. At the same
time, domestic demand grew significantly as a result of a stronger U.S. economy
and export sales strengthened due in part to a weaker U.S. dollar. As a result,
during fiscal years 1987 to 1989, the industry experienced increased levels of
demand for its products which resulted in near full capacity utilization rates,
higher domestic and export prices and record earnings. Feedstock prices were
also favorable during this period. In response to this rapid increase in demand
and profits, the U.S. LDPE, polypropylene and styrene industries increased total
rated annual production capacity by approximately 22%, 31% and 34%,
respectively, from 1988 to 1993. During the period 1990 to 1993, the rate in
U.S. demand slowed as a result of the general economic conditions, and
significant production capacity was added in some of the traditional export
markets in the Far East. As a consequence, the industry, including the Company,
experienced during this period an overcapacity condition that resulted in a
decline in utilization rates and substantially lower average selling prices and
margins.
Following a significant improvement in domestic economic growth since the
second half of 1993, these markets experienced increased levels of demand which
have resulted in greater capacity utilization and higher domestic and export
prices. According to CMAI, during the first six months of 1994, domestic demand
for LDPE, polypropylene and styrene increased by approximately 9%, 16% and 5%,
respectively, compared to the first six months of 1993. This increase in demand
has enabled the Company and the petrochemical industry in general to increase
selling prices significantly at a time when feedstock costs have either not
increased or only increased modestly compared to end product prices. For
example, from December 1993 to August 1994, the Company increased the average
selling prices on its polyethylene, polypropylene and styrene by 22%, 12% and
37% per pound, respectively. During the same period, prices for the Company's
feedstocks increased 34% for benzene and were relatively stable for ethane and
propane.
POLYMERS
POLYETHYLENE. The chart below details the average domestic selling prices
(for liner grade HPLDPE) and capacity utilization rates for the U.S. LDPE
industry during the period 1981 through September 30, 1994. Utilization rates
are derived by dividing production by total rated annual production capacity.
LDPE utilization rates are used because HPLDPE industry utilization rate data
are unavailable.
30
<PAGE>
EDGAR REPRESENTATION OF DATA POINTS USED IN PRINTED GRAPHIC
<TABLE>
<CAPTION>
Opr Rate Domestic
<S> <C> <C>
1981 81.0 36.4
1982 77.4 28.0
1983 88.1 34.4
1984 87.3 35.6
1985 88.2 29.4
1986 86.8 29.8
1987 91.8 33.6
1988 92.5 48.3
1989 79.2 44.3
1990 83.8 40.3
1991 81.9 33.2
1992 85.4 32.1
1993 88.1 30.7
I Q 94 92.00 28.00
II Q 94 93.50 32.33
III Q 94 e 91.20 36.00
IV Q 94 e 91.40 40.33
</TABLE>
Source: CMAI
Industry utilization rates based on LDPE
Price cents/pound based on HPLDPE
1994 third quarter estimated by CMAI
Polyethylene is the largest volume polymer in the world and is consumed in a
wide variety of consumer and industrial applications. In 1993, according to
CMAI, the total U.S. demand (including exports) for LDPE was approximately 13.2
billion pounds, consisting of 7.4 billion pounds of high pressure low density
polyethylene ("HPLDPE") and 5.8 billion pounds of linear low density
polyethylene ("LLDPE"). LDPE can be extruded or molded alone or with other
resins and additives into a wide variety of industrial and consumer products,
including film products (e.g., food packaging and pallet stretch wrap, coatings,
bags, grocery sacks, toys and bottles). Although both types of LDPE are used to
make the foregoing types of products, LLDPE has some physical properties,
including film strength, that make it more suitable for some uses (e.g., trash
bags and stretch wrap) than HPLDPE. In contrast, HPLDPE is easier to extrude and
has the advantage of higher clarity. Rexene currently only participates in the
HPLDPE segment. According to the Society of the Plastics Industry, Inc. ("SPI"),
an industry trade association, total U.S. consumption of LDPE grew at an average
annual rate of approximately 4.3% from 1988 to 1993.
According to CMAI, in 1993 the U.S. LDPE market was comprised of 15
producers, with a total rated annual production capacity for HPLDPE of
approximately 8.1 billion pounds and an annual production capacity dedicated
exclusively for the production of LLDPE of approximately 5.6 billion pounds.
According to CMAI, the LDPE industry operated at a utilization rate of
approximately 88.1% in 1993. With LDPE demand projected to grow by approximately
7.6% in 1994 over the previous year, CMAI estimates the overall LDPE industry's
utilization rate will increase to approximately 92% in 1994, with both the
HPLDPE and LLDPE industries operating at a rate of approximately 92%. The LDPE
industry is projected by CMAI to have a utilization rate of approximately 92%
during 1995.
31
<PAGE>
POLYPROPYLENE. The chart below details the average selling prices (general
purpose, injection molding homopolymer grade) and capacity utilization rates for
the U.S. polypropylene industry during 1981 through September 30, 1994.
Utilization rates are derived by dividing production by total rated annual
production capacity.
EDGAR REPRESENTATION OF DATA POINTS USED IN PRINTED GRAPHIC
<TABLE>
<CAPTION>
Opr Rate Domestic
<S> <C> <C>
1981 82.6 37.8
1982 71.5 36.8
1983 87.6 35.1
1984 92.7 37.9
1985 91.4 34.8
1986 96.9 32.5
1987 96.5 40.3
1988 97.6 49.1
1989 87.5 42.3
1990 91.9 35.6
1991 88.6 34.5
1992 86.3 31.5
1993 88.4 26.7
I Q 94 93.80 27.00
II Q 94 92.30 30.17
III Q 94 e 92.20 33.00
IV Q 94 e 91.20 36.00
</TABLE>
Source: CMAI
1994 third quarter estimated by CMAI
Polypropylene is by volume sales one of the fastest growing major polymers.
According to CMAI, demand (including exports) for this polymer was approximately
9.1 billion pounds in 1993. Polypropylene is consumed in a variety of
applications, including automotive, appliance, housing, packaging, consumer
products, medical and electrical/electronic. According to CMAI, domestic
consumption of polypropylene grew at an average annual rate of approximately
6.7% from 1988 to 1993.
According to CMAI, in 1993 the U.S. polypropylene market consisted of 17
producers with a total rated annual production capacity of approximately 9.8
billion pounds. CMAI estimated the industry operating rate to have been
approximately 88% in 1993. With industry capacity expected to increase by
approximately 550 million pounds in 1994 and total demand (net of an
approximately 16% decline in export sales) expected to grow by approximately
8.4%, CMAI estimates the industry's utilization rate will be approximately 92%
during 1994. Since no material change in annual production capacity has been
announced for 1995, CMAI estimates that a 4.8% growth in total domestic demand
should result in an increase in the industry's utilization rate to 96% in 1995.
In addition, an additional 770 million pounds of capacity increases have been
announced for 1996.
AMORPHOUS POLYALPHAOLEFINS (APAO). APAO is used in a variety of
applications including adhesives, sealants, roofing materials, paper lamination
and wire and cable applications. While no definitive volume figures are
available for this industry, Rexene's management estimates the total U.S market
(including
32
<PAGE>
exports and imports) demand for APAO and atactic polypropylene ("APP") was
approximately 150 million pounds in 1993. In addition to the APAO supplied by
Rexene and one other producer in the U.S., customers also obtain a portion of
their needs from the supply of APP. APP is produced as a by-product material in
polypropylene processes that use a standard catalyst. The supply of the
by-product APP is declining as the remaining U.S. and global polypropylene
producers shift their production to more economical high activity catalyst
systems that produce little by-product APP.
STYRENE
The chart below details the average selling prices and capacity utilization
rates for the U.S. styrene industry during the period 1981 through September 30,
1994. Utilization rates are derived by dividing production by total rated annual
production capacity.
EDGAR REPRESENTATION OF DATA POINTS USED IN PRINTED GRAPHIC
<TABLE>
<CAPTION>
Opr Rate Domestic
<S> <C> <C>
1981 81.5 35.7
1982 72.2 29.3
1983 83.0 29.7
1984 88.9 29.1
1985 91.7 24.5
1986 94.6 18.5
1987 96.5 35.0
1988 98.9 45.1
1989 97.6 40.8
1990 87.4 38.8
1991 89.3 28.7
1992 87.6 24.7
1993 87.4 24.3
I Q 94 94.20 24.40
II Q 94 101.50 29.10
III Q 94 e 98.60 34.50
IV Q 94 e 86.30 40.00
</TABLE>
Source: CMAI
1994 third quarter estimated by CMAI
Styrene is a basic petrochemical used in a variety of applications,
including packaging, housing, automotive and appliances. In 1993, U.S. demand
(including exports) totaled approximately 10.9 billion pounds. According to
CMAI, domestic consumption of styrene grew at an average annual rate of 1.3%
from 1988 to 1993. Following the record results in 1988, demand for styrene in
the U.S. declined each year through 1991 due primarily to sluggish economic
growth and environmental concerns related to the use of polystyrene, its largest
volume derivative. According to CMAI, growth in domestic demand has improved
since 1992 with increases of approximately 8.7% and 5.4% in 1992 and 1993,
respectively. CMAI estimates that domestic demand will increase by approximately
4.2% in 1994.
In 1993, the U.S. styrene market consisted of 10 producers with total annual
rated production capacity of approximately 11.6 billion pounds. According to
CMAI, the industry operated at a utilization rate of
33
<PAGE>
approximately 87.4% in 1993. The U.S. supply is currently supplemented by
approximately 600 million pounds of imports, primarily from Canada. Based on the
estimated growth in styrene demand, CMAI estimates that domestic operating rates
for the industry will be approximately 95% in 1994.
PLASTIC FILM
The U.S. polyethylene film industry is highly fragmented, with over 450
producers ranging from a few large national producers such as CT Film to many
small, regional producers. Polyethylene films are used for a variety of
packaging and non-packaging applications for consumer and industrial uses,
including trash bags, carry-out/retail bags, food and non-food packaging,
personal care, medical uses, agricultural and horticultural uses, greenhouse,
construction uses, stretch films for industrial uses and shrink films for
consumer and industrial packaging.
According to SPI, on the basis of polyethylene resins sold into the film
market, the size of the U.S. market was estimated to be approximately 8 billion
pounds in 1993. According to SPI, domestic demand for polyethylene films has
grown at an average annual rate of approximately 5.6% from 1988 to 1993.
BUSINESS STRATEGY
The Company's operating strategy to market value added specialty products
and to improve its operating costs is designed to allow it to compete
effectively against larger competitors in both periods of rising and declining
prices. The Company believes that its operating strategy will enable it to take
advantage of improved market conditions in a strong economy and to lessen the
impact of depressed pricing and demand in market downturns.
The following factors are central to the Company's operating strategy:
- MAINTAIN CUSTOMER DRIVEN FOCUS TO PROVIDE VALUE ADDED SPECIALTY PRODUCTS
AND QUALITY SERVICE: The Company seeks to be the premier provider of
specialty polymers, tailored with tight performance specifications and
high quality standards to the customer's specific applications. The
Company believes that this focus distinguishes it from larger competitors,
many of which focus primarily on customers that require large quantity,
commodity grade products where competition is based primarily on price.
The Company believes that its focus on the production of higher-margin,
specialty polymers will enable the Company to maintain premium pricing
relative to commodity grades of these products and preserve market share
during periods of oversupply in the industry.
- FOCUS ON NICHE MARKETS WHICH OPTIMIZE USE OF THE ODESSA FACILITY: The
Odessa Facility has smaller polymer reactors than many of its competitors
and the Company believes, therefore, that it is in a better position than
such competitors to respond efficiently and with greater flexibility to
customer requirements for specially tailored, high quality products in
small lot sizes. The Company currently produces over 300 different grades
of polymers, and is one of only two domestic producers of a super clean
grade of polypropylene utilized for medical applications and one of only
two domestic on-purpose producers of APAO. Because of their added value,
the Company's specialty polymers are generally priced as performance
resins, thus yielding profit margins for Rexene generally higher than
those that it otherwise would realize from the sale of commodity grade
products.
- CONTINUE TO DEVELOP PLASTIC FILM BUSINESS: CT Film sales increased from
approximately $109 million in 1989 to approximately $147 million in 1993,
an increase of approximately 35%. During the same period, the Company
increased its total rated annual film production capacity from
approximately 160 million pounds to approximately 225 million pounds. In
September 1994 the Company commenced operation of a new film production
plant with an annual rated production capacity of 20 million pounds in
Scunthorpe, England. The Company intends to continue to grow its plastic
film business through increased capacity utilization and, when
appropriate, capacity expansions and selected acquisitions. The Company
believes that such growth may reduce its sensitivity to the commodity
chemical cycle, because demand and profit margins in the plastic film
markets in which Rexene competes tend to be relatively stable.
34
<PAGE>
- DEVELOP NEW PRODUCTS AND APPLICATIONS THROUGH TECHNOLOGICAL INNOVATION:
The Company continually seeks to enhance and expand its portfolio of
specialty polymers through sustained in-house research and development and
licensing arrangements. For example, APAO, a special purpose polymer used
primarily in roofing materials and adhesives, was developed by the Company
in 1986. This polymer was developed principally to replace APP, a
by-product of polypropylene manufacturing, with an on-purpose higher
quality polymer. The Company's latest product development is a new
polyolefin polymer, REXFLEX-TM- FPO. The Company believes that FPO has the
potential for use in a wide variety of applications, including in
automotive components, containers for personal care products and medical
devices. The Company is currently producing FPO in a pilot plant at the
Odessa Facility and is currently developing the process technology for a
commercial plant. See "New Product Development."
- CONTINUE TO IMPROVE OPERATING EFFICIENCIES: The Company's operating
strategy includes making selective capital expenditures designed to
modernize and upgrade its facilities, reduce its production costs and
enable it to continue to produce technologically advanced products. For
example, the Company has recently approved capital expenditures of
approximately $4 million to upgrade portions of the olefins plant at the
Odessa Facility, which should lower unit costs for olefin production. In
addition, the Company has begun a program to selectively modernize and
upgrade both cast and blown equipment at its plastic film production
facilities to improve capacity.
- CONTINUE TO REINVEST IN CORE BUSINESSES AND REDUCE BALANCE SHEET LEVERAGE:
The polyethylene, polypropylene and styrene markets in which Rexene
competes are highly cyclical. The market is currently experiencing a
period of price escalation; industry capacity utilization rates are
increasing and firming while demand continues to grow. Recent price
increases announced by major domestic polymer and styrene producers,
including the Company, have made it likely that average prices will
continue at or above current levels during 1994 and 1995. The Company's
strategy is to take advantage of periods of market upturns by using cash
flow generated during these periods to make capital expenditures and other
reinvestments in its businesses and to continue to reduce the balance
sheet leverage of the Company. In addition, the Company intends to grow
its polymer and plastic film businesses, internally and through selected
strategic acquisitions and joint ventures.
PRINCIPAL PRODUCTS
Plastic film, polyethylene, polypropylene, APAO and styrene are used by the
Company's customers in different industrial processes to manufacture many
diverse finished goods. Examples of these processes and principal end market
products are set forth below:
<TABLE>
<CAPTION>
PRODUCT INDUSTRIAL PROCESS PRINCIPAL END MARKET PRODUCTS
- ---------------- ------------------------------------ ---------------------------------------------------------
<S> <C> <C>
Plastic film Lamination and other processes Disposable diapers, feminine hygiene products, medical
products, tapes, packaging, lamination and unsupported
overwraps and greenhouse and agricultural applications
Polyethylene Extrusion, injection or blow molding CT Film division, food packaging, industrial packaging,
medical bottles, produce films, laminated structures and
paper coatings
Polypropylene Extrusion, injection, thermoforming Capacitor film, electronic packaging, sterile medical
or blow molding products, automotive durables, eye care products, rigid
food containers, housewares and furniture
APAO Extrusion or blending Adhesives, sealants, roofing materials, paper lamination
and wire and cable applications
Styrene Through various intermediate Disposable cups and trays, luggage, housewares, toys and
products building products
</TABLE>
35
<PAGE>
The following chart presents the net sales, excluding intercompany sales,
contributed by the Company's products during the periods indicated:
<TABLE>
<CAPTION>
YEAR ENDED SIX MONTHS
DECEMBER 31, % OF ENDED JUNE % OF
1993 NET SALES 30, 1994 NET SALES
------------ ----------- ----------- -----------
<S> <C> <C> <C> <C>
Plastic film................................................. $ 147,468 34.3 $ 78,346 32.2
Polyethylene................................................. 120,060 28.0 65,544 27.0
Polypropylene................................................ 64,459 15.0 37,301 15.3
APAO......................................................... 15,084 3.5 10,132 4.2
Styrene...................................................... 61,372 14.3 38,299 15.7
Other........................................................ 20,910 4.9 13,594 5.6
------------ ----- ----------- -----
Total........................................................ $ 429,353 100.0 $ 243,216 100.0
------------ ----- ----------- -----
------------ ----- ----------- -----
</TABLE>
Except for one customer that accounted for approximately 9% and 10% of net
sales for the year ended December 31, 1993 and the six months ended June 30,
1994, respectively, no customer accounted for more than 4% of the Company's
consolidated net sales for the year ended December 31, 1993 or the six months
ended June 30, 1994.
PLASTIC FILM
THE PRODUCT
The Company, through CT Film, is a major participant in the specialty market
for polyethylene films. Product applications for these films include disposable
diapers, feminine hygiene products, tapes, packaging, lamination and unsupported
overwraps and greenhouse and agricultural applications. CT Film's products are
manufactured principally with its own proprietary processes.
CT Film develops specialty formulations of films to meet customer
specifications for various highly specific and value added applications.
Examples include a recycle film containing a minimum of 25% recycled materials,
low gel film developed for photo-resistant applications, MAXILENE-R- lamination
film and thin gauge barrier film for feminine hygiene products and medical
applications. CT Film produces films for coextruded forming webs, linear tear
films, and elastomeric films for surgical products. The Company currently
manufactures over 1,500 different plastic film products.
MARKETING
Domestically, CT Film ships film from its plants in Chippewa Falls,
Wisconsin; Clearfield, Utah; Dalton, Georgia; and Harrington, Delaware. The
Company sold plastic film to over 450 customers in 1993, of which approximately
180 have been customers of CT Film for more than the past five years. The
Company's customers include a number of Fortune 500 companies. Products are sold
primarily through the Company's plastic film sales staff, which, as of September
14, 1994, consisted of 29 persons, supported by 50 technical service personnel
(including research and development personnel) dedicated to plastic film.
COMPETITION
CT Film's domestic plants have a total rated annual production capacity of
approximately 225 million pounds. CT Film's principal competitors include
Tredegar Industries, Exxon Chemical Americas, Clopay Corporation, Blessings
Company, Deerfield Plastics Company, Inc., DuPont of Canada, and James River
Corporation. The plastic film business is based on custom formulations to meet
customer needs. Competition is based on the quality and properties of the film
as well as price. CT Film seeks to develop innovative products to meet customer
needs and seeks to compete by segmenting market niches and being responsive to
customers' specific requirements.
EUROPEAN OPERATIONS
In 1993, the Company formed a wholly-owned subsidiary in England, Rexene
Corporation Limited ("RCL"), to produce plastic film principally for European
customers. In 1993, RCL signed a long-term supply agreement with Kimberly-Clark
Limited ("KCL") to supply plastic film backsheet to KCL. Film
36
<PAGE>
backsheet is used in the production of disposable diapers and training pants.
RCL will be an Unrestricted Subsidiary for purposes of, and as defined in, the
Indenture and, accordingly, will not be subject to the restrictive covenants
contained therein. See "Description of Senior Notes."
RCL recently completed construction of a manufacturing facility in
Scunthorpe, England which will supply KCL and other potential customers in
Europe. The plant commenced operations in September 1994 and has an annual rated
production capacity of 20 million pounds.
POLYETHYLENE
THE PRODUCT
The majority of polyethylene produced in the United States is LDPE resin. In
1993, approximately 59% of LDPE capacity in the United States was used to make
HPLDPE and the balance to make LLDPE. The Company currently only participates in
the HPLDPE market.
The Company currently produces over 200 different grades of HPLDPE. Many of
these grades are combined with other polymers to meet specific customer
requirements. Examples of the Company's differentiated resins are ethylene-vinyl
acetate (EVA) resins used in film applications that require high clarity,
toughness and sealability, and specialty low-gel resins used in computer circuit
board production. The Company focuses on producing high performance, specially
tailored resins designed to meet the customer's specific requirements.
MARKETING
The Company participates in every principal market for HPLDPE, selling its
HPLDPE resins under the REXENE-R- name. Prime grade products are sold
domestically directly to customers primarily through the Company's sales and
technical service staffs. Most wide specification products are sold to dealers
for resale. Export sales are made through international trading companies or
agents. Approximately 61% of the Company's polyethylene sales during the six
months ended June 30, 1994 were made to customers (other than CT Film) who have
been customers of the Company for more than the past five years. Approximately
14% of the Company's polyethylene production in 1993 was shipped to CT Film. As
of September 14, 1994, the Company's sales staff for its polyethylene,
polypropylene and APAO products consisted of 37 persons, supported by 90
technical service personnel (including research and development personnel)
dedicated to such products.
COMPETITION
There are currently 15 domestic producers of LDPE, some of which produce
both HPLDPE and LLDPE. The largest manufacturer of LDPE is Quantum Chemical
Corporation. The other five largest domestic producers of LDPE include Dow
Chemical U.S.A., Union Carbide Corporation, Chevron Chemical Company, Exxon
Chemical Company and Mobil Chemical Company. In 1993, Rexene accounted for
approximately 3% of the U.S. capacity for LDPE and approximately 5% of the U.S.
capacity for HPLDPE. Competition for sales is generally based on price for less
specialized products and on price, product performance and customer service for
more specialized products. The Company seeks to compete with larger polyethylene
producers by providing a high level of customer service and developing resins
which are responsive to customers' specific requirements.
POLYPROPYLENE
THE PRODUCT
The Company currently produces over 100 different grades of polypropylene
resins, including several types of general purpose polypropylene for industrial
use and a variety of more differentiated types of polypropylene which have
properties or characteristics specifically tailored for special uses. The
Company emphasizes the manufacturing of polypropylene resins for specialty
segments of the polypropylene market such as medical, electrical and food
packaging applications. The Company is one of only two domestic producers of a
super clean grade of polypropylene utilized for medical applications, and is a
key supplier of this grade for electrical capacitor film uses. The Company's
line of impact copolymer polypropylene products is used primarily for automotive
components and rigid packaging. Other products include radiation
37
<PAGE>
resistant resins for medical applications requiring radiation sterilization,
capacitor resins for premium electrical grade film, and premium copolymer
blow-molding resins for medical and food applications. The Company has been
active in making technology improvements in process and catalyst technology and
works closely with customers in developing new products to meet their specific
needs.
MARKETING
The Company sells its polypropylene products under the REXENE-R- name.
Domestic and Canadian sales of products are sold primarily through the Company's
sales and technical service staffs. Most wide-specification products are sold to
brokers for resale. Export sales are made directly and through trading
companies. Approximately 64% of the Company's polypropylene sales during the six
months ended June 30, 1994 were made to customers who have been customers of the
Company for more than the past five years. As of September 14, 1994, the
Company's sales staff and technical services staff for its polyethylene,
polypropylene and APAO products consisted of 37 and 90 persons, respectively.
COMPETITION
In 1993, there were 17 domestic producers of polypropylene, with an
estimated combined rated annual production capacity of approximately 9.8 billion
pounds. In 1993, the four largest domestic producers of polypropylene were
Himont Incorporated, Amoco Chemicals Corporation, Fina, Inc. and Exxon Chemical
Company. Competition for sales is dependent upon a variety of factors, including
product price, technical support and customer service, the degree of
specialization of various grades of polypropylene and the extent to which
substitute materials such as wood, glass, metals and other plastics are
available on a cost-effective basis. General purpose polypropylene ordinarily
competes principally on the basis of price, while more differentiated
polypropylene competes principally on the basis of product quality, performance
specifications and price. In 1993, Rexene accounted for approximately 2% of U.S.
production capacity for polypropylene. The Odessa Facility has a total rated
annual production capacity for polypropylene of approximately 180 million
pounds. The Company seeks to compete effectively with larger competitors by
focusing on specialty products responsive to customers' specific requirements.
APAO
THE PRODUCT
The Company is one of only two U.S. on-purpose producers of APAO. APAO is
used primarily in the production of adhesives, sealants, roofing materials,
paper lamination and wire and cable applications.
MARKETING
The Company sells APAO under the REXTAC-R- name. APAO is sold domestically
through the Company's sales and technical service staffs. The Company
supplements its sales of APAO with purchases from Ube Rexene Corporation
("URC"), a joint venture company located in Japan in which the Company holds a
50% equity interest. In 1993, purchases from URC were approximately 4.3 million
pounds. The Company expects to purchase similar quantities from URC in 1994.
COMPETITION
The Company and Eastman Chemical Company are currently the only domestic
on-purpose producers of APAO. In addition, a few producers of polypropylene also
produce APP, which competes with APAO for some less performance driven uses.
Based on management estimates, in 1993 Rexene accounted for approximately 30% of
the United States capacity for APAO and APP. The Company has a total rated
annual production capacity of approximately 45 million pounds per year. The
Company seeks to compete by providing a high level of customer service and
developing products which are responsive to customers' specific requirements.
STYRENE
THE PRODUCT
Styrene is a petrochemical commodity with a variety of applications. Styrene
is made from ethylene and benzene and is principally used in the manufacture of
intermediate products such as polystyrene, latex, acrylonitrile butadiene
styrene (ABS) resins, synthetic rubbers and unsaturated polyester resins.
Through these products, styrene can be found in consumer products, including
disposable cups and trays, luggage, housewares, toys and building products such
as roof insulation, pipes and fittings.
38
<PAGE>
MARKETING
The Company sells the vast majority of its styrene directly to a small
number of domestic customers under year to year contracts, and handles export
sales through international trading companies.
COMPETITION
The total rated annual production capacity of the Odessa Facility for
styrene is approximately 320 million pounds, which, in 1993, represented
approximately 3% of the total rated domestic production capacity for styrene
during such period. The six largest domestic producers of styrene are Arco
Chemical Company, Huntsman Chemicals Corporation, Amoco Chemicals Corporation,
Sterling Chemicals, Inc., Dow Chemical U.S.A. and Chevron Chemical Company.
Competition for sales of styrene is generally based on price.
EXPORT SALES
The Company had total export sales in 1993 of approximately $30.5 million,
or 7.1% of the Company's total sales. During the first six months of 1994, the
Company had total export sales of approximately $22.6 million, or 9.3% of the
Company's total sales. The export sales percentage increased during the six
months ended June 30, 1994 principally due to exports of plastic film to KCL,
pending start-up of the Company's plant in Scunthorpe, England. The Company is
decreasing its emphasis on this market to reduce the effect of wide price
fluctuations in periods of tight demand and industry overcapacity. See Note 15
of the Notes to the Consolidated Financial Statements included elsewhere herein.
NEW PRODUCT DEVELOPMENT
The Company continually seeks to enhance and expand its portfolio of
specialty polymers through sustained in-house research and development and
licensing arrangements. For example, in 1993 the Company developed a new
polyolefin polymer, REXFLEX-TM- FPO. The Company believes that FPO has the
potential for use in a wide variety of applications, including in automotive
components, containers for personal care products and medical devices. The
Company is currently producing experimental quantities of FPO in a small-scale
pilot plant at the Odessa Facility and is developing the process technology for
a commercial plant. Commercial production of FPO is subject to the successful
development of such technology, the completion of a commercial plant and
necessary governmental approvals.
RAW MATERIALS FOR PRINCIPAL PRODUCTS
Principal raw materials purchased by the Company consist of ethane, propane
(extracted from natural gas liquids), propylene and benzene for the polymer and
styrene businesses and polyethylene resins for the film business. The prices of
feedstocks fluctuate widely based upon the prices of natural gas and oil. During
the past four years, feedstocks accounted for between approximately 24% and 32%
of the Company's total cost of sales. As a result, the Company's ability to pass
on increases in raw material costs to customers has a significant impact on
operating results. Current market conditions for the Company's products indicate
that increases in feedstock costs may be passed on to customers, but an adverse
change in market conditions for such products could reduce pricing flexibility,
including the ability to pass on any such increase.
The Odessa Facility obtains a combination of pure and mixed streams of
natural gas liquids from NGL pipelines and NGL extraction plants located in West
Texas and uses such streams to obtain ethane and propane feedstocks for the
Company's olefins plant. In 1993, the Company consumed approximately 526 million
pounds of ethane and 422 million pounds of propane, and during the first two
quarters of 1994, the Odessa Facility consumed ethane and propane at an annual
rate of 563 million and 462 million pounds, respectively. In 1993 and the first
two quarters of 1994, the Company produced all of its ethylene and 54% of its
propylene requirements for the Odessa Facility. The Company's feedstock supplies
are currently adequate for its requirements. The Company has storage capacity
for an approximately ten-day supply of feedstocks.
The Odessa Facility uses benzene and ethylene to produce styrene. In 1993,
approximately 62% of the Company's benzene purchases were under contracts from
Gulf Coast producers and approximately 16% was purchased from Midwest producers
at prevailing contract prices, with the balance of its needs being filled with
purchases on the spot market. The Odessa Facility has historically served as its
own source of ethylene.
39
<PAGE>
The principal feedstocks for the Company's captive ethylene and propylene
production of the Odessa facility are ethane and propane. Ethane and propane
prices are established in Mont Belvieu, Texas (Gulf Coast) according to
prevailing market conditions, but the Company is able to purchase natural gas
liquids containing ethane and propane in West Texas at prices discounted from
the prevailing reported average Mont Belvieu, Texas prices. These discounts
reflect a significant portion of the cost for the producers to transport natural
gas liquids containing ethane and propane to Mont Belvieu, Texas and to
fractionate them into pure ethane and propane. In 1993, the Company acquired all
of the Odessa Facility's requirements for ethane and propane under such
arrangements.
CT Film raw materials consist principally of polyethylene resins and
additives. CT Film obtains its raw materials from a variety of sources
(including the Odessa Facility) and has been able to order these materials in
advance as its needs dictate. CT Film has adequate storage capabilities for its
raw materials.
EMPLOYEES AND LABOR RELATIONS
As of September 14, 1994, the Company employed domestically approximately
1,280 persons and utilized approximately 120 contract workers. Approximately 520
(in addition to the contract workers) are employed at the Odessa Facility in the
development and production of olefins, polyethylene, polypropylene, APAO and
styrene. In addition, approximately 90 employees at the Odessa Facility are
involved in various technical support activities to the manufacturing
operations. Also, approximately 40 employees located in Odessa, Dallas and field
sales locations are involved in sales, marketing and distribution of the
Company's products. Approximately 580 people are employed by CT Film, including
520 who are directly involved in the manufacture of plastic film products at
various manufacturing locations in the U.S. Approximately 80 people are employed
by CT Film in sales, marketing, engineering and technical support positions.
Also, approximately 80 people are employed in various corporate staff positions
in Dallas, which support all business activities of the Company. In addition,
the Company employs approximately 30 people at its Scunthorpe, England facility.
None of the Company's employees are unionized, except for approximately 120
employees at the CT Film facility in Chippewa Falls, Wisconsin. The Company and
the union are parties to a collective bargaining agreement through February 28,
1997. The Company believes its relationship with its employees is satisfactory.
TRADEMARKS AND PATENTS
The Company is the owner of many United States and foreign patents and uses
trade secrets, including substantial know-how, which relate to its polyethylene,
polypropylene, APAO and plastic film products. The Company has spent over $6
million for research and development during each of the last three fiscal years
and anticipates spending a similar amount in 1994. Although patents and trade
secrets are important to the Company, permitting it to retain ownership and use
of its technological advances, the Company does not believe that the loss of any
patent would have a material adverse effect on its financial condition. The
Company also uses the technology of others under license agreements in certain
of its manufacturing operations.
REXENE-R- and REXTAC-R- are important trademarks for the Company's resins
and are widely known among purchasers of these products. The Company is the
owner of other trademarks used on or in connection with its products.
The Company has been sued by Phillips Petroleum Company in two separate
proceedings for alleged infringement of its crystalline and block copolymer
polypropylene patents. The Company believes that, based upon its current
knowledge of the facts of each case, the Company has meritorious defenses to the
claims made and intends to defend each lawsuit vigorously. See "-- Litigation."
PROPERTIES
The Company manufactures its polymers and petrochemicals at the Odessa
Facility. The Odessa Facility is located on an approximately 875-acre site in
West Texas which contains plants producing polyethylene, polypropylene, APAO and
styrene, as well as ethylene and propylene primarily for captive use. The
40
<PAGE>
Odessa Facility is located near four NGL pipelines from which it derives its
supply. CT Film has five manufacturing facilities for the production of blown
and cast plastic film, located in Chippewa Falls, Wisconsin; Clearfield, Utah;
Dalton, Georgia; Harrington, Delaware and Scunthorpe, England.
The polyethylene plant in Odessa, Texas has been in operation since 1961 and
has a total rated annual production capacity of approximately 405 million
pounds. The plant is capable of producing a wide range of products including
film, injection molding, extrusion coating and blow molding resins, such as
ethylene homopolymers and ethylene vinyl acetate copolymers.
The polypropylene plant in Odessa, Texas has been in operation since 1964
and has a total rated annual production capacity of approximately 180 million
pounds. APAO is produced in a former polypropylene plant that was converted in
1986 and has a total rated annual production capacity, including expansions in
1994, of approximately 45 million pounds.
The styrene plant in Odessa, Texas has been in operation since 1958 and has
a total rated annual production capacity of approximately 320 million pounds.
The olefins plant at the Odessa Facility has been in operation since 1961
and has a total rated annual production capacity for ethylene of approximately
540 million pounds and for propylene of approximately 210 million pounds.
CT Film's Chippewa Falls plant began operations in 1948 and contains 24
production lines. The total rated annual production capacity is approximately 76
million pounds.
The Clearfield plant began operations in 1991 and contains seven production
lines. The total rated annual production capacity is approximately 44 million
pounds.
The Dalton plant began operations in 1966 and contains eleven production
lines. In addition there are three printing presses, five slitter rewinders and
six bag machines in the converting area. The total rated annual production
capacity is approximately 38 million pounds.
The Harrington plant began operations in 1972 and contains 12 production
lines. The total rated annual production capacity is approximately 67 million
pounds.
In September 1994, CT Film commenced operations at a 62,000 square foot film
production plant in Scunthorpe, England. The plant includes one production line
with a total rated annual production capacity of approximately 20 million
pounds.
The Company's executive offices are located in Dallas, Texas in leased
office space aggregating approximately 45,500 square feet. Additionally, the
Company owns an off-site warehouse in Odessa, Texas and parcels of land held for
sale in the La Porte and Pasadena industrial districts near Houston, Texas.
ENVIRONMENTAL AND RELATED REGULATION
GENERAL
The Company (and the industry in which it competes) is subject to extensive
environmental laws and regulations and is also subject to other federal, state
and local laws and regulations regarding health and safety matters. The Company
believes that its business, operations and facilities generally have been and
are being operated in compliance in all material respects with applicable
environmental and health and safety laws and regulations, many of which provide
for substantial fines, criminal sanctions, and in certain extreme circumstances,
temporary or permanent plant closures for violations. Nevertheless, from time to
time the Company has received notices of alleged violations of certain
environmental laws, and has endeavored promptly to remedy such alleged
violations. The ongoing operations of chemical manufacturing plants entail risks
in these areas and there can be no assurance that material costs or liabilities
will not be incurred in the future. Further, existing groundwater and/or soil
contamination at the Odessa Facility may require remediation that could involve
significant expenditures.
In addition, future developments, such as increasingly strict requirements
of environmental and health and safety laws and regulations and enforcement
policies thereunder could bring into question the handling,
41
<PAGE>
manufacture, use, emission or disposal of substances or pollutants at the
Company's facilities. Changes to or reinterpretations of existing laws could
materially and adversely affect the Company's business and results of
operations.
The Company's operating expenditures for environmental remediation and waste
disposal were approximately $6.4 million in 1993 and are expected to be
approximately $6.0 million in 1994. In 1993 the Company also expended
approximately $5.1 million relating to environmental capital expenditures. In
1994, the Company expects to spend approximately $3.2 million for environmental
related capital expenditures, which is lower than historical levels due to
timing of expenditures pertaining to several projects. Thereafter for the
foreseeable future, the Company expects to incur approximately $4.0 to $5.0
million per year in capital spending to address the requirements of
environmental laws. Annual amounts could vary depending on a variety of factors,
such as the control measures or remedial technologies ultimately required and
the time allowed to meet such requirements.
The Company believes that, in light of its historical expenditures and
expected future results of operations, it will have adequate resources to
conduct its operations in compliance with currently applicable environmental and
health and safety laws and regulations. However, in order to comply with
changing licensing and regulatory standards, the Company may be required to make
additional significant site or operational modifications that are not currently
contemplated. Further, the Company has incurred and may in the future incur
liability to clean up waste or contamination at its current or former
facilities, or which it may have disposed of at facilities operated by third
parties. The Company recorded $23.3 million as an estimate at June 30, 1994 of
its total potential environmental liability with respect to remediating known
site contamination. However no assurance can be given that all potential
liabilities arising out of the Company's present or past operations have been
identified or that the amounts that might be required to remediate such
conditions will not be significant to the Company. The Company continually
reviews its estimates of potential environmental liabilities. The Company does
not currently carry environmental impairment liability insurance to protect it
against such contingencies because the Company has found such coverage available
only at great cost and with broad exclusions.
WASTEWATER
The Company currently disposes of wastewater from the Odessa Facility
through injection wells operated under permits from the Texas Natural Resource
Conservation Commission ("TNRCC"). These permits expired in 1990, but the
Company has been working with TNRCC since before their expiration to develop
renewal permits. TNRCC has indicated that it intends to renew the Company's
current injection well permits for an additional three years, but it has stated
that it does not intend to renew the permits again after the expiration of the
proposed three-year renewal period. Further, TNRCC may order the Company to
cease using one or more of the wells if certain periodic testing results
indicate that continued injection cannot be conducted safely. TNRCC has also
granted the Company a permit to drill and operate a new deeper well to provide
for wastewater disposal. Company consultants have estimated the cost of
installing a new deep well injection system at $5.7 million, but the Company has
not elected to drill such a well unless and until its other alternatives become
unavailable. The Company, with neighboring industrial facilities, has begun
investigating the possibility of entering into an agreement with a
quasi-governmental authority to acquire, modify and operate a publicly-owned
wastewater treatment plant (the "South Dixie Plant") to dispose of industrial
waste water. Although no assurances can be given, the Company believes that it
will be able to use its existing wells until it develops a satisfactory
alternative waste water disposal system. If the Company is forced to cease using
such injection wells before an alternative system is developed or the
anticipated renewal permits do not provide for sufficient wastewater disposal
capacity, there could be a material adverse effect on the Company's financial
condition and results of operations.
SOLID WASTES
In March 1994, TNRCC granted the Company a permit to operate three of its
hazardous waste management units at the Odessa Facility as
treatment/storage/disposal facilities under RCRA. This permit includes a
compliance plan requiring the Company to take corrective action with regard to
existing contamination at the Odessa Facility. Pursuant to this compliance plan,
the Company must complete an investigation
42
<PAGE>
into the extent of onsite contamination, conduct a risk assessment to determine
the level of risk it presents to human health and the environment, develop a
corrective measures study on the ways to remediate the contamination, and
implement a remediation plan approved by TNRCC. During the investigations of
contamination at the Odessa Facility, the Company discovered, and reported to
TNRCC, the presence of low levels of contaminants in an intermittently-flowing
stream adjacent to the Odessa Facility. The Company is continuing its
investigations as to the source, extent and effect of contaminants in this
stream.
Based upon the results of its investigations of onsite contamination, the
Company does not believe that implementation of a corrective action plan will
have a material adverse effect on its financial condition. However, no assurance
can be given that all conditions any corrective action plan may be required to
address have been identified, or that the amounts that might be required to
implement that plan will not be significant to the Company.
AIR EMISSIONS
In 1990, Congress amended the federal Clean Air Act, as amended (the "Clean
Air Act"), to require control of certain emissions not previously regulated,
some of which are emitted by the Company's facilities. This legislation will
require the Company (and others in the industry with such emissions) to
implement certain pollution control measures in addition to those currently
used. The Company cannot determine the full impact of such legislation on its
operations until all the implementing regulations are adopted, and can give no
assurance at this time that the costs it may incur to comply with those
regulations will not be significant.
The Company operates its styrene plant under an air permit that was first
issued in 1979. The permit has been amended several times, and it currently
covers both the styrene plant and the styrene loading facilities. During the
current renewal process, two parties requested a public hearing on the permit.
One of the requesting parties is the law firm representing the plaintiffs in the
Odessa Residents Tort Litigation. See "Litigation -- Odessa Residents' Tort
Litigation." If a public hearing is allowed by TNRCC, the process would probably
take from six to thirteen months to complete. During the pendency of the public
hearing process, the Company would continue to operate under its existing
permit. While there can be no assurance, the Company expects TNRCC to renew its
styrene air permit, although the renewal permit may contain additional modeling
or monitoring requirements.
ADDITIONAL ENVIRONMENTAL ISSUES
The Federal Comprehensive Environmental Response Compensation and Liability
Act, as amended ("CERCLA"), and similar laws in many states, impose liability
for the clean-up of certain waste sites and for related natural resource
damages, without regard to fault or the legality of the waste disposal. Liable
persons generally include the site owner or operator, former site owners, and
persons that disposed or arranged for the disposal of hazardous substances found
at those sites. The Company has sent wastes from its operations to various
third-party waste disposal sites. From time to time the Company receives notices
from representatives of governmental agencies and private parties contending
that the Company is potentially liable for a portion of the remediation at such
third-party and formerly-owned sites. Although there can be no assurance, the
Company does not believe that its liabilities for remediation of such sites,
either individually or in the aggregate, will have a material adverse effect on
the Company.
The Odessa Facility is located near the South Dixie Plant owned by the City
of Odessa ("Odessa"). Odessa is implementing a plan to expand a second water
treatment plant and abandon the South Dixie Plant. Odessa has alleged that the
Company has contributed to groundwater contamination at the South Dixie Plant.
If Odessa's allegations are correct, then the Company could be liable for some
or all of the remediation at the site. Although there can be no assurance, the
Company does not believe that any such costs will have a material adverse effect
on the Company.
LITIGATION
BANKRUPTCY
On October 18, 1991, and pursuant to an agreement in principle detailing the
terms for Old Rexene's recapitalization, Old Rexene and its wholly-owned
subsidiaries, Rexene Products Company ("Products")
43
<PAGE>
and Poly-Pac, Inc., filed voluntary petitions for reorganization under Chapter
11 of the United States Bankruptcy Code in the United States Bankruptcy Court
for the District of Delaware (the "Bankruptcy Court"), case numbers 91-1058,
91-1057 and 91-1059, respectively. Pursuant to an Order Providing for Joint
Administration entered by the Bankruptcy Court on October 21, 1991, the Old
Rexene and Poly-Pac, Inc. cases were consolidated with the Products case for
administrative purposes only. On July 7, 1992, the Bankruptcy Court entered an
order confirming the Amended Plan, which, among other things, provided for the
merger of Old Rexene with and into Products to form the Company (the "1992
Merger"). Thereafter, all conditions to the effectiveness of the 1992 Merger and
the Amended Plan were either satisfied or waived. The 1992 Merger and the
Amended Plan were then consummated on September 11, 1992 and September 18, 1992
(the "Effective Date"), respectively. Substantially all distributions
contemplated by the Amended Plan have been made. Certain matters, including the
Izzarelli Class (as defined below) claims, remain pending before the Bankruptcy
Court.
STOCKHOLDER CLASS ACTION LITIGATION
In January 1990, a purported class action was filed in the United States
District Court, Northern District of Texas, by an alleged stockholder of Old
Rexene on behalf of purchasers of Old Rexene common stock between October 23,
1989 and December 27, 1989. The defendants in this action presently include
Rexene, one of its current directors and certain of its former directors. The
class has been certified with an intervenor as the class representative. The
intervenor's complaint asserts claims under Rule 10b-5 under the Securities
Exchange Act of 1934, and state common law grounds. The plaintiff alleges that
public statements made by certain directors of Old Rexene created a misleading
impression of Old Rexene's financial condition thereby artificially inflating
the price of the common stock of Old Rexene. The plaintiff seeks compensatory
damages, prejudgment interest, a recovery of costs and attorneys' fees, and such
other relief as may be deemed just and proper. Discovery is ongoing.
In Old Rexene's Chapter 11 bankruptcy proceeding, the intervening plaintiff
filed a proof of claim on behalf of herself and the purported class seeking in
excess of $10 million based upon the allegations in the litigation. The Company
objected to the claim and elected to leave the legal, equitable and contractual
rights of the plaintiff unaltered, thereby allowing this litigation to proceed
as of the Effective Date without regard to the bankruptcy proceeding.
IZZARELLI STOCK BONUS PLAN CLASS ACTION LITIGATION
In February 1991, a class action lawsuit was filed in the United States
District Court for the Western District of Texas-Midland Division against the
Company, the El Paso Products Company Stock Bonus Plan (the "Stock Bonus Plan")
and Texas Commerce Bank -- Odessa (the former trustee for the Stock Bonus Plan)
by two former participants in the Stock Bonus Plan on behalf of the 1986
participants in the Stock Bonus Plan (the "Izzarelli Class"). The complaint
alleged that the Company amended the Stock Bonus Plan in 1987 and 1988 to
deprive the Izzarelli Class of benefits to which they would have been entitled
had the Stock Bonus Plan not been amended. The Izzarelli Class asserts claims
under the Employee Retirement Income Security Act of 1974, as amended ("ERISA"),
for alleged breach of fiduciary duties to the participants and for alleged
violation of ERISA's provision prohibiting amendments to the Stock Bonus Plan
after benefits had accrued to participants. The plaintiffs seek actual damages,
attorneys' fees, costs and expenses, prejudgment interest and such further
relief as may be deemed appropriate. After a trial, the trial court in July 1992
entered a judgment against the Company in the amount of $6.6 million (as
subsequently amended) plus court costs. In November 1992, the trial court
awarded the Izzarelli Class $595,000 for attorneys' fees and out-of-pocket
expenses. The Company has recorded an accrual of $7.4 million to reflect this
judgment.
The Company appealed the judgment to the United States Court of Appeals for
the Fifth Circuit. The Izzarelli Class also filed an appeal with respect to the
amount of damages awarded and the judgment in favor of Texas Commerce Bank --
Odessa. On June 22, 1994, the appeals court reversed the trial court and held
that Rexene did not violate ERISA or any fiduciary duty in amending the Stock
Bonus Plan. It also affirmed the trial court's judgment that the trustee was not
liable to the plaintiffs. On August 11, 1994, the appeals court refused the
plaintiffs' request that it reconsider its decision.
44
<PAGE>
In Old Rexene's Chapter 11 bankruptcy proceeding, the Izzarelli Class filed
proofs of claim for $27.7 million. The Izzarelli Class has pending before the
Bankruptcy Court a motion to alter or amend the Confirmation Order and a motion
to allow their claim based upon the judgment entered by the trial court. The
Bankruptcy Court has deferred ruling on these motions until resolution of all
appeals arising from the trial court's judgment.
Pursuant to an agreement in December 1992 regarding the distribution of the
remaining balance in an escrow account established in connection with a 1988
merger involving the Company, $2 million is being retained in the escrow account
which will be available to the Company to pay up to 50% of any portion of a
final judgment or settlement in the Izzarelli litigation which is not paid by
insurance, should the judgment be reinstated. The Company intends to pursue
claims for recovery of the amount of any final judgment or settlement against
its insurance carrier subject to policy limits of $10 million. Although the
insurance carrier has been paying the Company's attorneys' fees in the Izzarelli
litigation, it has otherwise denied coverage and reserved all rights.
PHILLIPS BLOCK COPOLYMER LITIGATION
In March 1984, Phillips Petroleum Company ("Phillips") filed a lawsuit
against the Company in the United States District Court for the Northern
District of Illinois, Eastern Division, seeking injunctive relief, an
unspecified amount of compensatory damages and treble damages. The complaint
alleges that the Company's copolymer process for polypropylene infringes
Phillips' two "block" copolymer patents. This action has been transferred to the
United States District Court for the Southern District of Texas, Houston
Division. Discovery in this case has been completed. The Company has filed a
motion for summary judgment. Phillips has filed a motion for partial summary
judgment. Pursuant to an agreement among the parties, the court appointed a
special master who conducted a hearing on these motions and thereafter
recommended to the court that the Company's motion be granted and Phillips'
motion be denied. Thereafter, Phillips filed motions to disqualify the special
master, to reject the recommendation of the special master and to enter partial
summary judgment for Phillips. The court has entered an order denying Phillips'
motion to disqualify the special master. The summary judgment motions are still
pending. In Old Rexene's Chapter 11 bankrupcty proceeding, Phillips filed a
proof of claim seeking in excess of $108 million based upon the allegations in
this litigation. The Company objected to the claim and elected to leave the
legal, equitable and contractual rights of Phillips unaltered, thereby allowing
this litigation to proceed as of the Effective Date without regard to the
bankruptcy proceeding.
PHILLIPS CRYSTALLINE LICENSE LITIGATION
In May 1990, Phillips filed a lawsuit against the Company in the United
States District Court for the District of Delaware seeking injunctive relief, an
unspecified amount of compensatory damages, treble damages and attorneys' fees,
costs and expenses. The complaint alleges that the Company is infringing
Phillips' Patent No. 4,376,851 (the "'851 Patent") for crystalline
polypropylene. Pursuant to a License Agreement dated as of May 15, 1983, as
amended, (the "License Agreement"), Phillips granted the Company a non-exclusive
license to make, use and sell crystalline polypropylene covered by the '851
Patent. The complaint alleges that effective April 21, 1990, Phillips terminated
the License Agreement because it believed that, by the terms of the License
Agreement, all conditions precedent to such termination had occurred. The
complaint further alleges that, without an effective License Agreement, the
Company's continuing use of the '851 Patent constitutes an infringing use. An
amended complaint filed in May 1990 further alleges that the Company made a
material misrepresentation that induced Phillips to enter into the License
Agreement and that Phillips entered into the License Agreement as a consequence
of a mutual mistake of the parties. The amended complaint therefore alleges that
the License Agreement is void AB INITIO. The Company filed a motion to dismiss
Phillips' amended complaint for failure to state a claim. On December 30, 1993,
the court entered an order dismissing Phillips' claim that the License Agreement
was void AB INITIO, and ordered that the 1990 license termination issue be
resolved at trial. Trial is scheduled for October 19, 1994. In Old Rexene's
Chapter 11 bankruptcy proceeding, Phillips filed a proof of claim seeking in
excess of $147 million based upon the allegations in this litigation. The
Company objected to the claim and elected to leave the legal, equitable and
contractual rights of Phillips unaltered thereby allowing this litigation to
proceed as of the Effective Date without regard to the bankruptcy proceeding.
45
<PAGE>
ODESSA RESIDENTS' TORT LITIGATION
On April 15, 1994, the national and state chapters of the NAACP and
approximately 770 residents of a neighborhood approximately one mile northwest
of the Shell Oil Company ("Shell"), Rexene and Dynagen, Inc. ("Dynagen") plants
in Odessa, Texas petitioned the State District Court in Odessa, Texas to
intervene in a previously existing lawsuit against Dynagen to (a) add as
additional defendants Rexene, Shell and General Tire Corporation (the parent of
Dynagen) and (b) have the litigation certified as a class action. The
plaintiffs' petition seeks an unspecified amount of money damages for past,
present and future injuries to plaintiffs' health, wrongful death, loss of
consortium and reduction in property values; the conduct and payment of property
clean up, remediation and relocation costs; payment of expenses for medical
testing and monitoring; funding of pollution and health studies; attorney's
fees; punitive damages and injunctive relief. Plaintiffs' petition specified
alleged pollution from air emissions from the three plants as a basis for their
claims. The trial court has allowed intervention and severed the action from the
original lawsuit against Dynagen. Plaintiffs have withdrawn their motion to have
the litigation certified as a class claim. This litigation is in the early
stages of pretrial discovery. Plaintiff's attorneys have also requested a public
hearing in connection with the renewal of the Company's air permit for its
styrene plant. See
"-- Environmental and Related Regulation -- Air Emissions."
Although there can be no assurance of the final resolution of any of these
matters, the Company believes that it has meritorious defenses to the various
claims made and intends to defend each suit vigorously. If, however, any of such
litigation matters is adversely resolved, it could have a material adverse
effect on the Company's financial position or results of operations.
With respect to certain pending or threatened proceedings involving the
discharge of materials into or protection of the environment, see "--
Environmental and Related Regulation". The Company is also a party to various
lawsuits arising in the ordinary course of business and does not believe that
the outcome of any of these lawsuits will have a material adverse effect on the
Company's financial position or results of operations.
46
<PAGE>
MANAGEMENT
DIRECTORS AND EXECUTIVE OFFICERS OF THE COMPANY
The table set forth below provides certain information with respect to those
persons who are currently serving as directors and executive officers of the
Company.
<TABLE>
<CAPTION>
NAME AGE POSITION
- ------------------------ --- ---------------------------------------------
<S> <C> <C>
Arthur L. Goeschel 72 Chairman of the Board
Andrew J. Smith 53 Director, Chief Executive Officer
Lavon N. Anderson 59 Director, President and Chief Operating
Officer
Kevin N. Clowe 43 Director
William B. Hewitt 56 Director
Ilan Kaufthal 47 Director
Fred P. Rullo, Jr. 54 Director
Phillip Siegel 51 Director
Heinn F. Tomfohrde, III 60 Director
Kevin W. McAleer 44 Executive Vice President and Chief Financial
Officer
Jack E. Knott 40 Executive Vice President -- Sales and Market
Development
James M. Ruberto 47 Executive Vice President and President -- CT
Film
Jonathan R. Wheeler 43 Senior Vice President -- Administration
Bernard J. McNamee 59 Vice President, Secretary and General Counsel
Geff Perera 40 Vice President and Controller
</TABLE>
Mr. Goeschel has been Chairman of the Board of the Company since March 1992.
He also was a director of Old Rexene from April 1988 to May 1989. Mr. Goeschel
is presently retired. He was Chairman of the Board of Tetra Technologies, Inc.,
a company which recycles and treats environmentally sensitive by-product and
wastewater streams, and then markets end-use chemicals extracted from such
streams, from November 1992 to October 1993. He is a director of Calgon Carbon
Corporation, a manufacturer of activated carbon, and National Picture Frame
Company, a manufacturer of picture frames. He is also a member of the board of
trustees of the Laurel Mutual Funds.
Mr. Smith has been Chief Executive Officer and a director of the Company
since March 1992. From December 1991 to March 1992, he was a private consultant.
From June 1991 to December 1991, he was President and Chief Operating Officer of
Itex Enterprises, Inc., an environmental remediation company. Mr. Smith also
served as a consultant to Old Rexene from January 1991 to June 1991. Immediately
prior thereto, he had been a director of Old Rexene since May 1988 and the
President and Chief Executive Officer of Old Rexene since June 1988. Prior
thereto he had held various positions with Old Rexene since 1976.
Dr. Anderson has been President and Chief Operating Officer of the Company
since January 1991 and a director since February 1990. From May 1988 to January
1991 Dr. Anderson was Executive Vice President -- Manufacturing and Technical of
Old Rexene. Prior thereto he had held various engineering, manufacturing and
research and development positions with Old Rexene since 1972.
Mr. Clowe has served as a director of the Company since September 1992. He
has served as Assistant Treasurer and Corporate Officer of American
International Group, Inc., an international insurance and financial services
company, since January 1988, as Vice President and Corporate Officer of American
International Group Capital Corporation since 1987, and as President and
Director of American International Fund Distributors, Inc. since 1988. Mr. Clowe
is also a director of Concurrent Computer Corporation.
Mr. Hewitt has served as a director of the Company since February 1990. He
has been Chairman of the Board and Chief Executive Officer of Capital Credit
Corporation, a receivables management company, since
47
<PAGE>
September 1991 and Executive Vice President of Union Corporation since March
1994. Mr. Hewitt was Executive Vice President of First Manhattan Consulting
Group, a management consulting firm, from 1980 to September 1991. He is also a
director of the Union Corporation.
Mr. Kaufthal has served as a director of the Company since September 1992.
He has been a managing director of Wertheim Schroder & Co. Incorporated, an
investment banking firm, since 1987. He is also a director of Formica
Corporation, United Retail Group, Inc. and Cambrex Corporation.
Mr. Rullo has served as a director of the Company since September 1992. He
has been President and Chief Executive Officer of Freedom Chemical Company, a
specialty chemical company, since October 1991. He was President of ABB
Combustion Engineering Systems and Service Inc., a manufacturer of power plants
for utilities and industrial concerns, from September 1989 through September
1991.
Mr. Siegel has served as a director of the Company since September 1992. He
is an independent business consultant. From December 1989 to February 1993, Mr.
Siegel served as Senior Vice President of Presidential Life Insurance Company, a
company involved in the sale of life and annuity products. During 1989, Mr.
Siegel was an independent consultant with respect to mergers and acquisitions.
Mr. Siegel is a director of West Point Stevens, Inc. and Bally's Grand, Inc.
Mr. Tomfohrde has served as a director of the Company since September 1992.
He is currently retired. From January 1987 to his retirement in December 1991,
Mr. Tomfohrde served as President and Chief Operating Officer and a director of
GAF Chemicals Corp. and its successor company, International Specialty Products,
Inc., a specialty chemicals company. He is also a director of Sybron Chemicals
Corp., Creative Technologies Group, Inc., OSI Specialties, Inc. and McWhorter
Technologies, Inc.
Mr. McAleer has been Executive Vice President and Chief Financial Officer of
the Company since July 1990. From 1985 to 1990, Mr. McAleer was Chief Financial
Officer of Varo, Inc., a manufacturer of specialty electronics equipment.
Mr. Knott has been Executive Vice President -- Sales and Market Development
of the Company since March 1992. Prior thereto, Mr. Knott was an Executive Vice
President of Old Rexene since January 1991 and President of CT Film since
February 1989. Mr. Knott held various positions with CT Film from 1985 to
February 1989.
Mr. Ruberto has been Executive Vice President of the Company and President
of CT Film since March 1992. Prior thereto, Mr. Ruberto had been Executive Vice
President -- Sales and Market Development of Rexene since January 1991. From
April 1989 to January 1991, Mr. Ruberto was Executive Vice President --
Marketing and Business Planning of Old Rexene. From October 1987 through March
1989, Mr. Ruberto was Vice President -- Strategic Planning of Plicon Corp., a
manufacturer of flexible packaging materials.
Mr. Wheeler has been Senior Vice President -- Administration of the Company
since December 1990. Prior thereto, Mr. Wheeler had been Vice President -- Human
Resources and Administration of Old Rexene since September 1988.
Mr. McNamee has been Vice President, Secretary and General Counsel of the
Company since May 1993. From September 1989 to November 1992, Mr. McNamee was
Vice President and General Counsel of Ferro Corporation, a multinational
manufacturer of specialty materials. From July 1985 to August 1989, Mr. McNamee
was Associate General Counsel of Chevron Chemical Company, a manufacturer of
petrochemicals, polymers and other chemical products.
Mr. Perera has been Vice President of the Company since January 1991 and
Controller since February 1989. From October 1988 to February 1989, Mr. Perera
was Director of External Reporting of Old Rexene.
In October 1991, Old Rexene filed a petition for reorganization under the
federal bankruptcy laws from which the Company emerged on September 18, 1992,
pursuant to the Reorganization. At the time Old Rexene filed its petition for
reorganization, Dr. Anderson and Mr. Hewitt served as directors. In addition, in
48
<PAGE>
connection with the Reorganization, Messrs. Clowe, Kaufthal, Rullo, Siegel and
Tomfohrde were appointed to serve on the Company's board at the request of the
committee of creditors participating in the Reorganization. Messrs. Goeschel and
Smith, who served as directors of Old Rexene prior to the filing of its petition
for reorganization, returned to Old Rexene's board after the petition was filed.
Dr. Anderson and Messrs. Smith, McAleer, Knott, Ruberto, Wheeler and Perera each
served as executive officers of Old Rexene at some time within two years before
the filing by Old Rexene of its petition for reorganization.
Ilan Kaufthal, a director of the Company, is a managing director of Wertheim
Schroder & Co. Incorporated, a managing underwriter of the Offerings. See
"Underwriting."
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
The following tabulation sets forth as of September 1, 1994, information
with respect to each person who was known by Rexene to be the beneficial owner
of more than five percent of the Common Stock.
<TABLE>
<CAPTION>
COMMON STOCK
BENEFICIALLY OWNED
---------------------------
NUMBER OF PERCENT OF
NAME AND ADDRESS OF BENEFICIAL OWNER SHARES (1) CLASS
- ------------------------------------------------------------------------------ -------------- -----------
<S> <C> <C>
Executive Life Insurance Company of New York ................................. 1,147,144(2) 10.9%
390 North Broadway
Jericho, New York 11753-2167
Energy Management Corporation ................................................ 921,174(3) 8.8
1733 Woodstead Court
The Woodlands, Texas 77380
Kingdon Capital Management Corporation ....................................... 844,200(4) 8.0
152 West 57th Street
New York, New York 10019
M.D. Sass Investors Services, Inc. ........................................... 633,293(5) 6.0
1133 Avenue of the Americas
New York, New York 10036
The Prudential Insurance Company of America .................................. 567,455(6) 5.4
Prudential Plaza
Newark, New Jersey 07102-3777
Household Commercial of California, Inc. ..................................... 539,682(7) 5.1
2700 Sanders Road
Prospect Heights, Illinois 60070
<FN>
- ------------------------
(1) All shares listed are directly held with sole voting and investment power
unless otherwise indicated.
(2) Based upon information reported in a Schedule 13G filed with the Securities
and Exchange Commission (the "Commission") by Kevin E. Foley, Deputy
Superintendent of Insurance of the State of New York, as Rehabilitator of
Executive Life Insurance Company of New York, on November 25, 1992.
(3) Based upon information reported in a Schedule 13D filed with the Commission
by Energy Management Corporation ("EMC") and John W. Adams on June 14,
1994. EMC is a Colorado corporation whose principal business is the
purchase and sale of publicly and privately traded securities, accounts
receivable and other claims against distressed and troubled debtors. Does
not include 4,656 shares of Common Stock beneficially owned by John W.
Adams, a director of EMC whose business address is 767 Third Avenue, New
York, New York 10017.
(4) Based upon information reported in a Schedule 13D filed with the Commission
by Kingdon Capital Management Corporation ("Kingdon") on June 9, 1994.
Kingdon is a Delaware corporation whose principal business is to act as an
investment adviser.
</TABLE>
49
<PAGE>
<TABLE>
<S> <C>
(5) Based upon information reported in a Schedule 13G filed with the Commission
by M. D. Sass Investors Services, Inc. ("Sass") dated February 10, 1994.
Sass has sole investment power with respect to 124,700 of such shares and
shared investment power with respect to 508,593 of such shares.
(6) Based upon information reported in a Schedule 13G filed with the Commission
by The Prudential Insurance Company of America ("Prudential") on or about
February 11, 1993, as amended by an amendment thereto dated January 31,
1994. Includes 1,709 shares as to which Prudential has sole voting and
investment power, and 565,746 shares as to which Prudential has shared
voting and investment power, which are held for the benefit of its clients.
(7) Based upon information reported in a Schedule 13D filed with the Commission
by Household Commercial of California, Inc. on October 13, 1992, as amended
by an amendment thereto filed on October 22, 1992.
</TABLE>
SECURITY OWNERSHIP OF MANAGEMENT
The following tabulation sets forth information with respect to the
beneficial ownership of the Common Stock as of September 1, 1994 by each
director and executive officer of the Company and by all directors and executive
officers of the Company as a group.
<TABLE>
<CAPTION>
COMMON STOCK
BENEFICIALLY OWNED
-------------------------
NUMBER OF PERCENT OF
NAME SHARES (1) CLASS
- ---------------------------------------------------------------------------- ------------ -----------
<S> <C> <C>
DIRECTORS
Lavon N. Anderson........................................................... 7,916 *
Kevin N. Clowe.............................................................. 6,250 *
Arthur L. Goeschel.......................................................... 37,333(2) 0.3%
William B. Hewitt........................................................... 6,250 *
Ilan Kaufthal............................................................... 6,250 *
Fred P. Rullo, Jr........................................................... 6,250 *
Phillip Siegel.............................................................. 9,250 *
Andrew J. Smith............................................................. 14,845 0.1%
Heinn F. Tomfohrde, III..................................................... 6,250 *
EXECUTIVE OFFICERS (EXCLUDING ANY DIRECTOR NAMED ABOVE)
Kevin W. McAleer............................................................ 5,000 *
Jack E. Knott............................................................... 7,000(3) *
James M. Ruberto............................................................ 4,000 *
Jonathan R. Wheeler......................................................... 4,000 *
Bernard J. McNamee.......................................................... 4,000 *
Geff Perera................................................................. 0 *
ALL DIRECTORS AND EXECUTIVE OFFICERS AS A GROUP (15 PERSONS)................ 124,594(4) 1.2%
<FN>
- ------------------------
* Less than .1%
(1) All shares listed are directly held with sole voting and investment power
unless otherwise indicated.
(2) Includes 1,000 shares held by Mr. Goeschel's spouse.
(3) Includes 3,000 shares held by Mr. Knott's spouse in a custodial capacity
under the Uniform Gift to Minors Act.
(4) Includes 67,499 shares subject to stock options which are exercisable
within 60 days.
</TABLE>
50
<PAGE>
DESCRIPTION OF NEW CREDIT AGREEMENT
The following is a summary of the terms of the New Credit Agreement. For
more complete information regarding such indebtedness, reference is made to the
New Credit Agreement, a copy of which has been filed as an exhibit to the
Registration Statement of which this Prospectus is a part and which is
incorporated by reference herein.
The Company has received the Commitment Letter from the Bank with respect to
the New Credit Agreement, which provides for up to $180 million of term and
revolving loans for working capital and general corporate purposes and for
letters of credit. The Company will be required to repay a portion of its
borrowings under the Term Loan, each year, commencing in 1995, so as to retire
such indebtedness in its entirety by November 1999. Availability of borrowings
under the New Credit Agreement is initially contingent upon the receipt by the
Company of gross proceeds from the Common Stock Offering of at least $85 million
and of aggregate gross proceeds from the Offerings of at least $275 million,
and, thereafter, availability of borrowings under the revolving portion of the
New Credit Agreement is based upon a formula related to inventory and accounts
receivable. The Company estimates it will be necessary for it to make initial
borrowings of approximately $100 million under the Term Loan in connection with
the Recapitalization. See "The Recapitalization". Borrowings under the New
Credit Agreement will bear interest at a floating rate based on the Bank's prime
rate or, at the Company's option, on the Bank's reserve-adjusted LIBO rate and
will be secured by the pledge of substantially all of the assets of the Company,
including inventory and accounts receivable and the proceeds thereof.
The Company will be required to make quarterly principal payments under the
Term Loan commencing on March 31, 1995. The first four payments will each be in
the amount of $2.5 million, the next four payments will each be in the amount of
approximately $3.75 million and all payments thereafter will each be in the
amount of $6.25 million.
The New Credit Agreement will contain covenants which restrict, among other
things, the incurrence of additional indebtedness by the Company, the payment of
dividends and other distributions in respect of the capital stock of the
Company, the creation of liens on the assets of the Company, the making of
investments by the Company, certain mergers, sales of assets and similar
transfers and the prepayment of the Senior Notes. The New Credit Agreement will
also contain certain financial covenants relating to the financial condition of
the Company, including covenants relating to the ratio of its earnings to its
interest expense, the ratio of its earnings to its fixed charges and a leverage
ratio.
The Commitment Letter contemplates a number of events of default customary
for the type of transaction proposed, including, without limitation, the failure
to make timely payments of principal, fees and interest and the occurrence of a
change of control of the Company. The New Credit Agreement will include a
cross-default to other indebtedness of the Company.
DESCRIPTION OF SENIOR NOTES
GENERAL
The Senior Notes will be issued pursuant to an Indenture (the "Indenture")
between the Company and , as trustee (the "Trustee"). The terms of the
Senior Notes include those stated in the Indenture and those made part of the
Indenture by reference to the Trust Indenture Act of 1939 (the "Trust Indenture
Act"). The Senior Notes are subject to all such terms, and Holders of Senior
Notes are referred to the Indenture and the Trust Indenture Act for a statement
thereof. The following summary of certain provisions of the Indenture does not
purport to be complete and is qualified in its entirety by reference to the
Indenture, including the definitions therein of certain terms used below. A copy
of the proposed form of Indenture has been filed as an exhibit to the
Registration Statement of which this Prospectus is a part and is available as
set forth under "Available Information." The definitions of certain of the terms
used in the following summary are set forth below under "Certain Definitions."
51
<PAGE>
The Senior Notes will rank senior in right of payment to all future
subordinated Indebtedness of the Company. The Senior Notes will rank PARI PASSU
in right of payment with all senior borrowings, including borrowings under the
New Credit Agreement. However, borrowings under the New Credit Agreement will be
secured by substantially all of the assets of the Company.
As of the date of the Indenture, none of the Company's domestic operations
are conducted through Subsidiaries and none of the Company's Subsidiaries has
any operations or material assets or liabilities, other than a foreign sales
corporation and RCL. RCL was formed in late 1993 to operate the Company's
European film operations. As of June 30, 1994, the aggregate total assets and
total liabilities of RCL and the foreign sales corporation were $12.6 million
and $9.6 million, respectively, and for the year ended December 31, 1993 and the
six months ended June 30, 1994, RCL and the foreign sales corporation had no
cash flow from operations and net losses of $1,000 and $303,000, respectively
(all of the preceding amounts are approximate). As of the date of the Indenture,
all of the Company's Subsidiaries will be Unrestricted Subsidiaries. Under
certain circumstances, the Company will be able to designate future Subsidiaries
as Unrestricted Subsidiaries. Unrestricted Subsidiaries will not be subject to
any of the restrictive covenants set forth in the Indenture.
PRINCIPAL, MATURITY AND INTEREST
The Senior Notes will be limited in aggregate principal amount to $175
million and will mature on , 2004. Interest on the Senior Notes will
accrue at the rate of % per annum and will be payable semi-annually in
arrears on and , commencing on , 1995, to
Holders of record on the immediately preceding and .
Interest on the Senior Notes will accrue from the most recent date to which
interest has been paid or, if no interest has been paid, from the date of
original issuance. Interest will be computed on the basis of a 360-day year
comprised of twelve 30-day months. Principal, premium, if any, and interest on
the Senior Notes will be payable at the office or agency of the Company
maintained for such purpose within the City and State of New York, or at the
option of the Company, payment of interest may be made by check mailed to the
Holders of the Senior Notes at their respective addresses set forth in the
register of Holders of Senior Notes; PROVIDED that all payments with respect to
Senior Notes the Holders of which have given wire transfer instructions to the
Company will be required to be made by wire transfer of immediately available
funds to the accounts specified by the Holders thereof. Until otherwise
designated by the Company, the Company's office or agency in New York will be
the office of the Trustee maintained for such purpose. The Senior Notes will be
issued in denominations of $1,000 and integral multiples thereof.
OPTIONAL REDEMPTION
The Senior Notes will not be redeemable at the Company's option prior to
. Thereafter, the Senior Notes will be subject to redemption at
the option of the Company, in whole or in part, upon not less than 30 nor more
than 60 days' notice, at the redemption prices (expressed as percentages of
principal amount) set forth below plus accrued and unpaid interest thereon to
the applicable redemption date, if redeemed during the twelve-month period
beginning on of the years indicated below:
<TABLE>
<CAPTION>
YEAR PERCENTAGE
- ------------------------------------------------------------------------ -------------
<S> <C>
%
</TABLE>
Notwithstanding the foregoing, during the first 36 months after the date of
this Prospectus, the Company may, from time to time, redeem up to $ million
in aggregate principal amount of Senior Notes, upon not less than 30 nor more
than 60 days' notice, at a redemption price of % of the principal amount
thereof plus accrued and unpaid interest thereon to the redemption date, with
the net proceeds of an offering or offerings of common stock of the Company;
PROVIDED that at least $100 million in aggregate
52
<PAGE>
principal amount of Senior Notes remains outstanding immediately after the
occurrence of such redemption; and PROVIDED, FURTHER, that each such redemption
shall occur within 60 days of the date of the closing of the related offering of
common stock of the Company.
MANDATORY REDEMPTION
Except as set forth below under "Repurchase at the Option of Holders," the
Company is not required to make mandatory redemption or sinking fund payments
with respect to the Senior Notes.
REPURCHASE AT THE OPTION OF HOLDERS
CHANGE OF CONTROL
Upon the occurrence of a Change of Control, each Holder of Senior Notes will
have the right to require the Company to purchase all or any part (equal to
$1,000 or an integral multiple thereof) of such Holder's Senior Notes pursuant
to the offer described below (the "Change of Control Offer") at an offer price
in cash equal to 101% of the aggregate principal amount thereof plus accrued and
unpaid interest thereon to the date of purchase (the "Change of Control
Payment"). Within ten days following any Change of Control, the Company will
mail a notice to each Holder stating: (1) that the Change of Control Offer is
being made pursuant to the covenant entitled "Change of Control" and that all
Senior Notes properly tendered will be accepted for payment; (2) the purchase
price and the purchase date, which will be no earlier than 30 days nor later
than 40 days from the date such notice is mailed (the "Change of Control Payment
Date"); (3) that any Senior Note not properly tendered will continue to accrue
interest; (4) that, unless the Company defaults in the payment of the Change of
Control Payment, all Senior Notes accepted for payment pursuant to the Change of
Control Offer will cease to accrue interest after the Change of Control Payment
Date; (5) that Holders electing to have any Senior Notes purchased pursuant to a
Change of Control Offer will be required to surrender the Senior Notes, with the
form entitled "Option of Holder to Elect Purchase" on the reverse of the Senior
Notes completed, or transfer by book-entry, to the Payment Agent at the address
specified in the notice prior to the close of business on the third Business Day
preceding the Change of Control Payment Date; (6) that Holders will be entitled
to withdraw their election if the Paying Agent receives, not later than the
close of business on the second Business Day preceding the Change of Control
Payment Date, a telegram, telex, facsimile transmission or letter setting forth
the name of the Holder, the principal amount of Senior Notes delivered for
purchase, and a statement that such Holder is withdrawing his election to have
such Senior Notes purchased; and (7) that Holders whose Senior Notes are being
purchased only in part will be issued new Senior Notes equal in principal amount
to the unpurchased portion of the Senior Notes surrendered (or transferred by
book-entry), which unpurchased portion must be equal to $1,000 in principal
amount or an integral multiple thereof. The Company will comply with the
requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), and any other securities laws and regulations thereunder
to the extent such laws and regulations are applicable in connection with the
repurchase of the Senior Notes in connection with a Change of Control.
On the Change of Control Payment Date, the Company will, to the extent
lawful, (1) accept for payment all Senior Notes or portions thereof properly
tendered pursuant to the Change of Control Offer, (2) deposit with the Paying
Agent an amount equal to the Change of Control Payment in respect of all Senior
Notes or portions thereof so tendered and (3) deliver or cause to be delivered
to the Trustee the Senior Notes so accepted together with an Officers'
Certificate stating the aggregate principal amount of Senior Notes so tendered
and the Change of Control Payment for such Senior Notes, and the Trustee will
promptly authenticate and mail (or cause to be transferred by book entry) to
each Holder a new Senior Note equal in principal amount to any unpurchased
portion of the Senior Notes surrendered, if any; PROVIDED that each such new
Senior Note will be in a principal amount of $1,000 or an integral multiple
thereof. The Company will publicly announce the results of the Change of Control
Offer on or as soon as practicable after the Change of Control Payment Date.
Except as described above with respect to a Change of Control, the Indenture
does not contain provisions that permit the Holders of the Senior Notes to
require that the Company repurchase or redeem the Senior Notes in the event of a
takeover, recapitalization or similar restructuring.
53
<PAGE>
The New Credit Agreement contains prohibitions of certain events that would
constitute a Change of Control. In addition, the exercise by the Holders of the
Senior Notes of their right to require the Company to repurchase the Senior
Notes upon the occurrence of a Change of Control or an Asset Sale is prohibited
by the New Credit Agreement. Finally, the Company's ability to pay cash to the
Holders of Senior Notes upon such an event may be limited by the Company's then
existing financial resources.
The definition of Change of Control includes the sale, lease, transfer,
conveyance or other disposition of "all or substantially all" of the assets of
the Company and its Restricted Subsidiaries taken as a whole. Although there is
a developing body of case law interpreting the phrase "substantially all," there
is no precise established definition of the phrase under applicable law.
Accordingly, the ability of a Holder of Senior Notes to require the Company to
repurchase such Senior Notes as a result of a sale, lease, transfer, conveyance
or other disposition of less than all of the assets of the Company and its
Restricted Subsidiaries taken as a whole to another Person or group may be
uncertain.
ASSET SALES
The Indenture will provide that the Company will not, and will not permit
any of its Restricted Subsidiaries to, engage in an Asset Sale unless (i) the
Company (or the Restricted Subsidiary, as the case may be) receives
consideration at the time of such Asset Sale at least equal to the fair market
value (evidenced by a resolution of the Board of Directors set forth in an
Officers' Certificate delivered to the Trustee) of the assets or Equity
Interests issued, sold or otherwise disposed of in such Asset Sale less the
amount of liabilities (as shown on the Company's or such Restricted Subsidiary's
most recent balance sheet or in the notes thereto) and obligations assumed in
connection with such Asset Sale by the transferee of any such assets or on
behalf of such transferee by a third party and (ii) except with respect to Asset
Sales involving Obsolete Plants, at least 80% of the consideration therefor
received by the Company or such Restricted Subsidiary (after deducting expenses
associated with such Asset Sale) is in the form of cash or Cash Equivalents;
PROVIDED that the amount of (x) any liabilities (as shown on the Company's or
such Restricted Subsidiary's most recent balance sheet or in the notes thereto)
of the Company or such Restricted Subsidiary that are assumed in connection with
such Asset Sale by the transferee of any such assets or on behalf of such
transferee by a third party and (y) any notes or other obligations received by
the Company or any such Restricted Subsidiary from such transferee that are
immediately converted by the Company or such Restricted Subsidiary into cash or
Cash Equivalents and (z) with respect to any Asset Sale for consideration not
exceeding $10 million, up to $10 million principal amount of notes or other
obligations received by the Company or such Restricted Subsidiary from such
transferee that are repaid in cash or Cash Equivalents to the Company or such
Restricted Subsidiary within 360 days after consummation of such Asset Sale (to
the extent of the cash or Cash Equivalents received), shall be deemed to be cash
for purposes of this provision.
Within 360 days after the consummation of any Asset Sale, the Company may
apply the Net Proceeds from such Asset Sale, at its option, (a) to reduce Senior
Term Debt or (b) to an acquisition of a Permitted Business, the making of
capital expenditures or the acquisition of other fixed assets, in each case,
engaged or used in a Permitted Business. At any time on or prior to 360 days
following consummation of any Asset Sale, the Company may designate all or any
portion of the Net Proceeds from such Asset Sale as "Excess Proceeds." Pending
the final application of any such Net Proceeds in accordance with the first
sentence of this paragraph or to an Asset Sale Offer, the Company may invest
such Net Proceeds in any manner that is not prohibited by the Indenture and may
temporarily repay Senior Revolving Debt. Any Net Proceeds from Asset Sales that
are not applied or invested as provided in the first sentence of this paragraph
or which are designated "Excess Proceeds" as provided above in this paragraph
will constitute "Excess Proceeds." When the aggregate amount of Excess Proceeds
exceeds $25 million, the Company will be required to make an offer to all
Holders of Senior Notes (an "Asset Sale Offer") to purchase the maximum
principal amount of Senior Notes that may be purchased out of the Excess
Proceeds, at an offer price in cash equal to 100% of the principal amount
thereof plus accrued and unpaid interest thereon to the date of purchase in
accordance with the procedures set forth in the Indenture. To the extent that
the aggregate amount of Senior Notes tendered pursuant to an Asset Sale Offer is
less than the Excess Proceeds, the Company may use any remaining Excess Proceeds
for general corporate purposes. If the aggregate principal amount of Senior
54
<PAGE>
Notes tendered pursuant to an Asset Sale Offer exceeds the amount of Excess
Proceeds, the Trustee shall select the Senior Notes to be purchased on a pro
rata basis. Upon completion of such offer to purchase, the amount of Excess
Proceeds shall be reset at zero.
SELECTION AND NOTICE
If less than all of the Senior Notes are to be redeemed at any time,
selection of Senior Notes for redemption will be made by the Trustee in
compliance with the requirements of the principal national securities exchange,
if any, on which the Senior Notes are listed, or, if the Senior Notes are not so
listed, on a pro rata basis, by lot or by such method as the Trustee shall deem
fair and appropriate; PROVIDED that no Senior Notes of $1,000 or less shall be
redeemed in part. Notices of redemption shall be mailed by First Class mail at
least 30 but not more than 60 days before the redemption date to each Holder of
Senior Notes to be redeemed at its registered address. If any Senior Note is to
be redeemed in part only, the notice of redemption that relates to such Senior
Note shall state the portion of the principal amount thereof to be redeemed. A
new Senior Note in principal amount equal to the unredeemed portion thereof will
be issued in the name of the Holder thereof upon cancellation of the original
Senior Note. On and after the redemption date, interest ceases to accrue on
Senior Notes or portions of them called for redemption.
CERTAIN COVENANTS
RESTRICTED PAYMENTS
The Indenture will provide that the Company will not, and will not permit
any of its Restricted Subsidiaries to, directly or indirectly: (i) declare or
pay any dividend or make any distribution on account of the Company's Equity
Interests (other than dividends or distributions payable to any Wholly Owned
Restricted Subsidiary of the Company); (ii) purchase, redeem or otherwise
acquire or retire for value any Equity Interests of the Company; (iii) purchase,
redeem or otherwise acquire or retire for value any Indebtedness that is
subordinated to the Senior Notes, except at final maturity thereof as set forth
in the original documentation governing such Indebtedness; or (iv) make any
Restricted Investment (all such payments and other actions set forth in clauses
(i) through (iv) above being collectively referred to as "Restricted Payments"),
unless, at the time of such Restricted Payment:
(a) no Default or Event of Default shall have occurred and be continuing
or would occur as a consequence thereof; and
(b) the Company would, at the time of such Restricted Payment and after
giving pro forma effect thereto as if such Restricted Payment had been made
at the beginning of the applicable four-quarter period, have been permitted
to incur at least $1.00 of additional Indebtedness pursuant to the Fixed
Charge Coverage Ratio test set forth in the first paragraph of the covenant
entitled "Incurrence of Indebtedness and Issuance of Preferred Stock"; and
(c) such Restricted Payment, together with the aggregate of all other
Restricted Payments made by the Company and its Restricted Subsidiaries
after the date of the Indenture (including Restricted Payments permitted by
clauses (v), (w) and (y) of the next succeeding paragraph), is less than the
sum of (w) 50% of the Consolidated Net Income of the Company (excluding the
amount of all cash payments received by the Company and its Wholly Owned
Restricted Subsidiaries from URC or the APAO Joint Venture after the date of
Indenture as fees for licensing of intellectual property rights or other
proprietary technology that are applied to an Investment in either such
joint venture pursuant to clause (d) of the definition of "Permitted
Investments") for the period (taken as one accounting period) from the
beginning of the first month commencing after the date of the Indenture to
the end of the Company's most recently ended fiscal quarter for which
internal financial statements are available at the time of such Restricted
Payment (or, if such Consolidated Net Income for such period is a deficit,
less 100% of such deficit) PLUS (x) 100% of the aggregate net cash proceeds
received by the Company from the issue or sale since the date of the
Indenture of Equity Interests of the Company or of debt securities of the
Company that have been converted into such Equity Interests (other than
Equity Interests (or convertible debt securities) sold to a Subsidiary of
the Company and other than Disqualified Stock or debt securities that have
been converted into Disqualified Stock), PLUS (y) to the extent that any
55
<PAGE>
Restricted Investment that was made after the date of the Indenture is sold
for cash or otherwise liquidated or repaid for cash, the lesser of (A) the
cash return of capital with respect to such Restricted Investment (less the
cost of disposition if any) and (B) the initial amount of such Restricted
Investment, plus (z) 50% of any dividends received by the Company or a
Wholly Owned Subsidiary after the date of the Indenture from an Unrestricted
Subsidiary of the Company.
The foregoing provisions will not prohibit (v) the payment of any dividend
within 60 days after the date of declaration thereof if, at said date of
declaration, such payment would have complied with the provisions of the
Indenture; (w) the redemption, repurchase, retirement or other acquisition of
any Equity Interests of the Company in exchange for, or out of the proceeds of,
the substantially concurrent sale (other than to a Restricted Subsidiary of the
Company or a Designated Unrestricted Subsidiary) of other Equity Interests of
the Company (other than any Disqualified Stock); (x) the defeasance, redemption
or repurchase of subordinated Indebtedness with the net proceeds from an
incurrence of Permitted Refinancing Indebtedness; (y) the repurchase, redemption
or other acquisitions or retirement for value of any Equity Interests of the
Company or any Restricted Subsidiary of the Company held by any member of the
Company's (or any of its Restricted Subsidiaries') management pursuant to any
management equity subscription agreement or stock option agreement; PROVIDED
that (1) the aggregate price paid for all such repurchased, redeemed, acquired
or retired Equity Interests shall not exceed $1.0 million in any twelve-month
period plus the aggregate cash proceeds received by the Company during such
twelve-month period from any reissuance of Equity Interests by the Company to
members of management of the Company and its Restricted Subsidiaries and (2) no
Default or Event of Default shall have occurred and be continuing immediately
after such transaction; or (z) Restricted Payments to the extent made with
Equity Interests (other than Disqualified Stock) of the Company.
In no event will the Company or any Restricted Subsidiary of the Company
make an Investment after the date of the Indenture in any Person in which it has
an Equity Interest on the date of the Indenture but which is not a Subsidiary of
the Company on the date of the Indenture, including any Guarantee of
Indebtedness of such Person, in excess of the aggregate cash received from such
Person after the date of the Indenture by the Company and its Wholly Owned
Restricted Subsidiaries as fees for the licensing of any intellectual property
rights or other proprietary technology.
Not later than the thirtieth day after the end of each calendar quarter in
which any Restricted Payment is made, the Company shall deliver to the Trustee
an Officers' Certificate stating that such Restricted Payment was permitted and
setting forth the basis upon which the calculations required by the covenant
entitled "-- Restricted Payments" were computed, which calculations may be based
upon the Company's latest available financial statements at the time such
Officers' Certificate is delivered.
The Board of Directors may designate any Restricted Subsidiary to be an
Unrestricted Subsidiary if (x) the Company would, at the time of such
designation and after giving pro forma effect thereto as if such designation had
been made at the beginning of the applicable four-quarter period, have been
permitted to incur at least $1.00 of additional Indebtedness pursuant to the
Fixed Charge Coverage Ratio test set forth in the first paragraph of the
covenant described below under the caption "-- Incurrence of Indebtedness and
Issuance of Preferred Stock" and (y) such designation would not cause a Default.
For purposes of making such determination, all outstanding Investments by the
Company and its Restricted Subsidiaries in the Subsidiary so designated will be
deemed to be Restricted Payments at the time of such designation and will reduce
the amount available for Restricted Payments under the first paragraph of this
covenant. All such outstanding Investments will be deemed to constitute
Investments in an amount equal to the greater of (y) the net book value of such
Investments at the time of such designation or (z) the fair market value of such
Investments at the time of such designation. Such designation will only be
permitted if such Restricted Payment would be permitted at such time and if such
Restricted Subsidiary otherwise meets the definition of an Unrestricted
Subsidiary.
56
<PAGE>
INCURRENCE OF INDEBTEDNESS AND ISSUANCE OF PREFERRED STOCK
The Indenture will provide that the Company will not, and will not permit
any of its Restricted Subsidiaries to, create, incur, issue, assume, guarantee
or otherwise become liable with respect to (collectively, "incur") any
Indebtedness (including Acquired Debt) and that the Company will not issue any
Disqualified Stock and will not permit any of its Restricted Subsidiaries to
issue any shares of preferred stock; PROVIDED, HOWEVER, that the Company and any
Subsidiary Guarantor may incur Indebtedness (including Acquired Debt) or the
Company may issue shares of Disqualified Stock if the Fixed Charge Coverage
Ratio for the Company's most recently ended four full fiscal quarters for which
internal financial statements are available immediately preceding the date on
which such additional Indebtedness is incurred or such Disqualified Stock is
issued would have been at least 2.0 to 1, with respect to any such Indebtedness
incurred, or Disqualified Stock issued, on or prior to , 1997, and at
least 2.25 to 1, with respect to any such Indebtedness incurred, or Disqualified
Stock issued, after , determined on a pro forma basis (including a
pro forma application of the net proceeds therefrom), as if the additional
Indebtedness had been incurred, or the Disqualified Stock had been issued, as
the case may be, at the beginning of such four-quarter period.
The restrictions imposed in the foregoing paragraph will not apply to:
(i) the incurrence by the Company and any Subsidiary Guarantor of Senior
Term Debt in an aggregate principal amount outstanding at any time not to
exceed $100 million LESS the aggregate amount of all repayments after the
date of the Indenture, optional or mandatory, of the principal of such
Indebtedness, including, without limitation, pursuant to the covenant
entitled "-- Asset Sales";
(ii) the incurrence by the Company and any Subsidiary Guarantor of
Senior Revolving Debt and letters of credit (and any Guarantees thereof by
the Company and any Subsidiary Guarantor) in an aggregate principal amount
at any time outstanding (with letters of credit and Guarantees being deemed
to have a principal amount equal to the maximum potential liability of the
Company and its Restricted Subsidiaries thereunder) not to exceed the
Borrowing Base;
(iii) the incurrence by the Company and any Subsidiary Guarantor of
Acquisition Debt, if the Fixed Charge Coverage Ratio for the Company's most
recently ended four full fiscal quarters for which internal financial
statements are available immediately preceding the date on which such
Acquisition Debt is incurred, determined on a pro forma basis as if the
Acquisition Debt had been incurred and the related acquisition had been
consummated at the beginning of such four-quarter period, would be greater
than the actual Fixed Charge Coverage Ratio of the Company for such
four-quarter period;
(iv) the incurrence by the Company and any Subsidiary Guarantor of
Permitted Refinancing Indebtedness in exchange for, or the net proceeds of
which are used to extend, refinance, renew, replace, decrease or refund
Indebtedness that was permitted by the Indenture to be incurred;
(v) the incurrence by the Company or any of its Restricted Subsidiaries
of intercompany Indebtedness between or among the Company and any of its
Restricted Subsidiaries;
(vi) the incurrence in the ordinary course of business by the Company
and any Subsidiary Guarantor of Hedging Obligations;
(vii) the incurrence by the Company and any Subsidiary Guarantor of
Indebtedness pursuant to letters of credit issued in the ordinary course of
business to support payment by the Company and such Subsidiary Guarantors of
insurance premiums;
(viii) the incurrence by the Company of Existing Debt;
(ix) the incurrence of Indebtedness which also constitutes Investments,
to the extent permitted by the covenant entitled "-- Restricted Payments";
(x) the incurrence of Indebtedness for general corporate purposes by any
Foreign Subsidiary that is a Restricted Subsidiary and not a Subsidiary
Guarantor in an aggregate principal amount outstanding at any time not
exceeding such Foreign Subsidiary's Foreign Subsidiary Borrowing Base; and
57
<PAGE>
(xii) the incurrence by the Company and any Subsidiary Guarantor of
additional Indebtedness in an aggregate principal amount outstanding at any
one time not exceeding $30 million.
LIENS
The Indenture will provide that the Company will not, and will not permit
any of its Restricted Subsidiaries to, directly or indirectly, create, incur,
assume or suffer to exist any Lien on any asset now owned or hereafter acquired,
or any income or profits therefrom, or assign or convey any right to receive any
income or profits therefrom, except Permitted Liens.
DIVIDEND AND OTHER PAYMENT RESTRICTIONS AFFECTING RESTRICTED SUBSIDIARIES
The Indenture will provide that the Company will not, and will not permit
any of its Restricted Subsidiaries to, directly or indirectly, create or
otherwise cause or suffer to exist or become effective any contractual
encumbrance or other restriction on the ability of any Restricted Subsidiary to
(i) (a) pay dividends or make any other distributions to the Company or any of
its Restricted Subsidiaries (1) on its Capital Stock or (2) with respect to any
other interest or participation in, or measured by, its profits or (b) pay any
Indebtedness owed to the Company or any of its Restricted Subsidiaries, (ii)
make loans or advances to the Company or any of its Restricted Subsidiaries or
(iii) transfer any of its properties or assets to the Company or any of its
Restricted Subsidiaries, except for such encumbrances or restrictions existing
under or by reason of (a) applicable law, (b) any instrument governing
Indebtedness or Capital Stock of a Person acquired by the Company or any of its
Restricted Subsidiaries as in effect at the time of such acquisition (except to
the extent such Indebtedness was incurred in connection with or in contemplation
of such acquisition), which encumbrance or restriction is not applicable to any
Person, or the properties or assets of any Person, other than the Person, or the
property or assets of the Person, so acquired, provided that the Consolidated
Cash Flow of such Person is not taken into account in determining whether such
acquisition was permitted by the terms of the Indenture, (c) any Bank Credit
Agreement, PROVIDED that such encumbrances and restrictions are no more
restrictive than such encumbrances and restrictions under the New Credit
Agreement as in effect on the date of the Indenture, (d) by reason of customary
non-assignment provisions in leases entered into in the ordinary course of
business and consistent with past practices or (e) purchase money obligations
and Capital Lease Obligations for property acquired in the ordinary course of
business that impose restrictions of the nature described in clause (iii) above
on the property so acquired.
MERGER, CONSOLIDATION, OR SALE OF ASSETS
The Indenture will provide that the Company may not consolidate or merge
with or into (whether or not the Company is the surviving corporation), or sell,
assign, transfer, lease, convey or otherwise dispose of all or substantially all
of its properties or assets in one or more related transactions, to another
corporation, Person or entity unless (i) the Company is the surviving
corporation or the entity or the Person formed by or surviving any such
consolidation or merger (if other than the Company) or to which such sale,
assignment, transfer, lease, conveyance or other disposition shall have been
made is a corporation organized or existing under the laws of the United States,
any state thereof or the District of Columbia, (ii) the entity or Person formed
by or surviving any such consolidation or merger (if other than the Company) or
the entity or Person to which such sale, assignment, transfer, lease, conveyance
or other disposition shall have been made assumes all the obligations of the
Company under the Senior Notes and the Indenture pursuant to a supplemental
Indenture in a form reasonably satisfactory to the Trustee; (iii) immediately
after such transaction no Default or Event of Default exists; and (iv) the
Company or the entity or Person formed by or surviving any such consolidation or
merger (if other than the Company), or to which such sale, assignment, transfer,
lease, conveyance or other disposition shall have been made (A) will have
Consolidated Net Worth (immediately after the transaction but prior to any
purchase accounting adjustments resulting from the transaction) equal to or
greater than the Consolidated Net Worth of the Company immediately preceding the
transaction and (B) will, at the time of such transaction and after giving pro
forma effect thereto as if such transaction had occurred at the beginning of the
applicable four-quarter period, be permitted to incur at least $1.00 of
additional Indebtedness pursuant to the Fixed Charge Coverage Ratio test set
forth in the first paragraph of the covenant described above under the caption
"Incurrence of Indebtedness and Issuance of Preferred Stock."
58
<PAGE>
TRANSACTIONS WITH AFFILIATES
The Indenture will provide that the Company will not, and will not permit
any of its Restricted Subsidiaries to, sell, lease, transfer or otherwise
dispose of any of its properties or assets to, or purchase any property or
assets from, or enter into or make any contract, agreement, understanding, loan,
advance or guarantee with, or for the benefit of, any Affiliate (each of the
foregoing, an "Affiliate Transaction"), unless (i) such Affiliate Transaction is
on terms that are no less favorable to the Company or the relevant Restricted
Subsidiary than those that would have been obtained in a comparable transaction
by the Company or such Restricted Subsidiary with an unrelated Person and (ii)
the Company delivers to the Trustee (a) with respect to any Affiliate
Transaction involving aggregate consideration in excess of $1 million, a
resolution of the Board of Directors set forth in an Officers' Certificate
certifying that such Affiliate Transaction complies with clause (i) above and
that such Affiliate Transaction has been approved by a majority of the
disinterested members of the Board of Directors and (b) with respect to any
Affiliate Transaction involving aggregate consideration in excess of $10
million, an opinion as to the fairness to the Company or such Restricted
Subsidiary of such Affiliate Transaction from a financial point of view issued
by an investment banking firm of national standing; PROVIDED, HOWEVER, that (x)
any contract, agreement, understanding, payment, loan, advance or guarantee
(each a "Compensation Benefit") with, for the benefit of, or to an executive
officer of the Company as compensation for employment by the Company, whether
pursuant to an employment agreement, an employee benefit plan or other
compensation arrangement if either (1) such Compensation Benefit is less than $1
million or (2) is approved by the Compensation Committee or the Board of
Directors of the Company, (y) transactions between or among the Company and/or
its Restricted Subsidiaries and (z) transactions permitted by the covenant
entitled "-- Restricted Payments," in each case, shall not be deemed Affiliate
Transactions.
LIMITATION ON ISSUANCES AND SALES OF CAPITAL STOCK OF WHOLLY OWNED
RESTRICTED SUBSIDIARIES
The Indenture will provide that the Company (i) will not, and will not
permit any Wholly Owned Restricted Subsidiary of the Company to, transfer,
convey or sell any Capital Stock of any Wholly Owned Restricted Subsidiary of
the Company to any Person (other than the Company or a Wholly Owned Restricted
Subsidiary of the Company), unless (a) such transfer, conveyance or sale is of
all the Capital Stock of such Wholly Owned Restricted Subsidiary and (b) the
cash Net Proceeds from such transfer, conveyance or sale are applied in
accordance with the covenant described above under the caption "-- Asset Sales,"
and (ii) will not permit any Wholly Owned Restricted Subsidiary of the Company
to issue any of its Equity Interests (other than, if necessary, shares of its
Capital Stock constituting directors' qualifying shares) to any Person other
than to the Company or a Wholly Owned Restricted Subsidiary of the Company.
SUBSIDIARY GUARANTEES
The Indenture will provide that the Company will cause all Subsidiaries of
the Company that are designated or are otherwise deemed to be Restricted
Subsidiaries after the date of the Indenture (other than Foreign Subsidiaries)
to execute Subsidiary Guarantees. The Company may, at its option, cause any
Restricted Subsidiary that is a Foreign Subsidiary to execute a Subsidiary
Guarantee.
REPORTS
The Indenture will provide that, whether or not required by the rules and
regulations of the Securities and Exchange Commission (the "Commission"), so
long as any Senior Notes are outstanding, the Company will furnish to the
Holders of Senior Notes (i) all quarterly and annual financial information that
would be required to be contained in a filing with the Commission on Forms 10-Q
and 10-K if the Company were required to file such Forms including, in addition
to the "Management Discussion and Analysis of Financial Condition and Results of
Operations" with respect to the Company and its Subsidiaries required pursuant
to such Forms, (A) a "Management's Discussion and Analysis of Financial
Condition and Results of Operations" of the Company and its Restricted
Subsidiaries and (B) with respect to the annual information only, a report
thereon by the Company's certified independent accountants and (ii) all current
reports that would be required to be filed with the Commission on Form 8-K if
the Company were required to file such reports. In
59
<PAGE>
addition, whether or not required by the rules and regulations of the
Commission, the Company will file a copy of all such information and reports
with the Commission for public availability and make such information available
to securities analysts and prospective investors upon request.
EVENTS OF DEFAULT AND REMEDIES
The Indenture will provide that each of the following constitutes an Event
of Default: (i) default for 30 days in the payment when due of interest on any
Senior Note; (ii) default in payment when due of the principal of or premium, if
any, on any Senior Note; (iii) failure by the Company for 30 days to comply with
any of the provisions described under the captions "Certain Covenants -- Change
of Control," "-- Asset Sales," "-- Restricted Payments" or "-- Incurrence of
Indebtedness and Issuance of Preferred Stock"; (iv) failure by the Company for
60 days after notice to comply with any of its other agreements in the Indenture
or the Senior Notes; (v) default under any mortgage, indenture or instrument
under which there may be issued or by which there may be secured or evidenced
any Indebtedness for money borrowed by the Company or any of its Restricted
Subsidiaries (or the payment of which is guaranteed by the Company or any of its
Restricted Subsidiaries) whether such Indebtedness or guarantee now exists, or
is created after the date of the Indenture, which default (a) is caused by a
failure to pay principal of or premium, if any, or interest on such Indebtedness
prior to the expiration of the grace period provided in such Indebtedness on the
date of such default (a "Payment Default") or (b) results in the acceleration of
such Indebtedness prior to its express maturity and, in each case, the principal
amount of any such Indebtedness, together with the principal amount of any other
such Indebtedness under which there has been a Payment Default or the maturity
of which has been so accelerated, aggregates $5 million or more (excluding the
principal amount of the Senior Notes); (vi) failure by the Company or any of its
Restricted Subsidiaries to pay final judgments aggregating in excess of $5
million, which judgments are not paid, discharged or stayed for a period of 60
days; (vii) except as permitted by the Indenture or if, at the time thereof, the
obligor under such Subsidiary Guarantee is and is permitted to be designated as
an Unrestricted Subsidiary without causing a Default, any Subsidiary Guarantee
shall be held in any judicial proceeding to be unenforceable or invalid or shall
cease for any reason to be in full force and effect or any Subsidiary Guarantor,
or any Person acting on behalf of any Subsidiary Guarantor, shall deny or
disaffirm, in writing, its obligation under its Subsidiary Guarantee; and (viii)
certain events of bankruptcy or insolvency with respect to the Company or any of
its Subsidiaries.
If any Event of Default occurs and is continuing, the Trustee or the Holders
of at least 25% in principal amount of the then outstanding Senior Notes may
declare all the Senior Notes to be due and payable immediately. Notwithstanding
the foregoing, in the case of an Event of Default arising from certain events of
bankruptcy or insolvency, with respect to the Company, any Significant
Subsidiary or any group of Subsidiaries that, taken together, would constitute a
Significant Subsidiary, all outstanding Senior Notes will become due and payable
without further action or notice. Holders of the Senior Notes may not enforce
the Indenture or the Senior Notes except as provided in the Indenture. Subject
to certain limitations, Holders of a majority in principal amount of the then
outstanding Senior Notes may direct the Trustee in its exercise of any trust or
power. The Trustee may withhold from Holders of the Senior Notes notice of any
continuing Default or Event of Default (except a Default or event of Default
relating to the payment of principal, premium or interest) if it determines that
withholding notice is in their interest.
In the case of any Event of Default occurring by reason of any willful
action (or inaction) taken (or not taken) by or on behalf of the Company with
the intention of avoiding payment of the premium that the Company would have had
to pay if the Company then had elected to redeem the Senior Notes pursuant to
the optional redemption provisions of the Indenture, an equivalent premium shall
also become and be immediately due and payable to the extent permitted by law
upon the acceleration of the Senior Notes. If an Event of Default occurs prior
to by reason of any willful action (or inaction) taken (or not taken)
by or on behalf of the Company with the intention of avoiding the prohibition on
redemption of the Senior Notes prior to such date, then the Make-whole Premium
shall also become immediately due and payable to the extent permitted by law
upon the acceleration of the Senior Notes.
60
<PAGE>
The Holders of a majority in aggregate principal amount of the Senior Notes
then outstanding by notice to the Trustee may on behalf of the Holders of all of
the Senior Notes waive any existing Default or Event of Default and its
consequences under the Indenture except a continuing Default or Event of Default
in the payment of interest or premium on, or the principal of, the Senior Notes.
The Company is required to deliver to the Trustee annually a statement
regarding compliance with the Indenture, and the Company is required upon
becoming aware of any Default or Event of Default, to deliver to the Trustee a
statement specifying such Default or Event of Default.
NO PERSONAL LIABILITY OR DIRECTORS, OFFICERS, EMPLOYEES AND STOCKHOLDERS
No director, officer, employee, incorporator or stockholder of the Company
or any Subsidiary Guarantor, as such, shall have any liability for any
obligations of the Company or any Subsidiary Guarantor under the Senior Notes,
the Indenture or any Subsidiary Guarantee, or for any claim based on, in respect
of, or by reason of, such obligations or their creation. Each Holder of Senior
Notes by accepting a Senior Note waives and releases all such liability. The
waiver and release are part of the consideration for issuance of the Senior
Notes. Such waiver may not be effective to waive liabilities under the federal
securities laws and it is the view of the Commission that such a waiver is
against public policy.
LEGAL DEFEASANCE AND COVENANT DEFEASANCE
The Company may, at its option and at any time, elect to have all of its
obligations discharged with respect to the outstanding Senior Notes ("Legal
Defeasance") except for (i) the rights of Holders of outstanding Senior Notes to
receive payments in respect of the principal of, premium, if any, and interest
on such Senior Notes when such payments are due solely out of the trust funds
deposited pursuant to the following paragraph, (ii) the Company's obligations
with respect to the Senior Notes concerning issuing temporary Senior Notes,
registration of Senior Notes, mutilated, destroyed, lost or stolen Senior Notes
and the maintenance of an office or agency for payment and money for security
payments held in trust, and (iii) the rights, powers, trusts, duties and
immunities of the Trustee, and the Company's obligations in connection
therewith. In addition, the Company may, at its option and at any time, elect to
have the obligations of the Company released with respect to certain covenants
that are described in the Indenture ("Covenant Defeasance") and thereafter any
omission to comply with such covenants shall not constitute a Default or Event
of Default with respect to the Senior Notes. In the event Covenant Defeasance
occurs, certain events (not including non-payment, bankruptcy, receivership,
rehabilitation and insolvency events) described under "Events of Default" will
no longer constitute an Event of Default with respect to the Senior Notes.
In order to exercise either Legal Defeasance or Covenant Defeasance, (i) the
Company must irrevocably deposit with the Trustee, in trust, for the benefit of
the Holders of the Senior Notes, cash in U.S. dollars, non-callable Government
Securities, or a combination thereof, in such amounts as will be sufficient, in
the opinion of a nationally recognized firm of independent public accounts, to
pay the principal of, premium, if any, and interest on the outstanding Senior
Notes on the stated maturity or on the applicable redemption date, as the case
may be, and the Company must specify whether the Senior Notes are being defeased
to maturity or to a particular redemption date; (ii) in the case of Legal
Defeasance, the Company shall have delivered to the Trustee an Opinion of
Counsel in the United States reasonably acceptable to the Trustee confirming
that (A) the Company has received from, or there has been published by, the
Internal Revenue Service a ruling or (B) since the date of the Indenture, there
has been a change in the applicable federal income tax law, in either case to
the effect that, and based thereon such Opinion of Counsel shall confirm that,
the Holders of the outstanding Senior Notes will not recognize income, gain or
loss for federal income tax purposes as a result of such Legal Defeasance and
will be subject to federal income tax on the same amounts, in the same manner
and at the same times as would have been the case if such Legal Defeasance had
not occurred; (iii) in the case of Covenant Defeasance, the Company shall have
delivered to the Trustee an Opinion of Counsel in the United States reasonably
acceptable to the Trustee confirming that the Holders of the outstanding Senior
Notes will not recognize income, gain or loss for federal income tax purposes as
a result of such Covenant Defeasance and will be subject to federal income tax
on the same amounts, in the same manner and at the same times as would have been
the case if such Covenant Defeasance had not
61
<PAGE>
occurred, no Default or Event of Default shall have occurred and be continuing
on the date of such deposit (other than a Default or Event of Default resulting
from the borrowing of funds to be applied to such deposit) or insofar as Events
of Default from bankruptcy or insolvency events are concerned, at any time in
the period ending on the 91st day after the date of deposit; (v) such Legal
Defeasance or Covenant Defeasance will not result in a breach or violation of,
or constitute a default under any material agreement or instrument (other than
the Indenture) to which the Company or any of its Subsidiaries is a party or by
which the Company or any of its Subsidiaries is bound; (vi) the Company must
have delivered to the Trustee an Opinion of Counsel to the effect that after the
91st day following the deposit, the trust funds will not be subject to the
effect of any applicable bankruptcy, insolvency, reorganization or similar laws
affecting creditors' rights generally; (vii) the Company must deliver to the
Trustee an Officers' Certificate stating that the deposit was not made by the
Company with the intent of preferring the Holders of Senior Notes over the other
creditors of the Company with the intent of defeasing, hindering, delaying or
defrauding creditors of the Company or others; and (viii) the Company must
deliver to the Trustee an Officers' Certificate and an Opinion of Counsel, each
stating that all conditions precedent provided for relating to the Legal
Defeasance or the Covenant Defeasance have been complied with.
TRANSFER AND EXCHANGE
A Holder may transfer or exchange Senior Notes in accordance with the
Indenture. The Registrar and the Trustee may require a Holder, among other
things, to furnish appropriate endorsements and transfer documents and the
Company may require a Holder to pay any taxes and fees required by law or
permitted by the Indenture. The Company is not required to transfer or exchange
any Senior Note selected for redemption. Also, the Company is not required to
transfer or exchange any Senior Note for a period of 15 days before a selection
of Senior Notes to be redeemed.
The registered Holder of a Senior Note will be treated as the owner of it
for all purposes.
AMENDMENT, SUPPLEMENT AND WAIVER
Except as provided in the next two succeeding paragraphs, the Indenture or
the Senior Notes may be amended or supplemented with the consent of the Holders
of at least a majority in principal amount of the Senior Notes then outstanding
(including waivers obtained in connection with a tender offer or exchange offer
for Senior Notes), and any existing default or compliance with any provision of
the Indenture or the Senior Notes may be waived with the consent of the Holders
of a majority in principal amount of the then outstanding Senior Notes
(including consents obtained in connection with the tender offer or exchange
offer for Senior Notes).
Without the consent of each Holder affected, an amendment or waiver may not
(with respect to any Senior Notes held by a non-consenting Holder): (i) reduce
the principal amount of Senior Notes whose Holders must consent to an amendment,
supplement or waiver, (ii) reduce the principal of or change the fixed maturity
of any Senior Note or alter the provisions with respect to the redemption of the
Senior Notes (other than provisions relating to the covenants described above
under the captions "-- Repurchase at the Option of Holders"), (iii) reduce the
rate of or change the time for payment of interest on any Senior Note, (iv)
waive a Default or Event of Default in the payment of principal of or premium,
if any, or interest on the Senior Notes (except a rescission of acceleration of
the Senior Notes by the Holders of at least a majority in aggregate principal
amount of the Senior Notes and a waiver of the payment default that resulted
from such acceleration), (v) make any Senior Note payable in money other than
that stated in the Senior Notes, (vi) make any change in the provisions of the
Indenture relating to waivers of past Defaults or the rights of Holders of
Senior Notes to receive payments of principal of or premium, if any, or interest
on the Senior Notes, (vii) waive a redemption payment with respect to any Senior
Note (other than a payment required by one of the covenants described above
under the caption "-- Repurchase at the Option of Holders") or (viii) make any
change in the foregoing amendment and waiver provisions.
Without the consent of any Holder of Senior Notes, the Company and the
Trustee may amend or supplement the Indenture or the Senior Notes to cure any
ambiguity, defect or inconsistency, to provide for uncertificated Senior Notes
in addition to or in place of certificated Senior Notes, to provide for the
62
<PAGE>
assumption of the Company's obligations to Holders of Senior Notes in the case
of a merger or consolidation, to make any change that would provide any
additional rights or benefits to the Holders of Senior Notes or that does not
materially adversely affect the legal rights under the Indenture of any such
Holder, or to comply with requirements of the Commission in order to effect or
maintain the qualification of the Indenture under the Trust Indenture Act. The
Trustee may, without the consent of any Holders of the Senior Notes, waive any
Event of Default that relates to untimely or incomplete reports or information
if the legal rights of the Holders would not be materially adversely affected
thereby and may waive any other defaults the effect of which would not
materially adversely affect the rights of the Holders under the Indenture.
CONCERNING THE TRUSTEE
The Indenture contains certain limitations on the rights of the Trustee,
should it become a creditor of the Company, to obtain payment of claims in
certain cases, or to realize on certain property received in respect of any such
claim as security or otherwise. The Trustee will be permitted to engage in other
transactions; however, if it acquires any conflicting interest it must eliminate
such conflict within 90 days, apply to the Commission for permission to continue
or resign.
The Holders of a majority in principal amount of the then outstanding Senior
Notes will have the right to direct the time, method and place of conducting any
proceeding for exercising any remedy available to the Trustee, subject to
certain exceptions. The Indenture provides that in case an Event of Default
shall occur (which shall not be cured), the Trustee will be required, in the
exercise of its power, to use the degree of care of a prudent person in the
conduct of his own affairs. Subject to such provisions, the Trustee will be
under no obligation to exercise any of its rights or powers under the Indenture
at the request of any Holder of Senior Notes, unless such Holder shall have
provided to the Trustee security and indemnity satisfactory to it against any
loss, liability or expense.
CERTAIN DEFINITIONS
Set forth below are certain defined terms used in the Indenture. Reference
is made to the Indenture for a full disclosure of all such terms, as well as any
other capitalized terms used herein for which no definition is provided.
"ACQUIRED DEBT" means, with respect to the Company or any Restricted
Subsidiary of the Company, (i) Indebtedness of any other Person existing at the
time such other Person is merged with or into the Company or any such Restricted
Subsidiary or became a Restricted Subsidiary of the Company, including, without
limitation, Indebtedness incurred by such other Person in connection with, or in
contemplation of, such other Person merging with or into or becoming a
Restricted Subsidiary of the Company, and (ii) Indebtedness secured by a Lien
encumbering any asset acquired by such other Person prior to the date on which
the Company or any Restricted Subsidiary acquires such Person.
"ACQUISITION DEBT" means (i) Indebtedness incurred substantially
simultaneously with, and for the purpose of financing all or any part of the
purchase price or cost of, any acquisition of a Permitted Business, which
acquisition is permitted pursuant to the covenant entitled "-- Restricted
Payments" and (ii) Acquired Debt of the Person acquired with the proceeds of
Indebtedness described in the preceding clause (i).
"AFFILIATE" of any specified Person means any other Person directly or
indirectly controlling or controlled by or under direct or indirect common
control with such specified Person. For purposes of this definition, "control"
(including, with correlative meanings, the terms "controlling," "controlled by"
and "under common control with"), as used with respect to any Person, shall mean
the possession, directly or indirectly, of the power to direct or cause the
direction of the management or policies of such person, whether through the
ownership of voting securities, by agreement or otherwise; PROVIDED that
beneficial ownership of 10% or more of the voting securities of a Person shall
be deemed to be control; and PROVIDED FURTHER, that no employee or group of
employees of the Company (other than executive officers and directors) shall by
reason of their employment be deemed to be an Affiliate.
"APAO JOINT VENTURE" means a joint venture between the Company and any other
Person, other than URC, providing for the manufacture and sale of APAO outside
of the United States and Canada in geographic regions in which URC does not do
business.
63
<PAGE>
"APAO VENTURE INVESTMENT" means each of the following Investments by the
Company and its Restricted Subsidiaries in the APAO Joint Venture: (i)
Investments of cash in an aggregate amount outstanding at any time (measured by
their fair market value as of the date made) not in excess of the aggregate cash
received after the date of the Indenture by the Company and its Restricted
Subsidiaries from the APAO Joint Venture as fees for the licensing to the APAO
Joint Venture of any intellectual property rights or other proprietary
technology relating to the manufacture of APAO and (ii) the Guarantee by the
Company and any Subsidiary Guarantor of Indebtedness of the APAO Joint Venture
in a principal amount not exceeding $15 million less all Investments made by the
Company and the Subsidiary Guarantors to satisfy their obligations under any
such Guarantee.
"ASSET SALE" means (i) the sale, lease, transfer or conveyance of any assets
of the Company or any Restricted Subsidiary (including, without limitation, by
way of a sale and leaseback, but specifically excluding a sale and leaseback of
an asset occurring within 150 days after the completion of construction or
acquisition of such asset) other than in the ordinary course of business
(PROVIDED that the sale, lease, transfer or conveyance of all or substantially
all of the assets of the Company and its Restricted Subsidiaries taken as a
whole will be governed by the covenant entitled "-- Change of Control" and/or
the covenant entitled "-- Merger, Consolidation or Sale of Assets" and not by
the covenant entitled "Asset Sale"), (ii) the issuance by any Restricted
Subsidiary of the Company of Equity Interests of any of the Company's Restricted
Subsidiaries to any Person other than the Company or a Restricted Subsidiary,
and (iii) the sale by the Company or its Restricted Subsidiaries of Equity
Interests of any Restricted Subsidiary of the Company, in each case (a) whether
in a single transaction or a series of related transactions and (b) that have a
fair market value, as determined by the Board of Directors of the Company, in
excess of $1 million. Notwithstanding the foregoing: (i) a transfer of assets by
the Company to a Restricted Subsidiary or by a Restricted Subsidiary to the
Company or to another Restricted Subsidiary, (ii) a transfer of up to 375 acres
of undeveloped land located in Bayport, Texas, and owned by the Company on the
date of the Indenture, (iii) a disposition of any machinery, equipment,
furniture, apparatus, tools, implements, materials, supplies or other similar
property which have become worn out or obsolete, (iv) a Restricted Payment that
is permitted by the covenant entitled "-- Restricted Payments" or (v) a sale,
transfer or conveyance of any intellectual property rights of the Company (other
than those used in the CT Film division) to manufacture a product in any country
in which neither the Company nor any Restricted Subsidiary is manufacturing the
same product at the time of such sale, transfer or conveyance will not be deemed
to be an Asset Sale. In no event shall any sale, lease, transfer or conveyance
of (i) all or substantially all of the capital stock or assets of any of the
styrene, polymer or film businesses of the Company or (ii) all or substantially
all of the capital stock or assets of any Restricted Subsidiary or group of
Restricted Subsidiaries that singly or together would constitute a Significant
Subsidiary or (iii) assets which account for (A) at least 10% of the
consolidated assets of the Company and its Restricted Subsidiaries as of the end
of the most recently ended fiscal quarter of the Company or (B) at least 10% of
the Consolidated Cash Flow of the Company for the four full fiscal quarters
immediately preceding such sale, lease or conveyance be deemed to be made in the
ordinary course of business.
"BANK CREDIT AGREEMENTS" means one or more credit agreements between the
Company and lenders thereunder providing for term borrowings and/or revolving
borrowings, including all related notes, guarantees, collateral documents,
instruments and agreements executed in connection therewith, in each case as
amended, modified, renewed, refunded, replaced or refinanced, in whole or in
part, from time to time (and regardless of the number of lenders thereunder and
whether Indebtedness thereunder would constitute Permitted Refinancing
Indebtedness) and including, but not limited to, the New Credit Agreement.
"BORROWING BASE" means the greater of (i) $80 million and (ii) the sum of
(A) 80% of the net book value of all accounts receivable of the Company that are
not more than 60 days past due and (B) 60% of the net book value of all
inventory of the Company.
"CAPITAL LEASE OBLIGATION" means, at the time any determination thereof is
to be made, the amount of the liability in respect of a capital lease that would
at such time be required to be capitalized on a balance sheet in accordance with
GAAP.
64
<PAGE>
"CAPITAL STOCK" means (i) in the case of a corporation, corporate stock,
(ii) in the case of an association or business entity, any and all shares,
interests, participation, rights or other equivalents (however designated) of
corporate stock, (iii) in the case of a partnership, partnership interests
(whether general or limited) and (iv) any other interest or participation that
confers on a Person the right to receive a share of the profits and losses of,
or distributions of assets of, the issuing Person.
"CASH EQUIVALENTS" means (i) United States dollars, pounds sterling and any
other freely convertible currency, (ii) securities issued or directly and fully
guaranteed or insured by the United States government or any agency or
instrumentality thereof, having maturities of not more than six months from the
date of acquisition, (iii) certificates of deposit and eurodollar time deposits,
with maturities of six months or less from the date of acquisition, bankers'
acceptances with maturities not exceeding six months and overnight bank
deposits, in each case with any domestic commercial bank having capital and
surplus in excess of $500 million and a Keefe Bank Watch Rating of "B" or
better, (iv) repurchase obligations with a term of not more than seven days for
underlying securities of the types described in clauses (ii) and (iii) above
entered into with any financial institution meeting the qualifications specified
in clause (iii) above and (v) commercial paper having the highest rating
obtainable from Moody's Investors Service, Inc. or Standard & Poor's Corporation
and in each case maturing within six months after the date of acquisition.
"CHANGE OF CONTROL" means the occurrence of any of the following: (1) the
sale, lease, transfer, conveyance or other disposition in one or a series of
related transactions, by merger or consolidation or otherwise, of all or
substantially all of the assets of the Company and its Restricted Subsidiaries
taken as a whole to any Person or Group (as such term is used in Sections
13(d)(3) and 14(d)(2) of the Exchange Act), (ii) the adoption of a plan relating
to the liquidation or dissolution of the Company unless such plan is abandoned
within 30 days after the date of adoption of such plan, (iii) the acquisition by
any Person or Group (as defined above) of a direct or indirect interest in more
than 50% of the voting power of the voting stock of the Company, by way of
merger or consolidation or otherwise; or (iv) the first day on which a majority
of the members of the Board of Directors of the Company are not Continuing
Directors. For purposes of this definition, any transfer of an Equity Interest
of an entity that was formed for the purpose of acquiring voting stock of the
Company will be deemed to be a transfer of such portion of such voting stock as
corresponds to the portion of the equity of such entity that has been so
transferred, and the acquisition of voting power of the voting stock of the
Company by any Subsidiary of the Company shall be disregarded.
"COGEN ASSETS" means (i) feasibility studies and other similar developmental
items related to one or more joint ventures to produce steam and power for the
Odessa Facility; PROVIDED, HOWEVER, that the aggregate cost thereof does not
exceed $3.0 million and (ii) up to ten acres of unused land at the Odessa
Facility which is owned by the Company as of the date of the Indenture.
"CONSOLIDATED CASH FLOW" means, with respect to any Person for any period,
the Consolidated Net Income of such Person for such period PLUS (i) an amount
equal to any extraordinary loss plus any net loss realized in connection with an
Asset Sale (to the extent such losses were deducted in computing such
Consolidated Net Income), PLUS (ii) provision for taxes based on income or
profits of such Person and its Restricted Subsidiaries for such period, to the
extent that such provision for taxes was included in computing such Consolidated
Net Income PLUS (iii) consolidated interest expense of such Person and its
Restricted Subsidiaries for such period, whether paid or accrued and whether or
not capitalized (including, without limitation, amortization of original issue
discount, non-cash interest payments, the interest component of any deferred
payment obligations, the interest component of all payments associated with
Capital Lease Obligations, commissions, discounts and other fees and charges
incurred in respect of letter of credit or bankers' acceptance financings, and
net payments (if any) pursuant to Hedging Obligations), to the extent that any
such expense was deducted in computing such Consolidated Net Income, PLUS (iv)
depreciation and amortization (including amortization of goodwill and other
intangibles but excluding amortization of prepaid cash expenses that were paid
in a prior period) of such Person and its Restricted Subsidiaries for such
period to the extent that such depreciation and amortization were deducted in
computing such Consolidated Net Income PLUS (v) any other non-cash charges that
were deducted in computing such Consolidated Net Income less all non-cash income
that was included in computing such Consolidated Net Income. Notwithstanding the
foregoing, the provision for taxes on the income or profits of, and the
depreciation and
65
<PAGE>
amortization of, a Subsidiary of the referent person shall be added to
Consolidated Net Income to compute Consolidated Cash Flow only to the extent
(and in same proportion) that the Net Income of such Subsidiary was included in
calculating the Consolidated Net Income of such Person and only if a
corresponding amount would be permitted at the date of determination to be
dividended to the Company by such Subsidiary without prior approval, pursuant to
the terms of its charter and all agreements, instruments, judgments, decrees,
orders, statutes, rules and governmental regulations applicable to that
Subsidiary or its stockholders.
"CONSOLIDATED NET INCOME" means, with respect to any Person for any period,
the aggregate of the Net Income of such Person and its Restricted Subsidiaries
for such period, on a consolidated basis, determined in accordance with GAAP;
PROVIDED that (i) except as set forth in clause (v) below, the Net Income of any
Person that is not a Restricted Subsidiary or that is accounted for by the
equity method of accounting shall be included only to the extent of the amount
of dividends or distributions paid in cash to the referent Person or a Wholly
Owned Restricted Subsidiary thereof, (ii) the Net Income of any Restricted
Subsidiary shall be excluded to the extent that the declaration or payment of
dividends or similar distributions by that Restricted Subsidiary of that Net
Income is not at the date of determination permitted without any prior
governmental approval (which has not been obtained) or, directly or indirectly,
by operation of the terms of its charter or any agreement, instrument, judgment,
decree, order, statute, rule or governmental regulation applicable to that
Restricted Subsidiary or its stockholders, (iii) the Net Income of any Person
acquired in a pooling of interests transaction for any period prior to the date
of such acquisition shall be excluded, (iv) the cumulative effect of a change in
accounting principles shall be excluded and (v) the Net Income of any
Unrestricted Subsidiary shall be excluded, whether or not distributed to the
Company or one of its Subsidiaries.
"CONSOLIDATED NET WORTH" means, with respect to any Person as of any date,
the sum of (i) the consolidated equity of the common stockholders of such Person
and its consolidated Subsidiaries as of such date plus (ii) the respective
amounts reported on such Person's balance sheet as of such date with respect to
any series of preferred stock (other than Disqualified Stock) that by its terms
is not entitled to the payment of dividends unless such dividends may be
declared and paid only out of net earnings in respect of the year of such
declaration and payment, but only to the extent of any cash received by such
Person upon issuance of such preferred stock, LESS (x) all write-ups (other than
write-ups resulting from foreign currency translations and write-ups of tangible
assets of a going concern business made within 12 months after the acquisition
of such business) subsequent to the date of the Indenture in the book value of
any asset owned by such Person or a consolidated Subsidiary of such Person, (y)
all investments as of such date in unconsolidated Subsidiaries and in Persons
that are not Subsidiaries (except, in each case, Permitted Investments), and (z)
all unamortized debt discount and expense and unamortized deferred charges as of
such date, all of the foregoing determined in accordance with GAAP.
"CONTINUING DIRECTORS" means, as of any date of determination, any member of
the Board of Directors of the Company who (i) was a member of such Board of
Directors on the date of the Indenture or (ii) was nominated for election or
elected to such Board of Directors with the affirmative vote of a majority of
the Continuing Directors who were members of such Board at the time of such
nomination or election.
"CONTRACT OBLIGATIONS" means contractual obligations of the Company and any
Subsidiary Guarantor to repay or credit to a third party amounts advanced by
such third party (or its Affiliates) to the Company or any Subsidiary Guarantor,
which obligations to repay or credit are secured by a lien on the assets of the
Company and/or any Subsidiary Guarantor. The amount of Contract Obligations
outstanding as of any date shall be equal to the aggregate amount of remaining
payments required to be made by, and credits required to be given by, the
Company and/or the Subsidiary Guarantors under the agreements related to such
Contractual Obligations at such time.
"CURRENCY AGREEMENT" means the obligation of any Person pursuant to any
foreign exchange contract, currency swap agreement or other similar agreement or
arrangement designed to protect such Person against fluctuations in currency
values.
"DEFAULT" means any event that is or with the passage of time or the giving
of notice or both would be an Event of Default.
66
<PAGE>
"DESIGNATED UNRESTRICTED SUBSIDIARY" means, as of any date, any Unrestricted
Subsidiary of the Company from which the Company and its Wholly Owned Restricted
Subsidiaries have received, as of the date of determination, cash distributions
in an amount less than the Investments made by the Company and its Restricted
Subsidiaries in such Unrestricted Subsidiary.
"DISQUALIFIED STOCK" means any Capital Stock that, by its terms (or by the
terms of any security into which it is convertible or for which it is
exchangeable), or upon the happening of any event, matures or is mandatorily
redeemable, pursuant to a sinking fund obligation or otherwise, or redeemable at
the option of the Holder thereof, in whole or in part, on or prior to the date
that is 91 days after the date on which the Senior Notes mature.
"EQUITY INTERESTS" means Capital Stock and all warrants, options or other
rights to acquire Capital Stock (but excluding any debt security that is
convertible into, or exchangeable for, Capital Stock).
"EXISTING DEBT" means all Indebtedness outstanding on the date of the
Indenture.
"FIXED CHARGES" means, with respect to any Person for any period, the sum of
(i) the consolidated interest expense of such Person and its Restricted
Subsidiaries for such period, whether paid or accrued, to the extent that such
expense was deducted in computing Consolidated Net Income (excluding all
non-cash amortization of financing fees incurred in connection with the
Recapitalization and including, without limitation, the interest component of
any deferred payment obligations, the interest component of all payments
associated with Capital Lease Obligations, commissions, discounts and other fees
and charges incurred in respect of letter of credit or bankers' acceptance
financings, and net payments (if any) pursuant to Hedging Obligations) and (ii)
the consolidated interest expense of such Person and its Restricted Subsidiaries
that was capitalized during such period, and (iii) any interest expense on
Indebtedness of another Person that is Guaranteed by such Person or any of its
Restricted Subsidiaries or secured by a Lien on assets of such Person or any of
its Restricted Subsidiaries (whether or not such Guarantee or Lien is called
upon) and (iv) the product of (a) all cash dividend payments (and non-cash
dividend payments in the case of a Person that is a Restricted Subsidiary) on
any series of preferred stock of such Person, times (b) a fraction, the
numerator of which is one and the denominator of which is one minus the then
current combined federal, state and local statutory tax rate of such Person,
expressed as a decimal, in each case, on a consolidated basis and in accordance
with GAAP.
"FIXED CHARGE COVERAGE RATIO" means with respect to any Person for any
period, the ratio of the Consolidated Cash Flow of such Person for such period
to the Fixed Charges of such Person for such period. In the event that the
Company or any of its Restricted Subsidiaries incurs, assumes, Guarantees or
redeems any Indebtedness (other than revolving credit borrowings) or issues
preferred stock subsequent to the commencement of the period for which the Fixed
Charge Coverage Ratio is being calculated but prior to the date on which the
event for which the calculation of the Fixed Charge Coverage Ratio is made (the
"Calculation Date"), then the Fixed Charge Coverage Ratio shall be calculated
giving pro forma effect to such incurrence, assumption, Guarantee or redemption
of Indebtedness, or such issuance or redemption of preferred stock, as if the
same had occurred at the beginning of the applicable four-quarter reference
period. For purposes of making the computation referred to above, (i)
acquisitions that have been made by the Company or any of its Restricted
Subsidiaries, including through mergers or consolidations and including any
related financing transactions, during the four-quarter reference period or
subsequent to such reference period and on or prior to the Calculation Date
shall be deemed to have occurred on the first day of the four-quarter reference
period, and (ii) the Consolidated Cash Flow attributable to discontinued
operations, as determined in accordance with GAAP, and operations or businesses
disposed of prior to the Calculation Date, shall be excluded, and (iii) the
Fixed Charges attributable to discontinued operations, as determined in
accordance with GAAP, and operations or businesses disposed of prior to the
Calculation Date, shall be excluded, but only to the extent that the obligations
giving rise to such Fixed Charges will not be obligations of the referent Person
or any of its Restricted Subsidiaries following the Calculation Date.
"FOREIGN SUBSIDIARY" means any Subsidiary of the Company organized under the
laws of a jurisdiction outside of the United States.
67
<PAGE>
"FOREIGN SUBSIDIARY BORROWING BASE" means, with respect to any Foreign
Subsidiary that is a Restricted Subsidiary and not a Subsidiary Guarantor, the
sum of (A) 80% of the net book value of all accounts receivable of such Foreign
Subsidiary that are not more than 60 days past due and (B) 60% of the net book
value of all inventory of such Foreign Subsidiary.
"GAAP" means generally accepted accounting principles set forth in the
opinions and pronouncements of the Accounting Principles Board of the American
Institute of Certified Public Accountants and statements and pronouncements of
the Financial Accounting Standards Board or in such other statements by such
other entity as have been approved by a significant segment of the accounting
profession, which are in effect on the date of the Indenture; provided, however,
that for purposes of all information and other reports required to be delivered
pursuant to the covenant described under the caption "Reports", GAAP shall mean
such generally accepted accounting principles as are in effect from time to
time.
"GUARANTEE" means, with respect to any Person, a guarantee (other than by
endorsement of negotiable instruments for collection in the ordinary course of
business), direct or indirect, in any manner (including, without limitation,
letters of credit and reimbursement agreements in respect thereof), of all or
any part of any Indebtedness that is owed by any other Person.
"HEDGING OBLIGATIONS" means, with respect to any Person, the obligations of
such Person under (i) Currency Agreements, (ii) Interest Rate Agreements and
(iii) agreements to protect against fluctuations in the price of feedstocks.
"HOLDER" means a Person in whose name a Senior Note is registered.
"INDEBTEDNESS" means, with respect to any Person, any indebtedness of such
Person, whether or not contingent, in respect of borrowed money or evidenced by
bonds, notes, debentures or similar instruments or letters of credit (or
reimbursement agreements in respect thereof) or indebtedness representing
Hedging Obligations, Capital Lease Obligations or the balance of the deferred
and unpaid portion of the purchase price of any property, except any such
balance that constitutes an accrued expense or trade payable, if and to the
extent any of the foregoing indebtedness (other than letters of credit and
Hedging Obligations) would appear as a liability upon a balance sheet of such
Person prepared in accordance with GAAP, as well as all Indebtedness of others
secured by a Lien on any asset of such Person (whether or not such Indebtedness
is assumed by such Person) and, to the extent not otherwise included, the
Guarantee by such Person of any indebtedness of any other Person other than a
Restricted Subsidiary of such Person.
"INTEREST RATE AGREEMENT" means the obligations of any person pursuant to
any interest rate swap agreement, interest rate collar agreement or other
similar agreement or arrangement designed to protect such Person against
fluctuations in interest rates.
"INVESTMENT" means, with respect to the Company and its Restricted
Subsidiaries, any investment by the Company or any of its Restricted
Subsidiaries in other Persons (including Affiliates) in the form of loans
(including Guarantees of Indebtedness), advances (excluding commission, travel
and similar advances to officers and employees made in the ordinary course of
business), capital contributions, purchases or other acquisitions from such
other Persons for consideration of Indebtedness, Equity Interests, cash or other
property, and all other items that are or would be classified as investments on
a balance sheet prepared in accordance with GAAP.
"LIEN" means, with respect to any asset owned by the Company or its
Restricted Subsidiaries, any mortgage, lien, pledge, charge, security interest
or encumbrance of any kind in respect of such asset, whether or not filed,
recorded or otherwise perfected under applicable law (including any conditional
sale or other title retention agreement, any option or other agreement to sell
or give a security interest in and any filing of or agreement to give any
financing statement under the Uniform Commercial Code (or equivalent statutes)
of any jurisdiction).
"MAKE-WHOLE PREMIUM" means, as of any date of determination, the greater of
(a) 1.0% of the then outstanding principal amount of the Senior Notes or (b) the
excess of (A) the present value of all required interest and principal payments
due on such Senior Notes from and after such date to the first date that the
68
<PAGE>
Senior Notes may be redeemed at the option of the Company assuming all such
Senior Notes so redeemed and computed using a discount rate equal to the
Treasury Rate on such date plus 100 basis points compounded semi-annually over
(B) the then outstanding principal amount of the Senior Notes.
"NET INCOME" means, with respect to any Person, the net income (loss) of
such Person, determined in accordance with GAAP and before any reduction in
respect of preferred stock dividends, excluding, however (i) any gain (but not
loss), together with any related provision for taxes on such gain (but not
loss), realized in connection with (a) any Asset Sale (including, without
limitation dispositions pursuant to sale and leaseback transactions) or (b) the
disposition of any securities by such Person or any of its Restricted
Subsidiaries or the extinguishment of any Indebtedness of such Person or any of
its Restricted Subsidiaries and (ii) any extraordinary gain (but not loss),
together with any related provision for taxes on such extraordinary gain (but
not loss).
"NET PROCEEDS" means the aggregate proceeds of cash and Cash Equivalents
received by the Company or any of its Restricted Subsidiaries in respect of any
Asset Sale (including, without limitation, any cash received upon the sale or
other disposition of any non-cash consideration received in any Asset Sale), net
of the direct costs relating to such Asset Sale (including, without limitation,
legal, accounting and investment banking fees, and sales commissions) and any
relocation expenses incurred as a result thereof, taxes paid or payable as a
result thereof (after taking into account any available tax credits or
deductions and any tax sharing arrangements) and any reserve for adjustment in
respect of the sale price of such asset or assets established in accordance with
GAAP.
"NEW CREDIT AGREEMENT" means the Credit Agreement, dated as of
, between the Company, the Bank of Nova Scotia and the lenders
party thereto.
"OBLIGATIONS" means any principal, interest, penalties, fees,
indemnifications, reimbursements, damages and other liabilities payable under
the documentation governing any Indebtedness.
"OBSOLETE PLANTS" means plant and equipment, together with land on which
such plant and equipment is situated, at the Odessa Facility that, as of the
date of the Indenture, has been shut down (other than plant or equipment that
has been temporarily shut down for repairs or maintenance); PROVIDED, HOWEVER,
that the aggregate net book value of all such Obsolete Plants on the date of the
Indenture shall not exceed $2.0 million.
"PERMITTED BUSINESS" means any business that is not unrelated to the
businesses in which the Company is engaged on the date of the Indenture.
"PERMITTED INVESTMENTS" means (a) Investments in the Company or in a Wholly
Owned Restricted Subsidiary of the Company; (b) Investments in Cash Equivalents;
(c) Investments by the Company or any Restricted Subsidiary of the Company in a
Person, if as a result of such Investment (i) such Person becomes a Wholly Owned
Restricted Subsidiary of the Company or (ii) such Person is merged, consolidated
or amalgamated with or into, or transfers or conveys substantially all of its
assets to, or is liquidated into, the Company or a Wholly Owned Restricted
Subsidiary of the Company; (d) the APAO Venture Investments and the URC Venture
Investments; (e) Investments received as consideration for Asset Sales permitted
under Indenture; (f) Investments by the Company and its Restricted Subsidiaries
in RCL not exceeding the amount of such Investment on the date of the Indenture,
calculated as of the date of each such Investment, (g) the transfer by the
Company of the Cogen Assets to one or more joint ventures and (h) other
Investments in joint ventures or Unrestricted Subsidiaries of the Company that
are engaged in a Permitted Business in an aggregate amount outstanding at any
time (measured by their fair market value as of the date made) not exceeding $15
million.
"PERMITTED LIENS" means:
(i) Liens on assets of the Company and the Subsidiary Guarantors securing
Indebtedness permitted to be incurred pursuant to clauses (i) and (ii) of the
second paragraph of the covenant entitled "-- Incurrence of Indebtedness and
Issuance of Preferred Stock";
(ii) Liens in favor of the Company or any Subsidiary Guarantor;
69
<PAGE>
(iii) first priority Liens (other than Liens permitted pursuant to any other
clause of this definition) securing Indebtedness of the Company and any
Subsidiary Guarantor that is not subordinated to any other Indebtedness of the
Company or such Subsidiary Guarantor and/or Contract Obligations of the Company
or such Subsidiary Guarantor, PROVIDED that the sum of the aggregate principal
amount of such Indebtedness and the total amount of such Contract Obligations
outstanding from time to time does not exceed $100 million LESS the principal
amount of Senior Term Debt (and Permitted Refinancing Indebtedness with respect
thereto) outstanding as of such time;
(iv) Liens existing on the property of any Person at the time such Person
becomes a Restricted Subsidiary of the Company (excluding Liens which were
incurred in connection with, or in contemplation of, such Person becoming a
Restricted Subsidiary of the Company) that do not extend to any other property
of the Company or its Restricted Subsidiaries;
(v) Liens on the shares of URC stock now owned or hereafter acquired by the
Company and on patents of the Company licensed to URC, in each case, to the
extent required pursuant to the agreements governing the URC Venture Investment,
as amended from time to time;
(vi) Liens on (x) the Company's Equity Interest in the APAO Joint Venture
and (y) intellectual property rights permitted by the Indenture to be licensed
and licensed to the APAO Joint Venture required pursuant to the agreements
governing the APAO Investments;
(vii) Liens to secure Acquisition Debt permitted to be incurred pursuant to
the covenant entitled "-- Incurrence of Indebtedness and Issuance of Preferred
Stock"; PROVIDED, HOWEVER, that (a) such Liens shall either (1) extend only to
the assets acquired with the proceeds of such Acquisition Debt or (2) otherwise
be permitted by clause (iv) or (xvii) of this definition, (b) the Acquisition
Debt secured thereby shall not exceed the fair market value of the assets
acquired with the proceeds of such Acquisition Debt and (c) such Lien shall be
created simultaneously with the incurrence of such Acquisition Debt.
(viii) Liens for taxes, assessments or governmental charges or claims that are
not yet delinquent or that are being contested in good faith by appropriate
proceedings promptly instituted and diligently concluded, provided that any
reserve or other appropriate provision as shall be required in conformity with
GAAP shall have been made therefor;
(ix) landlords', carriers', vendors', warehousemen's, mechanics',
materialmen's, repairmen's or other like Liens arising by operating of law in
the ordinary course of business and with respect to amounts that are not yet
delinquent or that are being contested in good faith by appropriate proceedings,
promptly instituted and diligently concluded, provided that any reserve or other
appropriate provision as shall be required in conformity with GAAP shall have
been made therefor;
(x) pledges or deposits in connection with workers' compensation,
unemployment insurance and other social security legislation;
(xi) deposits to secure the performance of bids, trade contracts, statutory
obligations, surety and appeal bonds, performance bonds and other obligations of
like nature incurred in the ordinary course of business;
(xii) easements, rights of way, restrictions, licenses, consignments and
other similar encumbrances on any property of the Company or of any Restricted
Subsidiary, including Liens constituting leases or subleases to third parties
granted by the Company or any Restricted Subsidiary, in each case to the extent
incurred in the ordinary course of business;
(xiii) judgment Liens that do not constitute a Default;
(xiv) Liens on unearned premiums of insurance policies that secure the
financing of such premiums for such policies;
(xv) Liens arising pursuant to Section 107(1) of the Comprehensive
Environmental Response, Compensation and Liability Act (42 U.S.C.
Section9607(1)) or pursuant to analogous state statutes, PROVIDED that the
aggregate of all obligations in respect of which the Company is required to
record a reserve in accordance with GAAP that are secured by such Liens shall
not exceed $ million at any time;
70
<PAGE>
(xvi) Liens existing on the date of the Indenture;
(xvii) Liens on property existing at the time of acquisition thereof by the
Company or any Restricted Subsidiary of the Company; PROVIDED that such Liens
were in existence prior to contemplation of such acquisition;
(xviii) Liens on assets of any Person which is not a Restricted Subsidiary;
(xix) Liens incurred to secure (A) Purchase Money Financings or (B) Capital
Lease Obligations but only, in the case of (A) and (B), if such Liens do not
extend to any assets other than the assets purchased with the proceeds of the
corresponding Purchase Money Financing or which are the subject of such Capital
Lease Obligation, and in each case to the extent the Indebtedness secured
thereby is permitted to be incurred pursuant to the covenant entitled "--
Incurrence of Indebtedness and Issuance of Preferred Stock";
(xx) Liens on accounts receivable and inventory of Foreign Subsidiaries that
are Restricted Subsidiaries and not Subsidiary Guarantors to secure Indebtedness
permitted to be incurred pursuant to clause (x) of second paragraph of the
covenant entitled "-- Incurrence of Indebtedness and Issuance of Preferred
Stock"; and
(xxi) Liens securing any extension, renewal or refunding of any obligations
secured by the foregoing Liens that do not increase the obligations secured
thereby and do not extend such Lien to any assets other than those previously
securing such obligations.
"PERMITTED REFINANCING INDEBTEDNESS" means any Indebtedness issued in
exchange for, or the net proceeds of which are used to extend, refinance, renew,
replace, defease or refund Indebtedness (other than the Senior Notes); PROVIDED
that: (i) the principal amount of such Permitted Refinancing Indebtedness does
not exceed the principal amount of the Indebtedness so extended, refinanced,
renewed, replaced, defeased or refunded (plus the amount of reasonable expenses
incurred in connection therewith), (ii) such Permitted Refinancing Indebtedness
has a final maturity date later than the final maturity date of, and has a
Weighted Average Life to Maturity equal to or greater than the Weighted Average
Life to Maturity of, the Indebtedness being extended, refinanced, renewed,
replaced, defeased or refunded; and (iii) if the Indebtedness being extended,
refinanced, renewed, replaced, defeased or refunded is subordinated in right of
payment to the Senior Notes or any Subsidiary Guarantee, such Permitted
Refinancing Indebtedness has a final maturity date later than the final maturity
date of, and is subordinated in right of payment to, the Senior Notes and the
Subsidiary Guarantee on terms at least as favorable to the Holders of Senior
Notes as those contained in the documentation governing the Indebtedness being
extended, refinanced, renewed, replaced, defeased or refunded.
"PERSON" means an individual, corporation, limited liability company,
partnership, association, joint stock company, trust or trustee thereof, estate
or executor thereof, unincorporated organization or joint venture.
"PURCHASE MONEY FINANCING" means, with respect to any Person, Indebtedness
incurred to finance the purchase of any assets of such Person (within 90 days of
such purchase) to the extent (i) the amount of Indebtedness thereunder shall not
exceed 95% of the purchase cost of such assets, (ii) the purchase cost for such
assets is or should be included in "additions to property plant and equipment"
in accordance with GAAP and (iii) the purchase of such assets is not part of an
acquisition of any Person.
"RCL" means Rexene Corporation Limited, an English company.
"RECAPITALIZATION" shall have the meaning ascribed to such term in the
Registration Statement on Form S-3 relating to the Senior Notes.
"RESTRICTED INVESTMENT" means any Investment other than a Permitted
Investment.
"RESTRICTED SUBSIDIARY" of a Person means any Subsidiary of the Company that
is designated as a Restricted Subsidiary by the Board of Directors or otherwise
fails to meet the requirement set forth in the definition of Unrestricted
Subsidiary.
71
<PAGE>
"SENIOR REVOLVING DEBT" means revolving credit borrowings under the Bank
Credit Agreements.
"SENIOR TERM DEBT" means term borrowings under the Bank Credit Agreements.
"SIGNIFICANT SUBSIDIARY" means any Subsidiary that would be a "significant
subsidiary" as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated
pursuant to the Act.
"SUBSIDIARY" means, with respect to any Person, (i) any corporation,
association or other business entity of which more than 50% of the total voting
power of shares of Capital Stock entitled (without regard to the occurrence of
any contingency) to vote in the election of directors, managers or trustees
thereof is at the time owned or controlled, directly or indirectly, by such
Person or one or more Subsidiaries of that Person (or a combination thereof) and
(ii) any partnership (a) the sole general partner or the managing general
partner of which is such Person or a Subsidiary of such Person or (b) the only
general partners of which are such Person or of one or more Subsidiaries of such
Person (or any combination thereof).
"SUBSIDIARY GUARANTEE" means (i) the full and unconditional guarantee by a
Restricted Subsidiary (other than a Foreign Subsidiary) of all of the Company's
obligations under the Indenture and the Senior Notes delivered pursuant to the
covenant entitled "Subsidiary Guarantees" and (ii) the full and unconditional
guarantee of all of the Company's obligations under the Indenture and the Senior
Notes by any Foreign Subsidiary that is a Restricted Subsidiary that elects to
so guarantee such obligations, in each case, in the form required by the
Indenture.
"SUBSIDIARY GUARANTOR" means any Restricted Subsidiary that has executed a
Subsidiary Guarantee.
"UNRESTRICTED SUBSIDIARY" means (i) each of the Subsidiaries of the Company
in existence on the date of the Indenture and (ii) any Subsidiary formed or
acquired by the Company after the date of the Indenture, but only to the extent
that such Subsidiary: (a) is not party to any agreement, contract, arrangement
or understanding with the Company or any Restricted Subsidiary of the Company
unless the terms of any such agreement, contract, arrangement or understanding
are no less favorable to the Company or such Restricted Subsidiary than those
that might be obtained at the time from Persons who are not Affiliates of the
Company; (b) is a Person with respect to which neither the Company nor any of
its Restricted Subsidiaries has any direct or indirect obligation to maintain or
preserve such Person's financial condition or to cause such Person to achieve
any specified levels of operating results; (c) has not guaranteed or otherwise
directly or indirectly provided credit support for any Indebtedness of the
Company or any of its Restricted Subsidiaries; and (d) has at least one director
on its board of directors that is not a director or executive officer of the
Company or any of its Restricted Subsidiaries and has at least one executive
officer that is not a director or executive officer of the Company or any of its
Restricted Subsidiaries. Any such designation by the Board of Directors shall be
evidenced to the Trustee by filing with the Trustee a certified copy of the
Board Resolution giving effect to such designation and an Officers' Certificate
certifying that such designation complied with the foregoing conditions and was
permitted by the covenant described above under the caption "Certain Covenants
- -- Restricted Payments." If, at any time, any Unrestricted Subsidiary would fail
to meet the foregoing requirements as an Unrestricted Subsidiary, it shall
thereafter cease to be an Unrestricted Subsidiary for purposes of the Indenture
and any Indebtedness of such Subsidiary shall be deemed to be incurred by a
Restricted Subsidiary of the Company as of such date (and, if such Indebtedness
is not permitted to be incurred as of such date under the covenant described
under the caption "Incurrence of Indebtedness and Issuance of Preferred Stock,"
the Company shall be in default of such covenant unless such default shall have
been cured within a period of 30 days thereafter). The Board of Directors of the
Company may at any time designate any Unrestricted Subsidiary to be a Restricted
Subsidiary; PROVIDED that such designation shall be deemed to be an incurrence
of Indebtedness by a Restricted Subsidiary of the Company of any outstanding
Indebtedness of such Unrestricted Subsidiary and such designation shall only be
permitted if (i) such Indebtedness is permitted under the covenant described
under the caption "Certain Covenants -- Incurrence of Indebtedness and Issuance
of Preferred Stock," (ii) no Default or Event of Default would be in existence
following such designation and (iii) unless such Subsidiary is a Foreign
Subsidiary, such Subsidiary executes a Subsidiary Guarantee.
72
<PAGE>
"URC VENTURE INVESTMENT" means (i) all Investments by the Company in URC
outstanding as of the date of the Indenture, PLUS (ii) all Investments made by
the Company and its Restricted Subsidiaries in URC after the date of the
Indenture; PROVIDED, HOWEVER, that the aggregate amount of all such Investments
made after the date of the Indenture (measured by their fair market value as of
the date made) shall not exceed the aggregate amount of the cash received after
the date of the Indenture by the Company and its Restricted Subsidiaries as fees
for the licensing of any intellectual property rights or other proprietary
technology to URC and (iii) the Guaranty (as defined in the Joint Venture
Modification Agreement dated as of (and as in effect on) February 25, 1992
between the Company and UBE Industries Inc.); PROVIDED that at no time shall the
Guaranty made by the Company and its Restricted Subsidiaries (A) be with
recourse to the Company or any of its Subsidiaries or (B) be secured by any
Liens on the property of the Company or any of its Subsidiaries (other than
Liens permitted pursuant to clause (v) of the definition of Permitted Liens);
and PROVIDED FURTHER that the amount of the obligations guaranteed pursuant to
such Guaranty shall be reduced by the amount of all Investments made to satisfy
the Company's obligations under such Guaranty.
"URC" means Ube Rexene Corporation, a Japanese corporation.
"WEIGHTED AVERAGE LIFE TO MATURITY" means, when applied to any Indebtedness
at any date, the number of years obtained by dividing (i) the sum of the
products obtained by multiplying (a) the amount of each then remaining
installment, sinking fund, serial maturity or other required payments of
principal, including payment at final maturity, in respect thereof, by (b) the
number of years (calculated to the nearest one-twelfth) that will elapse between
such date and the making of such payment, by (ii) the then outstanding principal
amount of such Indebtedness.
"WHOLLY OWNED RESTRICTED SUBSIDIARY" of any Person means a Restricted
Subsidiary of such Person all of the outstanding Capital Stock or other
ownership interests of which (other than directors' qualifying shares) shall at
the time be owned by such Person or by one or more Wholly Owned Restricted
Subsidiaries of such Person and one or more Wholly Owned Restricted Subsidiaries
of such Person.
DESCRIPTION OF CAPITAL STOCK
AUTHORIZED AND OUTSTANDING CAPITAL STOCK
The authorized capital stock of the Company consists of 1,000,000 shares of
preferred stock, par value $0.01 per share ("Preferred Stock"), and 100,000,000
shares of Common Stock, par value $0.01 per share. Upon the consummation of the
Common Stock Offering, 18,518,614 shares of Common Stock and no shares of
Preferred Stock will be outstanding. The following summary description of the
capital stock of the Company is qualified in its entirety by reference to the
Company's Restated Certificate of Incorporation, a copy of which is filed as an
exhibit to the Registration Statement of which this Prospectus is a part.
COMMON STOCK
The holders of Common Stock are entitled to one vote for each share held of
record on all matters submitted to the stockholders, including the election of
directors. There is no cumulative voting with respect to the election of
directors. As a result, in an election of directors the holders of record of
more than 50% of the outstanding shares of Common Stock can elect all of the
directors then standing for election if such holders choose to do so. Subject to
preferences that may be applicable to any Preferred Stock that may from time to
time be outstanding, the holders of Common Stock are entitled to receive
dividends when and if declared by the Board of Directors out of legally
available funds. In the event of a liquidation, dissolution or winding up of the
affairs of the Company, the holders of the Common Stock are entitled to share
ratably in all assets which are available for distribution to them after payment
of liabilities and after provision has been made for each class of stock, if
any, having preference over the Common Stock. Holders of shares of Common Stock,
as such, have no conversion, pre-emptive or other subscription rights and there
are no redemption provisions applicable to the Common Stock. All of the
outstanding shares of Common Stock are, and the shares of Common Stock offered
hereby will be, when issued for consideration as set forth in this Prospectus,
validly issued, fully paid and nonassessable.
73
<PAGE>
The Common Stock is traded on the New York Stock Exchange under the symbol
"RXN." The Transfer Agent and Registrar for the Common Stock is American Stock
Transfer & Trust Company.
PREFERRED STOCK
The Company's Restated Certificate of Incorporation authorizes the Board of
Directors to establish one or more series of Preferred Stock and to determine,
with respect to any series of Preferred Stock, the terms, rights and preferences
of such series, including voting, dividend, liquidation, conversion and other
rights. The authorized shares of Preferred Stock will be available for issuance
without further action by the Company's stockholders, unless such action is
required by applicable law or any stock exchange or automated quotation system
on which the Company's securities may be listed or traded. The issuance of
Preferred Stock could adversely affect the voting power of holders of Common
Stock and the likelihood that such holders will receive dividend payments and
payments upon liquidation and could have the effect of delaying, deferring or
preventing a change in control of the Company. The Company has no present plans
to issue any shares of Preferred Stock.
CERTAIN CORPORATE GOVERNANCE PROVISIONS
STOCKHOLDER ACTION BY WRITTEN CONSENT
The Restated Certificate of Incorporation provides that no action required
or permitted to be taken at any annual or special meeting of the stockholders of
the Company may be taken without a meeting unless a consent or consents in
writing, setting forth the action to be taken is signed by at least 66 2/3% of
the stockholders entitled to vote with respect to the subject matter thereof.
This provision may make it difficult for stockholders to effect actions
requiring a vote of stockholders.
SPECIAL MEETINGS OF STOCKHOLDERS
The Amended and Restated Bylaws provide that a special meeting of
stockholders of the Company may be called only by a majority of the Board of
Directors, a committee of the Board of Directors that has been duly designated
by the Board of Directors to have the power to call such meetings, or any holder
or holders of at least 50% of the then outstanding Common Stock of the Company.
This provision may make it difficult for stockholders to take action opposed by
the Board of Directors.
COMMON STOCK PURCHASE RIGHTS
In January 1993, the Company declared a dividend distribution of one Common
Stock Purchase Right (a "Right") for each outstanding share of Common Stock of
the Company. The Rights are exercisable only if a person or group acquires 15%
or more of Common Stock or announces a tender offer, the consummation of which
would result in ownership by a person or group of 15% or more of the Common
Stock. Each Right entitles stockholders to purchase such number of shares of
Common Stock at an exercise price of $60.00 (as amended by the Board of
Directors on August 29, 1994) as determined under formulas set out in the
agreement providing for the Rights. The existence of the Rights may, under
certain circumstances, render more difficult or discourage attempts to acquire
the Company.
SECTION 203 OF THE DELAWARE GENERAL CORPORATION LAW
The Company is covered by Section 203 of the Delaware General Corporation
Law. Generally, Section 203 prohibits a publicly held Delaware corporation from
engaging in a "business combination" with an "interested stockholder" for a
period of three years after the date of the transaction in which the person
became an interested stockholder, unless (i) prior to such date the board of
directors of the corporation approved the business combination or the
transaction which resulted in the stockholder becoming an interested
stockholder, (ii) upon consummation of the transaction which resulted in the
stockholder becoming an interested stockholder, the interested stockholder owns
at least 85% of the outstanding voting stock or (iii) on or after such date the
business combination is approved by the board and by the affirmative vote of at
least 66 2/3% of the outstanding voting stock which is not owned by the
interested stockholder. A "business combination" includes a merger, asset sale
or certain other transactions resulting in a financial benefit to the
stockholder. An "interested stockholder" is a person who, together with
affiliates and associates, owns (or within three years, did own) 15% or more of
the corporation's voting stock. For purposes of determining whether an
interested stockholder owns at least 85% of the outstanding voting stock, shares
held by persons
74
<PAGE>
who are both directors and officers and shares held by employee stock ownership
plans in which employee participants do not have the right to determine
confidentially whether shares held subject to the plan will be tendered in a
tender offer or exchange offer are excluded.
LIMITATION OF LIABILITY AND INDEMNIFICATION
The Company's Amended and Restated Bylaws provide that the Company shall
indemnify all directors and officers of the Company to the fullest extent now or
hereafter permitted by the Delaware General Corporation Law. Under such
provisions, any director or officer who, in his capacity as such, is made or
threatened to be made a party to any suit or proceeding, shall be indemnified if
such director or officer acted in good faith and in a manner he reasonably
believed to be in, or not opposed to, the best interests of the Company and,
with respect to any criminal proceeding, had no reasonable cause to believe his
conduct was unlawful. The Amended and Restated Bylaws and the Delaware General
Corporation Law further provide that such indemnification is not exclusive of
any other rights to which such individuals may be entitled under any bylaws,
agreement, vote of stockholders or disinterested directors or otherwise.
In addition, the Company's Restated Certificate of Incorporation provides
that to the fullest extent now or hereafter permitted by Delaware law, the
Company's directors will not be liable to the Company or its stockholders for
monetary damages for breach of fiduciary duty as a director. This provision in
the Restated Certificate of Incorporation does not eliminate the directors'
fiduciary duty of care, and in appropriate circumstances, equitable remedies
such as an injunction or other forms of non-monetary relief would remain
available under Delaware law. Furthermore, each director will continue to be
subject to liability for (i) breach of the director's duty of loyalty to the
Company and its stockholders, (ii) acts or omissions not in good faith or
involving intentional misconduct or knowing violations of law, (iii) liability
arising under Section 174 of the Delaware General Corporation Law (relating to
unlawful payment of dividends and unlawful purchases or redemptions of the
Company's stock) or (iv) any transaction from which the director derived an
improper personal benefit. This provision does not affect a director's
responsibilities under any other laws, including the federal securities laws and
state or federal environmental laws.
75
<PAGE>
UNDERWRITING
Smith Barney Inc. and Wertheim Schroder & Co. Incorporated (the
"Underwriters") have severally agreed, subject to the terms and conditions of
the Underwriting Agreement (a copy of which has been filed as an exhibit to the
Registration Statement of which this Prospectus is a part), to purchase from the
Company the respective principal amount of Senior Notes as set forth below:
<TABLE>
<CAPTION>
PRINCIPAL
UNDERWRITERS AMOUNT
- ---------------------------------------------------------------------------------------- --------------
<S> <C>
Smith Barney Inc. ...................................................................... $
Wertheim Schroder & Co. Incorporated....................................................
--------------
Total................................................................................. $ 175,000,000
</TABLE>
The Company has been advised by the Underwriters that they propose to offer
the Senior Notes initially to the public at the offering price set forth on the
cover page of this Prospectus. After the initial public offering, the offering
price and other selling terms may be changed.
The Company has agreed to indemnify the Underwriters and any person who
controls the Underwriters against certain liabilities, including liabilities
under the Securities Act of 1933, as amended.
The Senior Notes are a new issue of securities, have no established trading
market and may not be widely distributed. The Company does not intend to have
the Senior Notes listed for trading on any securities exchange or to seek their
admission to trading in any automated quotation system. If the Senior Notes are
traded after their initial issuance, they may trade at a discount from their
initial public offering price depending on many factors, including among other
things, the Company's results of operations, prevailing interest rates and the
market for similar securities. No assurance can be given that any market for the
Senior Notes will develop, or, if any such market develops, as to the liquidity
of such market. The Company has been informed by the Underwriters that they
currently intend to make a market in the Senior Notes, as permitted by
applicable laws and regulations; however, the Underwriters are not obligated to
make such a market and may discontinue market making at any time without notice.
Accordingly, no assurance can be given as to the liquidity of, or trading market
for, the Senior Notes.
The Underwriters are acting as underwriters in connection with the Common
Stock Offering and will receive customary underwriting discounts and commissions
in connection therewith.
LEGAL OPINIONS
The validity of the Senior Notes offered hereby will be passed upon for the
Company by Thompson & Knight, A Professional Corporation, Dallas, Texas. Certain
legal matters in connection with this offering will be passed upon for the
Underwriters by Latham & Watkins, New York, New York.
EXPERTS
The consolidated financial statements of the Company as of December 31, 1992
and 1993, and for the year ended December 31, 1991, the nine months ended
September 30, 1992, the three months ended December 31, 1992 and the year ended
December 31, 1993 included in this Prospectus and the financial statement
schedules included in the Registration Statement have been so included in
reliance on the reports of Price Waterhouse LLP, independent accountants, given
on the authority of said firm as experts in auditing and accounting.
AVAILABLE INFORMATION
The Company is subject to the informational requirements of the Exchange
Act, and in accordance therewith, files reports, proxy and information
statements, and other information with the Commission. These reports, proxy and
information statements, and other information concerning the Company, may be
inspected, without charge, at the offices of the Commission at 450 Fifth Street,
N.W, Washington, D.C. 20549 and at its regional offices at 7 World Trade Center,
New York, New York 10048 and Northwestern Atrium
76
<PAGE>
Center, 500 West Madison Street, Chicago, Illinois 60661-2551. Copies of such
materials may also be obtained by mail at prescribed rates from the Public
Reference Section of the Commission at its principal office at 450 Fifth Street,
N.W, Washington, D.C. 20549. In addition, the Company's Common Stock is listed
on the New York Stock Exchange, 20 Broad Street, New York, New York 10005, where
reports, proxy statements and other information concerning the Company can be
inspected.
The Company has filed with the Commission a registration statement on Form
S-3 (as amended and together with all exhibits and schedules thereto, the
"Registration Statement") under the Securities Act of 1933 with respect to the
Senior Notes offered hereby. As permitted by the rules and regulations of the
Commission, this Prospectus does not contain all of the information set forth in
the Registration Statement. For further information with respect to the Company
and the Senior Notes offered hereby, reference is made to the Registration
Statement. Statements contained in this Prospectus concerning the provisions of
any contract, agreement or other document may not be complete. With respect to
each contract, agreement or other document filed as an exhibit to the
Registration Statement, reference is made to the exhibit for the complete
contents of the exhibit, and each statement concerning its provisions is
qualified in its entirety by such reference.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The following documents which have been filed by the Company with the
Commission (File No. 1-9988) pursuant to the Exchange Act, are incorporated
herein by reference and made a part of this Prospectus: (i) the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 1993; and (ii) the
Company's Quarterly Reports on Form 10-Q for the quarters ended March 31, 1994
and June 30, 1994.
All documents filed by the Company pursuant to Section 13(a), 13(c), 14 or
15(d) of the Exchange Act subsequent to the date of this Prospectus and prior to
the termination of the Notes Offering shall be deemed to be incorporated by
reference into this Prospectus and to be a part hereof from the date of filing
of such documents. Any statement contained in a document or information
incorporated or deemed to be incorporated herein by reference shall be deemed to
be modified or superseded for purposes of this Prospectus to the extent that a
statement contained herein or in any subsequently filed document that also is,
or is deemed to be, incorporated herein by reference, modifies or supersedes
such statement. Any such statement so modified or superseded shall not be
deemed, except as so modified or superseded, to constitute a part of this
Prospectus.
THE COMPANY UNDERTAKES TO PROVIDE, WITHOUT CHARGE, TO EACH PERSON, INCLUDING
ANY BENEFICIAL OWNER, TO WHOM A COPY OF THIS PROSPECTUS IS DELIVERED, UPON THE
WRITTEN OR ORAL REQUEST OF SUCH PERSON, A COPY OF ANY AND ALL OF THE DOCUMENTS
OR INFORMATION REFERRED TO ABOVE THAT HAS BEEN OR MAY BE INCORPORATED BY
REFERENCE IN THIS PROSPECTUS (EXCLUDING EXHIBITS TO SUCH DOCUMENTS UNLESS SUCH
EXHIBITS ARE SPECIFICALLY INCORPORATED BY REFERENCE). REQUESTS SHOULD BE
DIRECTED TO NEIL DEVROY, DIRECTOR COMMUNICATIONS AND PUBLIC AFFAIRS, REXENE
CORPORATION, 5005 LBJ FREEWAY, OCCIDENTAL TOWER, SUITE 500, DALLAS, TEXAS 75244
(THE PRINCIPAL EXECUTIVE OFFICES OF THE COMPANY), TELEPHONE (214) 450-9000.
77
<PAGE>
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
<TABLE>
<CAPTION>
PAGE
----------
<S> <C>
Report of Independent Accountants:
Post-emergence Consolidated Financial Statements.................................................... F-2
Pre-emergence Consolidated Financial Statements..................................................... F-3
Audited Consolidated Financial Statements:
Consolidated Statements of Operations for the year ended December 31, 1991, the nine months ended
September 30, 1992, the three months ended December 31, 1992 and the year ended December 31,
1993............................................................................................... F-4
Consolidated Balance Sheets as of December 31, 1992 and 1993........................................ F-5
Consolidated Statements of Changes in Stockholders' Equity (Deficit) for the year ended December 31,
1991, the nine months ended September 30, 1992, the three months ended December 31, 1992 and the
year ended December 31, 1993....................................................................... F-6
Consolidated Statements of Cash Flows for the year ended December 31, 1991, the nine months ended
September 30, 1992, the three months ended December 31, 1992 and the year ended December 31,
1993............................................................................................... F-7
Notes to Consolidated Financial Statements.......................................................... F-9
Condensed Consolidated Financial Statements (Unaudited):
Condensed Consolidated Statements of Operations for the Six Months Ended June 30, 1993 and 1994..... F-27
Condensed Consolidated Balance Sheet as of June 30, 1994............................................ F-28
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 1993 and 1994..... F-29
Notes to Condensed Consolidated Financial Statements................................................ F-30
</TABLE>
F-1
<PAGE>
REPORT OF INDEPENDENT ACCOUNTANTS -- POST-EMERGENCE
CONSOLIDATED FINANCIAL STATEMENTS
To the Board of Directors and Stockholders of
Rexene Corporation
In our opinion, the accompanying consolidated financial statements as listed
on the Index on page F-1, present fairly, in all material respects, the
financial position of Rexene Corporation and its subsidiaries (the Company) at
December 31, 1992 and 1993, and the results of their operations and their cash
flows for the three months ended December 31, 1992 and the year ended December
31, 1993 in conformity with generally accepted accounting principles. These
financial statements are the responsibility of the Company's management; our
responsibility is to express an opinion on these financial statements based on
our audits. We conducted our audits of these statements in accordance with
generally accepted auditing standards which require that we plan and perform the
audits to obtain reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements,
assessing the accounting principles used and significant estimates made by
management, and evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for the opinion expressed
above.
As discussed in notes 2 and 3 to the consolidated financial statements, on
September 18, 1992 the Company's Plan of Reorganization was consummated.
Effective September 30, 1992, the Company accounted for the Chapter 11
reorganization using "fresh-start" reporting as set forth in the American
Institute of Certified Public Accountants' Statement of Position 90-7,
"Financial Reporting by Entities in Reorganization under the Bankruptcy Code."
Accordingly, the financial statements subsequent to the emergence from Chapter
11 have been prepared using a different basis of accounting and are therefore
not comparable to the pre-emergence consolidated financial statements.
PRICE WATERHOUSE LLP
Dallas, Texas
February 10, 1994
F-2
<PAGE>
REPORT OF INDEPENDENT ACCOUNTANTS -- PRE-EMERGENCE
CONSOLIDATED FINANCIAL STATEMENTS
To the Board of Directors and Stockholders of
Rexene Corporation
In our opinion, the accompanying consolidated financial statements as listed
on the Index on page F-1, present fairly, in all material respects, the results
of Rexene Corporation and its subsidiaries' (the Company) operations and their
cash flows for the year ended December 31, 1991 and the nine months ended
September 30, 1992, in conformity with generally accepted accounting principles.
These financial statements are the responsibility of the Company's management;
our responsibility is to express an opinion on these financial statements based
on our audits. We conducted our audits of these statements in accordance with
generally accepted auditing standards which require that we plan and perform the
audits to obtain reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements,
assessing the accounting principles used and significant estimates made by
management, and evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for the opinion expressed
above.
As discussed in notes 2 and 3 to the consolidated financial statements, on
October 18, 1991 the Company filed a voluntary petition for reorganization under
Chapter 11 of the United States Bankruptcy Code. The Company's Plan of
Reorganization was consummated on September 18, 1992 and, effective September
30, 1992, the Company accounted for the reorganization using "fresh-start"
reporting as set forth in the American Institute of Certified Public
Accountants' Statement of Position 90-7, "Financial Reporting by Entities in
Reorganization under the Bankruptcy Code."
PRICE WATERHOUSE LLP
Dallas, Texas
April 12, 1993
F-3
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
<TABLE>
<CAPTION>
PRE-EMERGENCE POST-EMERGENCE
--------------------------- ---------------------------
NINE MONTHS THREE MONTHS
YEAR ENDED ENDED ENDED YEAR ENDED
DECEMBER 31, SEPTEMBER 30, DECEMBER 31, DECEMBER 31,
1991 1992 1992 1993
------------ ------------- ------------- ------------
<S> <C> <C> <C> <C>
Net sales............................................. $ 449,728 $ 316,106 $ 98,854 $ 429,353
------------ ------------- ------------- ------------
Operating expenses:
Cost of sales....................................... 388,057 278,081 86,732 375,609
Marketing, general and administrative............... 43,388 23,918 9,045 32,641
Research and development............................ 6,255 4,715 1,659 6,599
------------ ------------- ------------- ------------
437,700 306,714 97,436 414,849
------------ ------------- ------------- ------------
Operating income...................................... 12,028 9,392 1,418 14,504
Interest expense:
Cash................................................ (55,029) -- (6,215) (24,446)
Non-cash............................................ (3,345) -- (6,445) (25,388)
Interest income....................................... 2,750 740 637 1,392
Debt restructuring costs.............................. (7,866) -- -- --
Other, net............................................ 1,001 (458) 169 (245)
------------ ------------- ------------- ------------
Income (loss) before reorganization items, income
taxes and extraordinary gain......................... (50,461) 9,674 (10,436) (34,183)
Reorganization items.................................. (5,730) (38,514) -- --
------------ ------------- ------------- ------------
Loss before income taxes and extraordinary gain....... (56,191) (28,840) (10,436) (34,183)
Income tax (expense) benefit.......................... 13,444 (2,636) 3,908 8,940
------------ ------------- ------------- ------------
Loss before extraordinary gain........................ (42,747) (31,476) (6,528) (25,243)
Extraordinary gain.................................... -- 123,672 -- --
------------ ------------- ------------- ------------
Net income (loss)..................................... $ (42,747) $ 92,196 $ (6,528) $ (25,243)
------------ ------------- ------------- ------------
------------ ------------- ------------- ------------
Weighted average shares outstanding................... 10,501 10,501
------------- ------------
------------- ------------
Net loss per share.................................... $ (.62) $ (2.40 )
------------- ------------
------------- ------------
</TABLE>
See notes to consolidated financial statements.
F-4
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)
ASSETS
<TABLE>
<CAPTION>
DECEMBER 31,
----------------------
1992 1993
---------- ----------
<S> <C> <C>
Cash and cash equivalents:
Unrestricted............................................................................ $ 30,444 $ 28,288
Restricted.............................................................................. 3,758 2,247
Accounts receivable, net.................................................................. 51,771 57,820
Inventories............................................................................... 53,692 52,621
Income taxes receivable................................................................... 71 4,965
Prepaid expenses and other................................................................ 1,246 1,522
---------- ----------
Total current assets.................................................................. 140,982 147,463
---------- ----------
Property, plant and equipment, net........................................................ 243,621 244,346
Reorganization value in excess of amounts allocable to identifiable assets, net........... 3,928 3,660
Intangible assets, net.................................................................... 5,317 4,198
Other noncurrent assets................................................................... 29,743 30,369
---------- ----------
$ 423,591 $ 430,036
---------- ----------
---------- ----------
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Accounts payable.......................................................................... $ 20,387 $ 27,386
Accrued liabilities....................................................................... 9,719 8,116
Accrued interest.......................................................................... 3,145 3,097
Employee benefits payable................................................................. 2,907 3,754
---------- ----------
Total current liabilities............................................................. 36,158 42,353
---------- ----------
Long-term debt............................................................................ 261,726 281,764
Other noncurrent liabilities.............................................................. 56,225 65,840
Deferred income taxes..................................................................... 49,376 45,216
Commitments and contingencies............................................................. -- --
Stockholders' equity (deficit):
Common stock, par value $.01 per share; 100 million shares authorized; 10.5 million
shares issued and outstanding.......................................................... 105 105
Paid-in capital......................................................................... 26,529 26,529
Accumulated deficit..................................................................... (6,528) (31,771)
---------- ----------
Total stockholders' equity (deficit).................................................... 20,106 (5,137)
---------- ----------
$ 423,591 $ 430,036
---------- ----------
---------- ----------
</TABLE>
See notes to consolidated financial statements.
F-5
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)
(IN THOUSANDS)
<TABLE>
<CAPTION>
COMMON STOCK
--------------- PAID-IN ACCUMULATED
SHARES AMOUNT CAPITAL DEFICIT TOTAL
------- ------ --------- ----------- ---------
<S> <C> <C> <C> <C> <C>
Balance, December 31, 1990.............. 31,239 $ 312 $ 147,543 $(203,791) $ (55,936)
Issuance of common stock................ 180 2 3,868 -- 3,870
Net loss................................ -- -- -- (42,747) (42,747)
------- ------ --------- ----------- ---------
Balance, December 31, 1991.............. 31,419 314 151,411 (246,538) (94,813)
Net loss -- pre-emergence............... -- -- -- (5,602) (5,602)
------- ------ --------- ----------- ---------
Balance, September 30, 1992 --
pre-emergence.......................... 31,419 314 151,411 (252,140) (100,415)
Adjustments for reorganization:
Extraordinary gain on debt exchange... -- -- -- 123,672 123,672
Fresh start reporting adjustments..... (31,419) (314) (151,411) 128,468 (23,257)
Issuance of common stock.............. 10,501 105 26,529 -- 26,634
------- ------ --------- ----------- ---------
Balance, September 30, 1992 -- post-
emergence.............................. 10,501 $ 105 $ 26,529 $ -- $ 26,634
------- ------ --------- ----------- ---------
------- ------ --------- ----------- ---------
Balance, September 30, 1992............. 10,501 $ 105 $ 26,529 $ -- $ 26,634
Net loss................................ -- -- -- (6,528) (6,528)
------- ------ --------- ----------- ---------
Balance, December 31, 1992.............. 10,501 105 26,529 (6,528) 20,106
Net loss................................ -- -- -- (25,243) (25,243)
------- ------ --------- ----------- ---------
Balance, December 31, 1993.............. 10,501 $ 105 $ 26,529 $ (31,771) $ (5,137)
------- ------ --------- ----------- ---------
------- ------ --------- ----------- ---------
</TABLE>
See notes to consolidated financial statements.
F-6
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
<TABLE>
<CAPTION>
PRE-EMERGENCE POST-EMERGENCE
--------------------------- ---------------------------
YEAR NINE MONTHS THREE MONTHS YEAR
ENDED ENDED ENDED ENDED
DECEMBER 31, SEPTEMBER 30, DECEMBER 31, DECEMBER 31,
1991 1992 1992 1993
------------ ------------- ------------- ------------
<S> <C> <C> <C> <C>
Cash flows from operating activities:
Net income (loss)................................... $ (42,747) $ 92,196 $ (6,528) $ (25,243)
Adjustments to reconcile net income (loss) to net
cash provided by operating activities:
Depreciation and amortization..................... 23,852 20,062 4,315 17,446
Reorganization items.............................. 5,730 38,514 -- --
Reversal of accrued interest...................... -- (6,831) -- --
Debt restructuring costs.......................... 7,866 -- -- --
Extraordinary gain................................ -- (123,672) -- --
Non-cash interest expense......................... -- -- 6,445 25,388
Deferred income taxes............................. 2,262 525 (3,690) (4,160)
Change in:
Accounts receivable............................. 11,080 (9,343) 5,756 (6,049)
Inventories..................................... 20,983 182 (3,030) 1,071
Prepaid expenses and other...................... (446) 727 (940) (276)
Income taxes.................................... (12,856) 17,441 (408) (4,894)
Accounts payable................................ 5,549 1,139 2,517 6,999
Accrued interest................................ 11,312 -- (2,914) (48)
Employee benefits payable and accrued
liabilities.................................... -- (1,552) 612 (756)
Prepetition liabilities paid:
Accounts payable................................ -- (15,834) (1,093) --
Accrued interest................................ -- (14,737) -- --
Increase in other noncurrent liabilities.......... 2,259 12,518 985 1,006
Other............................................. 844 (456) 782 857
------------ ------------- ------------- ------------
Total adjustments............................. 78,435 (81,317) 9,337 36,584
------------ ------------- ------------- ------------
Net cash provided by operating activities before
reorganization items paid............................ 35,688 10,879 2,809 11,341
Reorganization items paid........................... (3,396) (10,180) (2,053) --
------------ ------------- ------------- ------------
Net cash provided by operating activities............. 32,292 699 756 11,341
------------ ------------- ------------- ------------
(continued on page F-8)
</TABLE>
See notes to consolidated financial statements.
F-7
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
(IN THOUSANDS)
<TABLE>
<CAPTION>
PRE-EMERGENCE POST-EMERGENCE
--------------------------- ---------------------------
YEAR NINE MONTHS THREE MONTHS YEAR
ENDED ENDED ENDED ENDED
DECEMBER 31, SEPTEMBER 30, DECEMBER 31, DECEMBER 31,
1991 1992 1992 1993
------------ ------------- ------------- ------------
<S> <C> <C> <C> <C>
Cash flows from investing activities:
Capital expenditures................................ (33,464) (11,136) (3,961) (17,008)
Investment in joint venture......................... (733) -- (325) --
Proceeds from sale of property, plant and
equipment.......................................... 2,491 -- -- --
Deposits held in trust for the Texas Water
Commission......................................... (10,255) -- -- --
------------ ------------- ------------- ------------
Net cash used for investing activities................ (41,961) (11,136) (4,286) (17,008)
------------ ------------- ------------- ------------
Cash flows from financing activities:
Bank borrowings..................................... -- -- -- 2,000
Debt restructuring costs............................ (6,501) -- -- --
Proceeds from issuance of common stock, net......... 45 -- -- --
------------ ------------- ------------- ------------
Net cash provided by (used for) financing
activities........................................... (6,456) -- -- 2,000
------------ ------------- ------------- ------------
Net decrease in cash and cash equivalents............. (16,125) (10,437) (3,530) (3,667)
Cash and cash equivalents at beginning of period.... 64,294 48,169 37,732 34,202
------------ ------------- ------------- ------------
Cash and cash equivalents at end of period.......... $ 48,169 $ 37,732 $ 34,202 $ 30,535
------------ ------------- ------------- ------------
------------ ------------- ------------- ------------
Supplemental cash flow information:
Cash paid for interest.............................. $ 50,745 $ 14,737 $ 9,002 $ 24,039
Cash paid for income taxes.......................... $ -- $ 1,703 $ -- $ 114
</TABLE>
See notes to consolidated financial statements.
F-8
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
IDENTITY OF REGISTRANT
Rexene Corporation ("Old Rexene") was merged into its wholly-owned operating
subsidiary, Rexene Products Company, on September 11, 1992 pursuant to a First
Amended Plan of Reorganization (the "Amended Plan") under Chapter 11 of the
United States Bankruptcy Code (the "Bankruptcy Code") (see note 2). Upon
completion of the merger, Rexene Products Company changed its name to Rexene
Corporation ("New Rexene"). Old Rexene, Rexene Products Company and New Rexene
are hereinafter sometimes collectively or separately referred to as the
"Company".
PRINCIPLES OF CONSOLIDATION
The consolidated financial statements of the Company include its
wholly-owned direct and indirect subsidiaries.
CASH AND CASH EQUIVALENTS
Cash equivalents represent short-term investments with original maturities
of three months or less. Restricted cash is held in a reserve account under the
Amended Plan for payment of disputed claims and administrative expenses.
INVENTORIES
Inventories are stated at the lower of cost or market using the first-in,
first-out method.
PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment is stated at cost. Depreciation is provided
utilizing the straight-line method over the estimated useful lives of the
assets, ranging from 3 to 20 years. Improvements are capitalized, while repair
and maintenance costs are charged to operations as incurred. Certain interest
costs are capitalized as part of major construction projects. Upon disposal of
assets, the cost and related accumulated depreciation are removed from the
accounts and the resulting gain or loss is included in income.
REORGANIZATION VALUE IN EXCESS OF AMOUNTS ALLOCABLE TO IDENTIFIABLE ASSETS
Reorganization value in excess of amounts allocable to identifiable assets
is amortized on a straight-line basis over fifteen years.
INTANGIBLE ASSETS
Intangible assets are stated at cost and consist primarily of licensing
agreements and patents which are amortized on a straight-line basis over five
years.
DEFERRED PRE-OPERATING COSTS
The incremental costs of establishing a plant in the United Kingdom have
been deferred. This plant is scheduled to begin production in late 1994. These
deferred pre-operating costs will be amortized on a straight-line basis over
five years, after commencement of production.
INCOME TAXES
Concurrent with fresh start reporting (see note 3), on September 30, 1992
the Company adopted Statement of Financial Accounting Standard ("SFAS") 109,
"Accounting for Income Taxes", which requires an asset and liability approach to
financial accounting and reporting of income taxes. Prior to September 30, 1992,
the Company accounted for income taxes under the deferred method, as prescribed
under Accounting Principles Board ("APB") Opinion No. 11, "Accounting for Income
Taxes".
FOREIGN CURRENCY TRANSLATION
Operations of the foreign subsidiary use the local currency of the country
of operation as the functional currency. The resulting translation adjustments
are not significant in 1993.
F-9
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
NET LOSS PER SHARE
Net loss per share is based on the weighted average number of common stock
shares outstanding. The per share amount for the pre-emergence periods is not
presented since such information is not comparable with the post-emergence
periods.
RECLASSIFICATIONS
Certain amounts in the 1992 and 1991 consolidated financial statements have
been reclassified to conform with the 1993 presentation.
2. CHAPTER 11 REORGANIZATION
As a result of its reorganization under Chapter 11 of the Bankruptcy Code
and the confirmation of the Amended Plan by the United States Bankruptcy Court
for the District of Delaware (the "Bankruptcy Court"), the Company, among other
things, (i) reduced the principal amount of its long-term debt by replacing $403
million of outstanding senior and subordinated notes of Old Rexene, which was
scheduled to mature in July 1992, with $337 million of debt that becomes due in
1999 and 2002, (ii) reduced its annual cash interest requirements from
approximately $74 million to a minimum amount of approximately $24 million
through 1994, and (iii) issued 92.5% of the common stock of New Rexene to the
holders of such debt. The Amended Plan was consummated on September 18, 1992
(the "Effective Date"). Under the Amended Plan, the holders of outstanding
senior notes of Old Rexene received, pro rata as a class, (i) an equal principal
amount of Increasing Rate First Priority Notes due 1999 of New Rexene at an
initial interest rate of 9% per year (the "Old Senior Notes"), (ii) 26% of the
common stock of New Rexene to be outstanding after giving effect to the Amended
Plan, and (iii) $11.7 million in cash representing the prepetition interest
accrued on the outstanding senior notes of Old Rexene plus interest on the
prepetition interest during the reorganization under Chapter 11 of the
Bankruptcy Code proceedings. The holders of outstanding subordinated notes of
Old Rexene received, pro rata as a class, (i) $84.375 million aggregate
principal amount of Increasing Rate Second Priority Notes due 2002 (with certain
sinking fund requirements in 2001) at an initial interest rate of 10% per year
(the "Old Subordinated Notes", and together with the Old Senior Notes, the "Old
Notes"), (ii) 66.5% of the common stock in New Rexene to be outstanding after
giving effect to the Amended Plan, and (iii) $3.1 million in cash for settlement
of prepetition interest. Holders of the common stock of Old Rexene became
entitled to receive 7.5% of the common stock of New Rexene to be outstanding
after giving effect to the Amended Plan. The Company recorded an extraordinary
gain of $123.7 million as a result of exchanging the outstanding senior and
subordinated debt of Old Rexene for the Old Notes and the common stock of New
Rexene under the Amended Plan.
3. FRESH START REPORTING
In connection with the reorganization under Chapter 11 of the Bankruptcy
Code described in note 2, the Company adopted as of September 30, 1992, the
American Institute of Certified Public Accountants' Statement of Position No.
90-7, "Financial Reporting by Entities in Reorganization Under the Bankruptcy
Code" (the "Reorganization SOP"). The Company's basis of accounting for
financial reporting purposes changed as a result of adopting the Reorganization
SOP. Specifically, the Reorganization SOP required (i) the adjustment of the
Company's assets and liabilities to reflect a reorganization value (the
"Reorganization Value") generally approximating the fair value of the Company as
a going concern on an unleveraged basis, (ii) the elimination of its accumulated
deficit, and (iii) adjustments to its capital structure to reflect consummation
of the Amended Plan. Accordingly, the results of operations after September 30,
1992 are not comparable to results of operations prior to such date, and the
results of operations for the nine months ended September 30, 1992 and the three
months ended December 31, 1992 have not been aggregated.
F-10
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
3. FRESH START REPORTING (CONTINUED)
The Reorganization Value was determined by independent financial advisors.
At September 30, 1992, the Reorganization Value of $291 million was allocated to
assets and liabilities as follows (in thousands):
<TABLE>
<S> <C>
Working capital (excluding accrued interest).............. $ 112,860
Property, plant and equipment............................. 243,498
Reorganization value in excess of amounts allocable to
identifiable assets...................................... 4,298
Intangible assets......................................... 5,598
Other noncurrent assets................................... 30,031
Deferred income taxes..................................... (53,066)
Other noncurrent liabilities.............................. (52,219)
---------
$ 291,000
---------
---------
</TABLE>
Current assets and liabilities were recorded at their book value, which
approximated fair value. Property, plant and equipment was recorded at
reorganization value, which approximated fair value in continued use, based on
an independent appraisal. Intangible assets and other noncurrent assets were
recorded at their net book value, which approximated fair value. Long-term debt
was recorded at present values as determined by independent financial advisors.
Based on the allocation of the Reorganization Value in conformity with the
procedures specified by the Reorganization SOP, the portion of the
Reorganization Value which was not attributed to specific tangible or
identifiable intangible assets of the reorganized Company was reported as
"reorganization value in excess of amounts allocable to identifiable assets".
The Company recorded the following reorganization expenses and adjustments
to assets and liabilities to reflect fresh start reporting in its statement of
operations for the nine months ended September 30, 1992 (in thousands):
<TABLE>
<S> <C>
Professional fees......................................... $ (12,600)
Interest expense -- cash.................................. (6,059)
Interest expense -- non-cash.............................. (1,941)
Revaluation of assets and liabilities to fair values:
Property, plant and equipment........................... 50,535
Goodwill................................................ (16,604)
Reorganization value in excess of amounts allocable to
identifiable assets.................................... 4,298
Other noncurrent assets................................. (11,904)
Deferred income taxes................................... (50,346)
Pension liability....................................... 7,067
Other..................................................... (960)
---------
$ (38,514)
---------
---------
</TABLE>
F-11
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
4. ACCOUNTS RECEIVABLE
Accounts receivable consist of the following (in thousands):
<TABLE>
<CAPTION>
DECEMBER 31,
--------------------
1992 1993
--------- ---------
<S> <C> <C>
Trade................................................................... $ 52,137 $ 57,697
Other................................................................... 4,143 3,930
--------- ---------
56,280 61,627
Less allowances......................................................... (4,509) (3,807)
--------- ---------
$ 51,771 $ 57,820
--------- ---------
--------- ---------
</TABLE>
Bad debt expense for the year ended December 31, 1991, the nine months ended
September 30, 1992, the three months ended December 31, 1992 and the year ended
December 31, 1993 is $1,175,000, $327,000, $300,000 and $223,000, respectively.
5. INVENTORIES
Inventories consist of the following (in thousands):
<TABLE>
<CAPTION>
DECEMBER 31,
--------------------
1992 1993
--------- ---------
<S> <C> <C>
Raw materials........................................................... $ 14,971 $ 11,313
Work in progress........................................................ 7,481 6,694
Finished goods.......................................................... 31,240 34,614
--------- ---------
$ 53,692 $ 52,621
--------- ---------
--------- ---------
</TABLE>
6. PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment consists of the following (in thousands):
<TABLE>
<CAPTION>
DECEMBER 31,
----------------------
1992 1993
---------- ----------
<S> <C> <C>
Land.................................................................. $ 5,276 $ 5,738
Buildings............................................................. 13,841 17,758
Plant and equipment................................................... 216,440 230,026
Construction in progress.............................................. 11,728 10,530
---------- ----------
247,285 264,052
Less accumulated depreciation......................................... (3,664) (19,706)
---------- ----------
$ 243,621 $ 244,346
---------- ----------
---------- ----------
</TABLE>
Depreciation expense for the year ended December 31, 1991, the nine months
ended September 30, 1992, the three months ended December 31, 1992 and the year
ended December 31, 1993 is $20,656,000, $17,689,000, $3,664,000 and $16,059,000,
respectively. During the year ended December 31, 1991, the three months ended
December 31, 1992 and the year ended December 31, 1993, $4,685,000, $312,000 and
$1,259,000, respectively, of interest was capitalized in connection with
construction projects. No interest was capitalized during the nine months ended
September 30, 1992.
F-12
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
7. REORGANIZATION VALUE IN EXCESS OF AMOUNTS ALLOCABLE TO IDENTIFIABLE ASSETS
AND INTANGIBLE ASSETS
Reorganization value in excess of amounts allocable to identifiable assets
and intangible assets, net of accumulated amortization are (in thousands):
<TABLE>
<CAPTION>
DECEMBER 31,
--------------------
1992 1993
--------- ---------
<S> <C> <C>
Reorganization value in excess of amounts allocable to identifiable
assets................................................................... $ 4,298 $ 4,298
Less accumulated amortization............................................. (370) (638)
--------- ---------
$ 3,928 $ 3,660
--------- ---------
--------- ---------
Intangible assets......................................................... $ 5,598 $ 5,598
Less accumulated amortization............................................. (281) (1,400)
--------- ---------
$ 5,317 $ 4,198
--------- ---------
--------- ---------
</TABLE>
8. OTHER NONCURRENT ASSETS
Other noncurrent assets consist of the following (in thousands):
<TABLE>
<CAPTION>
DECEMBER 31,
--------------------
1992 1993
--------- ---------
<S> <C> <C>
Spare parts inventories................................................. $ 18,107 $ 16,654
Deposits held in trusts................................................. 10,428 10,523
Deferred pre-operating costs............................................ -- 1,322
Other................................................................... 1,208 1,870
--------- ---------
$ 29,743 $ 30,369
--------- ---------
--------- ---------
</TABLE>
The deposits held in trusts for the benefit of the Texas Water Commission
were established and funded to comply with the financial assurance requirements
of the Resource Conservation and Recovery Act.
9. ACCRUED LIABILITIES
Accrued liabilities consist of the following (in thousands):
<TABLE>
<CAPTION>
DECEMBER 31,
--------------------
1992 1993
--------- ---------
<S> <C> <C>
Accrued taxes, other than income.......................................... $ 3,122 $ 2,555
Accrued reorganization costs and disputed claims.......................... 2,422 435
Other accrued expenses.................................................... 4,175 5,126
--------- ---------
$ 9,719 $ 8,116
--------- ---------
--------- ---------
</TABLE>
10. LONG-TERM DEBT
Long-term debt consists of the following (in thousands):
<TABLE>
<CAPTION>
DECEMBER 31,
----------------------
1992 1993
---------- ----------
<S> <C> <C>
Old Senior Notes...................................................... $ 253,000 $ 253,000
Old Subordinated Notes................................................ 87,249 95,342
Less: unamortized discount............................................ (78,523) (68,578)
---------- ----------
261,726 279,764
Bank borrowings under the Old Credit Agreement........................ -- 2,000
---------- ----------
$ 261,726 $ 281,764
---------- ----------
---------- ----------
</TABLE>
F-13
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
10. LONG-TERM DEBT (CONTINUED)
The long-term debt was recorded at its fair market value at the Effective
Date. The resulting discount from the face amount is accreted to interest
expense over the term of the Notes. The Company believes, based on its
understanding of the bid and ask prices at December 31, 1993, that the aggregate
fair market value of the long-term debt is approximately $36 million greater
than its net book value.
The Old Senior Notes are secured by a first lien on all of the assets of the
Company and its subsidiaries, other than (i) accounts receivable, other than
intercompany receivables, (ii) inventory, (iii) cash and cash equivalents, and
(iv) certain nonmaterial excluded assets (the "Collateral").
Interest is payable on the Old Notes semiannually on May 15 and November 15.
In addition, the interest rates on the Old Senior and Old Subordinated Notes
increase beginning in 1995 and 1996, respectively. The annual interest rate on
the Old Senior Notes is 9% through November 14, 1995, 12% from November 15, 1995
through November 14, 1996 and 14% thereafter. The Old Subordinated Notes are
secured by a second lien on the Collateral. The annual interest rate on the Old
Subordinated Notes is 10% through November 14, 1996, 12% from November 15, 1996
through November 14, 1997 and 14% thereafter.
For each interest period ending on or prior to November 15, 1994, the
Company may pay up to 90% of the interest due on the Old Subordinated Notes by
delivering additional Old Subordinated Notes in lieu of cash ("Pay-in-Kind"), if
certain financial tests are met. In 1993 and 1992, the Board of Directors
exercised the Pay-in-Kind feature and issued $8.1 million and $2.9 million,
respectively, of Old Subordinated Notes.
The Pay-in-Kind feature expires on November 15, 1994, and the Company's
annual cash interest requirements will increase approximately $10.0 million,
commencing with the semi-annual interest payment due on May 15, 1995.
The Old Senior Notes, and after all Old Senior Notes are redeemed, the Old
Subordinated Notes, are redeemable at the option of the Company, at any time in
whole or from time to time in part, at a price equal to 100% of the principal
amount to be redeemed plus accrued interest to the redemption date. In addition
the Company may at any time purchase Old Senior Notes in the open market. In the
event the Company generates "excess cash flow" from operations (as defined in
the indenture governing the Old Senior Notes) in any fiscal year, the Company is
required to make an offer to purchase Old Senior Notes at par in an amount equal
to such excess cash flow. However, the cash purchase price of Old Senior Notes
acquired in the open market (not previously applied as a credit) may be credited
towards the excess cash flow offer requirement. In addition, in the event of
asset sales exceeding $8 million in the aggregate during any four consecutive
fiscal quarters, the Company is required to make an offer to purchase Old Senior
Notes and thereafter, if applicable, Old Subordinated Notes at par in an amount
equal to the net proceeds (as defined in the indentures governing the Notes (the
"Indentures")) of such asset sales. Open market purchases cannot be credited
towards the asset sale redemption requirement. The Indentures contain covenants
which, among other things (i) limit the Company's ability to incur additional
indebtedness, (ii) limit restricted payments (e.g. dividends, purchases or
redemption of subordinated indebtedness, purchases or redemption of capital
stock and certain investments), (iii) limit the incurrence of liens other than
certain permitted liens, (iv) restrict transactions with stockholders and
affiliates, (v) require the maintenance of a minimum stockholders' equity, and
(vi) limit certain investments.
The Company entered into a loan agreement dated September 18, 1992 (the "Old
Credit Agreement") as subsequently amended, with Transamerica Business Credit
Corporation providing for a credit facility for general corporate purposes of up
to $35 million, $15 million of which may be used for financing the operations of
a subsidiary in the United Kingdom. The Old Credit Agreement includes a
sub-facility of $15 million for stand-by letters of credit. The Old Credit
Agreement terminates December 31, 1996. The Company pays interest on borrowed
funds at 1.5% above the prime rate. At December 31, 1993, the Company had
borrowed $2.0 million under the Old Credit Agreement at an annual interest rate
of 7%.
F-14
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
10. LONG-TERM DEBT (CONTINUED)
There were no borrowings under the Old Credit Agreement in 1992. At December 31,
1993 and 1992 approximately $2.9 million and $1.1 million, respectively, of
stand-by letters of credit were outstanding under the Old Credit Agreement.
Funds advanced under the Old Credit Agreement are secured by a first lien on the
Company's (i) inventory, (ii) accounts receivable, other than intercompany
receivables, (iii) letters of credit and (iv) the proceeds of the above. The Old
Credit Agreement also contains certain continuing obligations, such as the
maintenance of a minimum cash flow coverage ratio, as well as restrictions or
prohibitions covering, among other things, the incurrence of other indebtedness,
asset sales, investments, dividend payments, mergers and acquisitions.
11. OTHER NONCURRENT LIABILITIES
Other noncurrent liabilities consist of the following (in thousands):
<TABLE>
<CAPTION>
DECEMBER 31,
--------------------
1992 1993
--------- ---------
<S> <C> <C>
Accrued environmental remediation costs................................. $ 24,298 $ 23,357
Accumulated postretirement benefit obligation (note 16)................. 13,152 14,729
Noncurrent interest payable............................................. 3,021 11,630
Lawsuit accrual (note 19)............................................... 7,400 7,400
Other................................................................... 8,354 8,724
--------- ---------
$ 56,225 $ 65,840
--------- ---------
--------- ---------
</TABLE>
Noncurrent interest payable represents non-cash interest accrued in
accordance with Emerging Issues Task Force ("EITF") Issue No. 86-15, "Increasing
Rate Debt". Under EITF Issue No. 86-15, aggregate interest expense is charged in
equal amounts over the estimated term of the Old Notes (see note 14).
12. COMMITMENTS
The future payments of rentals on buildings, computers, office equipment and
transportation equipment under the terms of noncancellable operating lease
agreements are as follows (in thousands):
<TABLE>
<S> <C>
For the years ending December 31,
1994............................................................... $ 7,721
1995............................................................... 6,255
1996............................................................... 3,786
1997............................................................... 1,581
1998............................................................... 512
1999 and thereafter................................................ 4,517
---------
Total minimum lease payments....................................... $ 24,372
---------
---------
</TABLE>
Rental expense under operating leases for the year ended December 31, 1991,
the nine months ended September 30, 1992, the three months ended December 31,
1992 and the year ended December 31, 1993, approximated $7,810,000, $6,451,000,
$2,024,000 and $7,630,000, respectively.
13. INCOME TAXES
At September 30, 1992, the Company adopted SFAS 109, "Accounting for Income
Taxes", concurrent with its adoption of fresh start reporting. For periods prior
to the three months ended December 31, 1992, the Company accounted for income
taxes under principles provided in APB 11. Therefore, the income tax benefit for
the three months ended December 31, 1992 and the year ended December 31, 1993 is
not comparable with the income tax expense (benefit) for the year ended December
31, 1991 and the nine months ended September 30, 1992.
F-15
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
13. INCOME TAXES (CONTINUED)
The current income tax benefit for the year ended December 31, 1993 includes
a federal income tax benefit of $4.0 million, relating primarily to the
carryback of the Company's 1993 net operating loss to the year ended December
31, 1990. The income tax benefit for the nine months ended September 30, 1992 is
principally for alternative minimum taxes. During the bankruptcy proceedings in
1992, all federal income tax matters through the 1991 tax year were resolved
which resulted in, among other things, a refund of $17.2 million from the
Internal Revenue Service.
The Company has unused net operating loss carryforwards of $1.2 million at
December 31, 1993 that expire in the year 2004 and an alternative minimum tax
credit carryforward of approximately $1.6 million. The utilization of the net
operating loss carryforwards and tax credit carryforwards is shown as a charge
equivalent to federal income taxes in 1991.
Income tax (expense) benefit consists of the following (in thousands):
<TABLE>
<CAPTION>
YEAR NINE MONTHS THREE MONTHS
ENDED ENDED ENDED YEAR ENDED
DECEMBER 31, SEPTEMBER 30, DECEMBER 31, DECEMBER 31,
1991 1992 1992 1993
------------ ------------- ------------ ------------
<S> <C> <C> <C> <C>
Current:
State............ $ 220 $ 683 $ 177 $ (610)
Federal.......... 16,399 (2,794) 41 5,390
Deferred income
taxes............. (2,262) (525) 3,690 4,160
Charge equivalent
to federal income
taxes............. (913) -- -- --
------------ ------------- ------ ------
$13,444 $(2,636) $3,908 $8,940
------------ ------------- ------ ------
------------ ------------- ------ ------
</TABLE>
Deferred income tax provisions under SFAS 109 result from temporary
differences between the basis of assets and liabilities for financial reporting
purposes. Under APB 11 the deferred income tax provisions result from timing
differences in the recognition of revenues and expenses for tax and financial
reporting purposes. The deferred income tax benefit for the year ended December
31, 1993 is net of a charge of $1.3 million to record the effect of the Omnibus
Budget Reconciliation Act of 1993, which increased the corporate federal tax
rate from 34% to 35%, retroactive from January 1, 1993. The nature of the
temporary differences under SFAS 109 and timing differences under APB 11 and the
tax effects are as follows (in thousands):
<TABLE>
<CAPTION>
YEAR NINE MONTHS THREE MONTHS
ENDED ENDED ENDED YEAR ENDED
DECEMBER 31, SEPTEMBER 30, DECEMBER 31, DECEMBER 31,
1991 1992 1992 1993
------------ ------------- ------------ ------------
<S> <C> <C> <C> <C>
Depreciation and
amortization...... $(2,708) $(3,010) $1,571 $(5,119)
Non-cash
interest.......... -- -- 2,096 10,700
Non-qualified
executive stock
option plan....... (970) -- -- --
Effect of change in
federal statutory
income tax
rates............. -- -- -- (1,333)
Accrual for
lawsuit........... -- 2,504 -- --
Capitalized
inventory costs... 312 -- -- --
Other, net......... 1,104 (19) 23 (88)
------------ ------------- ------ ------------
$(2,262) $ (525) $3,690 $ 4,160
------------ ------------- ------ ------------
------------ ------------- ------ ------------
</TABLE>
F-16
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
13. INCOME TAXES (CONTINUED)
Deferred income taxes consist of the following (in thousands):
<TABLE>
<CAPTION>
DECEMBER 31,
----------------------
1992 1993
---------- ----------
<S> <C> <C>
Excess financial over tax basis of property, plant and equipment................ $ 63,962 $ 69,533
Excess tax over financial basis of the Notes.................................... 16,396 9,168
---------- ----------
Gross deferred tax liabilities.............................................. 80,358 78,701
Accounts receivable............................................................. (2,188) (1,639)
Inventories..................................................................... (2,485) (666)
Intangible assets............................................................... (2,780) (1,140)
Other noncurrent assets......................................................... (3,180) (4,474)
Other noncurrent liabilities.................................................... (19,982) (23,600)
Other........................................................................... (367) (1,966)
---------- ----------
$ 49,376 $ 45,216
---------- ----------
---------- ----------
</TABLE>
The effective income tax rate differs from the amount computed by applying
the federal income tax rate to income before income taxes. The federal income
tax rate was 34% for the year ended December 31, 1991, the nine months ended
September 30, 1992 and the three months ended December 31, 1992 and 35% for the
year ended December 31, 1993. The reasons for these differences are as follows
(in thousands):
<TABLE>
<CAPTION>
NINE MONTHS THREE MONTHS
YEAR ENDED ENDED ENDED YEAR ENDED
DECEMBER 31, SEPTEMBER 30, DECEMBER 31, DECEMBER 31,
1991 1992 1992 1993
------------ ------------- ------------ ------------
<S> <C> <C> <C> <C>
Tax computed at
federal statutory
tax rate.......... $19,104 $ 9,806 $3,549 $11,964
State income
taxes............. 168 461 116 (397)
Differences in
financial and tax
bases of assets
and liabilities... (4,496) (3,893) -- --
Non-deductible
amortization...... -- -- -- (493)
Non-cash
interest.......... -- -- -- (728)
Effect of change in
federal statutory
income tax rate... -- -- -- (1,333)
Reorganization
items............. -- (8,133) 325 --
Non-qualified
executive stock
option plan....... (1,180) -- -- --
Other, net......... (152) (877) (82) (73)
------------ ------------- ------ ------------
Income tax
(expense)
benefit........... $13,444 $(2,636) $3,908 $ 8,940
------------ ------------- ------ ------------
------------ ------------- ------ ------------
</TABLE>
14. INTEREST EXPENSE
Cash interest for the three months ended December 31, 1992 and the year
ended December 31, 1993 consists of interest on the Old Senior Notes and 10% of
the interest on the Old Subordinated Notes. The remaining 90% of the interest on
the Old Subordinated Notes is included as non-cash interest in accordance with
the Pay-in-Kind feature (see note 10). In addition, non-cash interest includes
(i) accretion on the Old Notes (see note 10), (ii) an adjustment for EITF Issue
No. 86-15 (see note 11), and (iii) an adjustment for interest capitalized in
connection with construction projects (see note 6).
15. OTHER STATEMENT OF OPERATIONS INFORMATION
During 1991 the Company incurred $7.9 million of debt restructuring costs.
Included in other income for the year ended December 31, 1991 is approximately
$1 million in license fees from a joint venture with Ube Industries, Ltd.
F-17
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
15. OTHER STATEMENT OF OPERATIONS INFORMATION (CONTINUED)
Other, net for the nine months ended September 30, 1992 includes an accrual
of $7.4 million relating to the adverse judgment in the class action lawsuit
discussed in note 19 which was partially offset by a reversal of postpetition
interest of $6.8 million accrued as of December 31, 1991 and $1.5 million of
business interruption insurance proceeds received in 1992 for an electrical
outage at the Odessa, Texas facility in May 1991.
Export sales of the Company were $71,570,000, $33,806,000, $9,295,000 and
$30,495,000 for the year ended December 31, 1991, the nine months ended
September 30, 1992, the three months ended December 31, 1992 and the year ended
December 31, 1993, respectively. The majority of export sales were to foreign
companies through agents and domestic offices of foreign companies, which are
responsible for the actual export of the product to a variety of locations.
Accordingly, amounts of export sales to specific geographic locations are not
available.
Maintenance and repair expenses were $26,665,000, $18,244,000, $6,221,000
and $27,017,000 for the year ended December 31, 1991, the nine months ended
September 30, 1992, the three months ended December 31, 1992 and the year ended
December 31, 1993, respectively.
16. EMPLOYEE BENEFITS
SAVINGS PLAN
The Company sponsors an employee savings plan (the "Savings Plan") that is
intended to provide participating employees with additional income upon
retirement. Employees may contribute between 1% and 10% of their base salary up
to a maximum of $8,994 annually to the Savings Plan. The Company matches a
minimum of 25% of the employee's aggregate contributions up to 6% of the
employee's base salary. Employee contributions are fully vested. Employer
contributions are fully vested upon retirement or after five years of service.
For 1991, 1992 and 1993, the Company matched 25% of the employee contributions
up to the 6% limit. The Company contributed approximately $351,000, $275,000,
$96,000 and $351,000 to the Savings Plan during the year ended December 31,
1991, the nine months ended September 30, 1992, the three months ended December
31, 1992 and the year ended December 31, 1993, respectively.
PENSION PLANS
The Company has two noncontributory defined benefit plans (the "Pension
Plans") covering substantially all full time employees. Benefits provided under
the Pension Plans are primarily based on years of service and the employee's
final average earnings. The Company's funding policy is to contribute annually
an amount based upon actuarial and economic assumptions designed to achieve
adequate funding of projected benefit obligations.
Net pension expense consists of the following (in thousands):
<TABLE>
<CAPTION>
NINE MONTHS THREE MONTHS
YEAR ENDED ENDED ENDED YEAR ENDED
DECEMBER 31, SEPTEMBER 30, DECEMBER 31, DECEMBER 31,
1991 1992 1992 1993
------------ ------------- ------------ ------------
<S> <C> <C> <C> <C>
Service cost....... $ 1,601 $1,108 $ 369 $ 1,279
Interest accrued on
pension
obligations....... 1,064 717 239 976
Actual cash return
on plan assets.... (1,565) (446) (137) (1,278)
Net amortization
and deferral...... 726 (540) -- 162
------------ ------ ----- ------------
Net pension
expense........... $ 1,826 $ 839 $ 471 $ 1,139
------------ ------ ----- ------------
------------ ------ ----- ------------
</TABLE>
F-18
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
16. EMPLOYEE BENEFITS (CONTINUED)
The following table sets forth the funded status of the Pension Plan (in
thousands):
<TABLE>
<CAPTION>
1992 1993
---------- ----------
<S> <C> <C>
Actuarial present value of benefit obligations:
Vested benefits............................................................... $ 9,476 $ 11,924
---------- ----------
---------- ----------
Accumulated benefit obligation................................................ $ 10,820 $ 13,822
---------- ----------
---------- ----------
Projected benefit obligation.................................................... $ 13,161 $ 16,518
Plan assets at fair value....................................................... (12,109) (14,238)
---------- ----------
Excess of projected benefit obligations over plan assets........................ 1,052 2,280
Unrecognized net loss........................................................... -- (1,392)
Prior service cost.............................................................. -- 125
Other........................................................................... -- 100
---------- ----------
Pension liability included in other noncurrent liabilities...................... $ 1,052 $ 1,113
---------- ----------
---------- ----------
</TABLE>
At December 31, 1992 and 1993, in determining the present value of benefit
obligations, a discount rate of 7.5% and 7.0% was used, respectively. The
assumption for the increase in future compensation levels was 4.5% at December
31, 1992 and 1993. At December 31, 1992 and 1993, the expected long-term rate of
return on assets used in determining future service costs was 9.0%.
POSTEMPLOYMENT BENEFITS
Concurrent with fresh start reporting (see note 3), on September 30, 1992
the Company adopted SFAS No. 112, "Employers' Accounting for Postemployment
Benefits", which generally requires an employer to recognize the obligation to
provide postemployment benefits. The obligation for postemployment benefits at
December 31, 1992 and 1993 approximated $1.2 million and is included in other
noncurrent liabilities.
POSTRETIREMENT BENEFITS OTHER THAN PENSIONS
The Company sponsors life and health welfare benefits plans for its current
and future retirees. Concurrent with fresh start reporting (see note 3), on
September 30, 1992 the Company adopted SFAS 106, "Employers' Accounting for
Postretirement Benefits Other Than Pensions", which requires an accrual method
of accounting for certain postretirement benefits. Adoption of SFAS 106 did not
have a material effect on the September 30, 1992 financial statements since the
Company had recorded an estimated liability for these benefits as part of
purchase accounting entries recorded in 1988. Prior to September 30, 1992, the
cost of net postretirement benefits other than pensions were recognized using
the pay-as-you-go basis.
Net postretirement benefit cost consists of the following (in thousands):
<TABLE>
<CAPTION>
THREE MONTHS
ENDED YEAR ENDED
DECEMBER 31, DECEMBER 31,
1992 1993
------------ ------------
<S> <C> <C>
Service cost...................................... $175 $ 760
Interest cost..................................... 234 1,070
----- ------
$409 $1,830
----- ------
----- ------
</TABLE>
F-19
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
16. EMPLOYEE BENEFITS (CONTINUED)
The actuarial value of postretirement benefit obligations consists of (in
thousands):
<TABLE>
<CAPTION>
DECEMBER 31,
--------------------
1992 1993
--------- ---------
<S> <C> <C>
Active participants eligible for retirement....................................... $ 3,025 $ 3,016
Active participants not yet eligible for retirement............................... 5,655 3,736
Retired participants.............................................................. 4,472 3,154
Prior service cost................................................................ -- 914
Net unrecognized gain............................................................. -- 3,909
--------- ---------
Accumulated postretirement benefit obligation..................................... $ 13,152 $ 14,729
--------- ---------
--------- ---------
</TABLE>
In 1992 and 1993, in determining the value of postretirement benefit
obligations, a discount rate of 8.25% and 7.0%, respectively, was used, and in
1993 the health care trend rate used to measure the expected increase in cost of
benefits was assumed to be 15% in 1994, and descending to 6.5% in 2006 and
thereafter. A one percentage-point increase in the assumed health care cost
trend rate for each year would increase the accumulated postretirement benefit
obligation as of December 31, 1993 by approximately $800,000 and would increase
the net postretirement benefit cost for the year ended December 31, 1993 by
approximately $90,000.
STOCK OPTION PLANS FOR EMPLOYEES
In July 1988, the Company adopted a stock incentive plan (the "Stock
Incentive Plan") providing for the granting of stock options for, stock
appreciation rights in, and the sale of restricted shares of, common stock. The
number of shares of common stock issuable under the Stock Incentive Plan is
limited to 87,500 shares in the aggregate.
In 1993, the Company adopted a non-qualified stock option plan (the
"Employee Plan") providing for the granting of 700,000 stock options for common
stock to key salaried employees of the Company.
Changes in stock options during the year ended December 31, 1991, the nine
months ended September 30, 1992, the three months ended December 31, 1992 and
the year ended December 31, 1993, are summarized as follows:
<TABLE>
<CAPTION>
OPTIONS PRICE RANGE
OUTSTANDING PER SHARE
----------- ----------------
<S> <C> <C>
Balance at December 31, 1990............................................ 21,975 $10.00-$304.00
Granted................................................................. 20,125 93.60
Exercised............................................................... (4,500) 10.00
Cancelled............................................................... (2,350) 93.60- 304.00
-----------
Balance at December 31, 1991............................................ 35,250 10.00- 304.00
Cancelled............................................................... (3,250) 65.20- 304.00
-----------
Balance at December 31, 1992............................................ 32,000 10.00- 304.00
Granted................................................................. 207,000 3.43
Cancelled............................................................... (18,700) 93.60- 304.00
-----------
Balance at December 31, 1993............................................ 220,300 $ 3.43-$304.00
-----------
-----------
</TABLE>
All of the data above has been adjusted to reflect a 40-for-1 reverse stock
split effected in connection with the merger of Old Rexene into Rexene Products
Company as described in note 1. Of the employee options outstanding at December
31, 1993, 12,500 are exercisable.
F-20
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
16. EMPLOYEE BENEFITS (CONTINUED)
NON-QUALIFIED STOCK OPTION PLAN FOR OUTSIDE DIRECTORS
In 1993, the Company adopted a non-qualified stock option plan for outside
directors (the "Directors Plan") providing for the granting of 225,000 stock
options for common stock. The Directors Plan provided for the automatic grant as
of January 1, 1993 and January 1, 1994 to each non-employee director of options
to purchase 12,500 shares of common stock, other than the Chairman of the Board
for whom an award on each grant date of options to purchase 16,667 shares of
common stock was provided. The exercise price of the options to purchase 104,167
shares of common stock granted in each year under the Directors Plan as of
January 1, 1993 and 1994 was $0.63 and $0.43 per share, respectively.
STOCK OPTION FOR FORMER OFFICER
In 1992, the Company granted a stock option to purchase at an aggregate
exercise price of $901,120, for a five-year period, an amount equal to one
percent of the common stock outstanding from the Effective Date, giving effect
to the Amended Plan and other adjustments.
STOCK BONUS PLAN
During 1985, the Company established an employee stock bonus plan (the
"Stock Bonus Plan") for the benefit of its employees. Contributions were made at
the discretion of the Company. Effective January 1, 1992, all participants (as
defined) became 100% vested and participation in the Stock Bonus Plan was
frozen. The Company does not intend to make further contributions to the Stock
Bonus Plan (see note 19).
17. SHARE PURCHASE RIGHTS PLAN
In January 1993, the Company adopted a share purchase rights plan ("Share
Rights Plan") by declaring a dividend distribution on February 8, 1993 of one
Common Stock Purchase Right ("Right") on each outstanding share of common stock.
The Rights are exercisable only if a person or group acquires 15% or more of
common stock or announces a tender offer, the consummation of which would result
in ownership by a person or group of 15% or more of the common stock. Each Right
entitles stockholders to purchase such number of shares of common stock at an
exercise price of $25.00 as determined under formulas set out in the Share
Rights Plan.
If the Company is acquired in a merger or other business combination, each
Right will entitle its holder to purchase, at the Rights' then-current exercise
price, a number of shares of the acquiring Company's common stock having a
market value of twice such price. In addition, if a person or group acquires 15%
or more of the Company's common stock, each Right will entitle its holder (other
than the acquiring person or group) to purchase, at the Right's then-current
exercise price, a number of shares of common stock having a market value of
twice such price.
Following the acquisition by a person of beneficial ownership of 15% or more
of the Company's common stock and prior to an acquisition of 50% or more of the
common stock, the Board of Directors may exchange the Rights (other than Rights
owned by the acquiring person or group), in whole or in part, at an exchange
ratio of one share of common stock per Right.
The Company can terminate the Rights at no cost any time prior to the
acquisition of a 15% position. The termination period can be extended by the
Board of Directors. The rights expire February 8, 2003.
18. RELATED PARTY TRANSACTIONS
Pursuant to a letter agreement dated March 16, 1992 between the Company and
its Chairman of the Board, Arthur L. Goeschel, the Company agreed to pay Mr.
Goeschel, in addition to his normal director fees, a sum of $2,750 per day plus
expenses for each day over five days per quarter that he spends on Company
matters. Under this letter agreement, the Company paid Mr. Goeschel $137,500,
$60,500 and $107,250 in additional fees for the nine months ended September 30,
1992, the three months ended December 31, 1992 and the year ended December 31,
1993 respectively. Mr. Goeschel is also a director of
F-21
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
18. RELATED PARTY TRANSACTIONS (CONTINUED)
Calgon Carbon Corporation ("Calgon"). During the year ended December 31, 1991,
the nine months ended September 30, 1992, the three months ended December 31,
1992 and the year ended December 31, 1993, the Company purchased approximately
$126,000, $54,000, $36,000 and $44,000, respectively, of materials from Calgon
in the ordinary course of business.
A son of Mr. Andrew J. Smith, the Chief Executive Officer and a director of
the Company, became a Vice President in 1990 and a stockholder in 1993 of Orion
Pacific, Inc. ("Orion"). In August 1993 the son of Mr. Smith resigned as an
officer and employee of Orion. Pursuant to contractual arrangements originated
in 1988, (i) the Company sells to Orion certain (a) discarded by-products which
Orion extracts from Company landfills and (b) scrap products, and (ii) Orion
packages and processes a portion of the Rextac-R- amorphous polyalphaolefins
("APAO") manufactured by the Company at its plant in Odessa, Texas. During the
year ended December 31, 1991, the nine months ended September 30, 1992, the
three months ended December 31, 1992 and the year ended December 31, 1993, the
Company sold approximately $1,005,000, $671,000, $241,000 and $283,000,
respectively, of such by-product and scrap products to Orion in the ordinary
course of business.
For the same periods, the Company purchased approximately $1,087,000,
$1,033,000, $302,000 and $1,551,000, respectively, of APAO processing and
packaging services and miscellaneous materials from Orion. At December 31, 1992,
the net receivable from Orion was approximately $332,000 and at December 31,
1993, the net payable to Orion was approximately $55,000. In 1990, Orion sold
its APAO processing and packaging technology to the Company for $750,000. The
Company has also agreed to pay Orion an additional $250,000 per plant for each
APAO plant utilizing the technology which the Company builds outside the United
States (excluding a certain joint venture plant in Japan). The Company currently
licenses this technology to Orion so that Orion can continue providing these
services to the Company.
Mr. Ilan Kaufthal, a director of the Company, is a managing director of
Wertheim Schroder & Co. Incorporated ("Wertheim"). In February 1991, an
unofficial committee of holders of debt securities of the Company retained
Wertheim as its financial advisor at the Company's expense. In November 1991,
the official committee of unsecured creditors in the Company's bankruptcy
proceeding also retained Wertheim as its financial advisor at the Company's
expense. Pursuant to these engagements, the Company paid Wertheim fees of
$1,075,000 and $860,000 for the year ended December 31, 1991 and the nine months
ended September 30, 1992, respectively. In December 1992, the Company retained
Wertheim as its financial advisor with respect to the adoption of a share
purchase rights plan (see note 17) for approximately $78,000.
The American International Group, Inc. ("AIG") of which Mr. Kevin Clowe, a
director of the Company, is a corporate officer provides various types of
insurance for the Company. During 1993, the Company paid approximately $2.8
million in premiums and fees to subsidiaries of AIG. In addition, a subsidiary
of AIG is the beneficiary of a standby letter of credit of $1.2 million to
ensure payment of premiums.
On March 2, 1992, Mr. William Gilliam resigned as Chairman of the Board and
Chief Executive Officer of the Company. In connection with Mr. Gilliam's
resignation, the Company, Mr. Gilliam, and Gilliam and Company, Inc., a
corporation of which Mr. Gilliam was the sole shareholder ("GCI"), with the
approval of the Bankruptcy Court, entered into an agreement which, among other
things, (i) terminated a management agreement (the "Management Agreement")
between the Company and GCI which had been suspended during the Chapter 11
proceedings, (ii) granted to Mr. Gilliam a stock option (see note 16), and (iii)
paid $500,000 to Mr. Gilliam.
Under the Management Agreement, as consideration for advisory and consulting
services, the Company agreed to pay GCI a fee of $1 million per year plus
reimbursement of expenses. For the year ended
F-22
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
18. RELATED PARTY TRANSACTIONS (CONTINUED)
December 31, 1991, the Company paid GCI approximately $800,000. In addition, the
Company reimbursed GCI approximately $653,000 in such year for expenses
primarily consisting of the operating costs for GCI aircraft used in connection
with Company business.
In April 1988, the Company was sold (the "1988 Merger") by its then current
stockholders (the "Selling Stockholders"). Pursuant to the merger agreement for
the 1988 Merger (the "1988 Merger Agreement") and a related escrow agreement,
$30 million of the purchase price was deposited into an escrow account (the
"Escrow Account") on behalf of the Selling Stockholders to indemnify the Company
against certain contingencies. In December 1992, the Company entered into a
memorandum agreement (the "Escrow Settlement Agreement") for the disposition of
the principal balance of the Escrow Account and accrued interest thereon (less
certain prior distributions). Pursuant to the Escrow Settlement Agreement, the
Escrow Account, among other things, (i) distributed approximately $32.1 million
to the Selling Stockholders, (ii) paid approximately $1 million to reimburse the
Company for its net expenses (plus interest thereon) in defending certain
lawsuits, (iii) retained $2.25 million as a reserve to pay certain potential
expenses of the Escrow Account and (iv) retained $2 million which will be
available to the Company to pay up to 50% of any portion of a final judgment or
settlement in the Izzarelli litigation (as hereafter described in note 19) which
is not paid by insurance. As a result of the Escrow Settlement Agreement, Mr.
Smith, Dr. Lavon N. Anderson, the president and chief operating officer and a
director of the Company, and Mr. Jack E. Knott, executive vice president of
sales and market development of the Company, received approximately $660,000,
$85,000 and $71,000 from the Escrow Account, respectively in 1992. Any amounts
being reserved by the Escrow Account which are not utilized for their intended
purpose will be available for future distribution to the Selling Stockholders.
In all negotiations concerning the Escrow Account, the Selling Stockholders were
represented by a committee appointed under the 1988 Merger Agreement and by
counsel to such committee. Mr. Smith, Dr. Anderson and Mr. Knott were not
members of such committee and did not participate in any of the negotiations
between the Company and the committee.
19. CONTINGENCIES
The Company is subject to extensive environmental laws and regulations
concerning, for example, emissions to the air, discharges to surface and
subsurface waters and the generation, handling, storage, transportation,
treatment and disposal of waste and other materials. The Company believes that,
in light of its historical expenditures, it will have adequate resources to
conduct its operations in compliance with currently applicable environmental and
health and safety laws and regulations. However, in order to comply with
changing licensing and regulatory standards, the Company may be required to make
additional significant site or operational modifications. Further, the Company
has incurred and may in the future incur liability to clean up waste or
contamination at its current or former facilities, or which it may have disposed
of at facilities operated by third parties. Company management believes that the
$23.4 million accrued in the December 31, 1993 balance sheet is adequate for the
total potential environmental liability with respect to remediating site
contamination. However, no assurance can be given that all potential liabilities
arising out of the Company's present or past operations have been identified or
that the amounts that might be required to remediate such conditions will not be
significant to the Company. The Company continually reviews its estimates of
potential environmental liabilities.
STOCKHOLDER CLASS ACTION LITIGATION
In January 1990, a purported class action was filed in the United States
District Court, Northern District of Texas, by an alleged stockholder of the
Company on behalf of purchasers of common stock of Old Rexene between October
23, 1989 and December 27, 1989. The defendants in this action presently include
the Company, one of its current directors and certain of its former directors.
The class has been certified with an intervenor as the class representative. The
intervenor's complaint asserts claims under Section 10b-5 of the Securities
Exchange Act of 1934, and state common law grounds. The plaintiff alleges that
public statements made by certain directors of the Company created a misleading
impression of the Company's financial
F-23
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
19. CONTINGENCIES (CONTINUED)
condition thereby artificially inflating the price of the common stock of Old
Rexene. The plaintiff seeks compensatory damages, prejudgment interest, a
recovery of costs and attorneys' fees, and such other relief as may be deemed
just and proper. Discovery is ongoing.
In the Company's Chapter 11 proceeding, the intervening plaintiff filed a
proof of claim on behalf of herself and the purported class seeking in excess of
$10 million based upon the allegations in the litigation. The Company objected
to the claim and elected to leave the legal, equitable and contractual rights of
the plaintiff unaltered thereby allowing this litigation to proceed as of the
Effective Date without regard to the bankruptcy proceeding.
IZZARELLI STOCK BONUS PLAN CLASS ACTION LITIGATION
In February 1991, a class action lawsuit was filed in the United States
District Court for the Western District of Texas -- Midland Division (the "Trial
Court") against the Company, the Stock Bonus Plan and Texas Commerce Bank --
Odessa (the former trustee for the Stock Bonus Plan) by two former employees of
the Company on behalf of themselves and all other 1986 participants in the Stock
Bonus Plan (the "Izzarelli Class"). The complaint alleges that the Company
amended the Stock Bonus Plan in 1987 and 1988 to deprive the Izzarelli Class of
stock benefits to which they would have been entitled had the Stock Bonus Plan
not been amended. The plaintiffs assert claims under the Employee Retirement
Income Security Act of 1974, as amended ("ERISA") for breach of fiduciary duties
to the participants and for violation of ERISA's provision prohibiting
amendments to the Stock Bonus Plan after benefits have accrued to participants.
The plaintiffs seek actual damages, attorneys' fees, costs and expenses, and
such further relief as may be deemed appropriate. After a trial, the Trial Court
in July 1992 entered a judgment against the Company in the amount of $6.6
million (as subsequently amended) plus costs of court. In November 1992, the
Trial Court awarded the Izzarelli Class $595,000 for attorneys' fees and
out-of-pocket expenses. The Company has recorded an accrual of $7.4 million to
reflect this judgment. The Company has appealed the judgment to the United
States Court of Appeals for the Fifth Circuit. The Izzarelli Class has also
filed an appeal with respect to the amount of damages awarded and the judgment
in favor of Texas Commerce Bank -- Odessa. These appeals are pending.
In the Bankruptcy Court, the Izzarelli Class filed proofs of claim for $27.7
million. The Izzarelli Class has pending before the Bankruptcy Court a motion to
alter or amend the order confirming the Amended Plan and a motion to allow their
claim based upon the judgment entered by the Trial Court. The Company believes
that if the Bankruptcy Court granted these motions, the Izzarelli Class would be
allowed to enforce its judgment unless the Company posted a bond or other
security. Pursuant to a request by the Company, the Bankruptcy Court on November
4, 1992 entered an order continuing such motions until the resolution of the
appeals pending in the Fifth Circuit Court of Appeals. The Izzarelli Class has
appealed the Bankruptcy Court's continuation order to the United States District
Court for the District of Delaware, which dismissed the appeal on September 29,
1993. The Izzarelli Class then filed an appeal with the United States Court of
Appeals for the Third Circuit. This appeal is pending.
Pursuant to an agreement in December 1992 regarding the distribution of the
remaining balance in an escrow account established in connection with a 1988
merger involving the Company, there is $2 million being retained in the escrow
account which will be available to the Company to pay up to 50% of any portion
of a final judgment or settlement in this matter which is not paid by insurance.
The Company intends to pursue claims for recovery of the amount of any final
judgment or settlement against its insurance carrier subject to policy limits of
$10 million. Although the insurance carrier has been paying the Company's
attorneys' fees, it has otherwise denied coverage and reserved all rights.
PHILLIPS BLOCK COPOLYMER LITIGATION
In March 1984, Phillips Petroleum Company ("Phillips") filed a lawsuit
against the Company in the United States District Court for the Northern
District of Illinois, Eastern Division, seeking injunctive relief,
F-24
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
19. CONTINGENCIES (CONTINUED)
an unspecified amount of compensatory damages and treble damages. The complaint
alleges that the Company's copolymer process for polypropylene infringes
Phillips' two "block" copolymer patents. This action has been transferred to the
United States District Court for the Southern District of Texas, Houston
Division. Discovery proceedings in this case have been completed. The Company
has filed a motion for summary judgment. Phillips has filed a motion for partial
summary judgment. Pursuant to an agreement among the parties, the Court
appointed a Special Master who conducted a hearing on these motions and
thereafter recommended to the Court that the Company's motion be granted and
Phillips' motion be denied. Thereafter, Phillips filed motions to disqualify the
Special Master, to reject the recommendation of the Special Master and to enter
partial summary judgment for Phillips. The Court has entered an order denying
Phillips' motion to disqualify the Special Master. The summary judgment motions
are still pending. In the Company's Chapter 11 proceedings, Phillips filed
proofs of claim seeking in excess of $108 million based upon the allegations in
this litigation. The Company objected to the claims and elected to leave the
legal, equitable and contractual rights of Phillips unaltered thereby allowing
this litigation to proceed as of the Effective Date without regard to the
bankruptcy proceeding.
PHILLIPS CRYSTALLINE LICENSE LITIGATION
In May 1990, Phillips filed a lawsuit against the Company in the United
States District Court for the District of Delaware seeking injunctive relief, an
unspecified amount of compensatory damages, treble damages and attorneys' fees,
costs and expenses. The complaint alleges that the Company is infringing
Phillips' Patent No. 4,376,851 (the "851 Patent") for crystalline polypropylene.
Pursuant to a License Agreement dated as of May 15, 1983 (the "License
Agreement"), Phillips granted the Company a non-exclusive license to make, use
and sell crystalline polypropylene covered by the '851 Patent. The complaint
alleges that effective April 21, 1990, Phillips terminated the License Agreement
because it believed that, by the terms of the License Agreement, all conditions
precedent to such termination had occurred. The complaint further alleges that,
without an effective License Agreement, the Company's continuing use of the '851
Patent constitutes an infringing use. An amended complaint filed in May 1990
further alleges that the Company made a material misrepresentation that induced
Phillips to enter into the License Agreement and that Phillips entered into the
License Agreement as a consequence of a mutual mistake of the parties. The
amended complaint therefore alleges that the License Agreement is void AB
INITIO. The Company filed a motion to dismiss Phillips' amended complaint for
failure to state a claim. On December 30, 1993, the Court entered an order
dismissing Phillips' claim that the License Agreement was void AB INITIO, and
ordered that the 1990 license termination issue be resolved at trial. Trial has
been scheduled for October 19, 1994. In the Company's Chapter 11 proceedings,
Phillips filed proofs of claim seeking in excess of $147 million based upon the
allegations in this litigation. The Company objected to the claims and elected
to leave the legal, equitable and contractual rights of Phillips unaltered
thereby allowing this litigation to proceed as of the Effective Date without
regard to the bankruptcy proceeding.
With respect to each of the litigation matters described above, the Company
believes that, based upon its current knowledge of the facts of each case, the
Company has meritorious defenses to the various claims made and intends to
defend each such suit vigorously. Although there can be no assurance of the
final resolution of any of these litigation matters, the Company does not
believe that the outcome of any of these lawsuits will have a material adverse
effect on the Company's financial position or results of operations.
The Company is also a party to various lawsuits arising in the ordinary
course of business and does not believe that the outcome of any of these
lawsuits will have a material adverse effect on the Company's financial position
or results of operations.
F-25
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
20. QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
Summarized quarterly financial information for the year ended December 31,
1993, the three months ended December 31, 1992 and the nine months ended
September 30, 1992 is as follows (in thousands, except per share data):
<TABLE>
<CAPTION>
PRE-EMERGENCE POST-EMERGENCE
----------------------------------- -----------------------------------------------------------------
FOR THE QUARTERS ENDED
-------------------------------------------------------------------------------------------------------
MARCH 31, JUNE 30, SEPTEMBER 30, DECEMBER 31, MARCH 31, JUNE 30, SEPTEMBER 30, DECEMBER 31,
1992 1992 1992 1992 1993 1993 1993 1993
--------- -------- ------------- ------------ --------- -------- ------------- ------------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
Net sales................ $103,703 $102,763 $109,640 $98,854 $109,274 $105,998 $111,188 $102,893
Gross profit............. 9,351 16,288 12,386 12,122 13,410 13,613 14,537 12,184
Loss before extraordinary
gain.................... (237) (3,258) (27,981) (6,528) (8,153) (3,656) (7,826) (5,608)
Extraordinary gain....... -- -- 123,672 -- -- -- -- --
Net income (loss)........ (237) (3,258) 95,691 (6,528) (8,153) (3,656) (7,826) (5,608)
Loss per share........... (.62) (.78) (.35) (.75) (.53)
</TABLE>
The per share amount for the pre-emergence periods is not presented because
such information is not comparable with the post-emergence periods.
F-26
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNT)
(UNAUDITED)
<TABLE>
<CAPTION>
SIX MONTHS ENDED
JUNE 30,
----------------------
1993 1994
---------- ----------
<S> <C> <C>
Net sales................................................................................. $ 215,272 $ 243,216
---------- ----------
Operating expenses:
Cost of sales........................................................................... 188,249 199,553
Marketing, general and administrative................................................... 16,346 16,787
Research and development................................................................ 3,172 3,150
---------- ----------
207,767 219,490
---------- ----------
Operating income.......................................................................... 7,505 23,726
Interest expense:
Cash.................................................................................... (12,076) (12,129)
Non-cash................................................................................ (12,322) (13,023)
Interest income........................................................................... 696 856
Other, net................................................................................ (51) (268)
---------- ----------
Loss before income taxes.................................................................. (16,248) (838)
Income tax benefit........................................................................ 4,439 177
---------- ----------
Net loss.................................................................................. $ (11,809) $ (661)
---------- ----------
---------- ----------
Weighted average shares outstanding....................................................... 10,501 10,501
---------- ----------
---------- ----------
Net loss per share........................................................................ $ (1.12) $ (.06)
---------- ----------
---------- ----------
</TABLE>
See notes to condensed consolidated financial statements.
F-27
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET
(IN THOUSANDS)
(UNAUDITED)
ASSETS
<TABLE>
<CAPTION>
JUNE 30,
1994
----------
<S> <C>
Cash and cash equivalents:
Unrestricted........................................................................................ $ 35,611
Restricted.......................................................................................... 2,281
Accounts receivable, net.............................................................................. 66,386
Inventories........................................................................................... 53,350
Income taxes receivable............................................................................... --
Prepaid expenses and other............................................................................ 1,788
----------
Total current assets.............................................................................. 159,416
Property, plant and equipment, net.................................................................... 251,307
Reorganization value in excess of amounts allocable to identifiable assets............................ 3,527
Intangible assets, net................................................................................ 3,638
Other noncurrent assets............................................................................... 31,973
----------
$ 449,861
----------
----------
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable...................................................................................... $ 26,814
Accrued liabilities................................................................................... 6,647
Accrued interest...................................................................................... 3,103
Income taxes payable.................................................................................. 2,783
Employee benefits payable............................................................................. 4,770
----------
Total current liabilities......................................................................... 44,117
Long-term debt........................................................................................ 298,023
Other noncurrent liabilities.......................................................................... 70,536
Deferred income taxes................................................................................. 42,950
----------
Total liabilities................................................................................. 455,626
Commitments and contingencies......................................................................... --
Stockholders' deficit:
Common stock, par value $0.01 per share; 100 million shares authorized; 10.5 million shares issued
and outstanding.................................................................................... 105
Paid-in capital..................................................................................... 26,562
Accumulated deficit................................................................................. (32,432)
----------
Total stockholders' deficit....................................................................... (5,765)
----------
$ 449,861
----------
----------
</TABLE>
See notes to condensed consolidated financial statements.
F-28
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(UNAUDITED)
<TABLE>
<CAPTION>
SIX MONTHS ENDED
JUNE 30,
----------------------
1993 1994
---------- ----------
<S> <C> <C>
Cash flow from operating activities:
Net loss.................................................................................. $ (11,809) $ (661)
---------- ----------
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization........................................................... 8,560 9,194
Non-cash interest expense............................................................... 12,322 13,023
Deferred income taxes................................................................... (4,392) (2,266)
Change in:
Accounts receivable................................................................... (4,150) (8,566)
Inventories........................................................................... 117 (729)
Prepaid expenses and other............................................................ (828) (266)
Income taxes.......................................................................... (72) 7,748
Accounts payable...................................................................... (3,414) (572)
Accrued interest...................................................................... (53) 6
Employee benefits payable and accrued liabilities..................................... (1,543) (453)
Increase in other noncurrent liabilities................................................ 1,860 193
Other................................................................................... (882) (832)
---------- ----------
Total adjustments....................................................................... 7,525 16,480
---------- ----------
Net cash provided by (used for) operating activities...................................... (4,284) 15,819
---------- ----------
Cash flows from investing activities:
Capital expenditures.................................................................... (7,062) (15,462)
---------- ----------
Net cash used for investing activities.................................................... (7,062) (15,462)
---------- ----------
Cash flows from financing activities:
Bank borrowings......................................................................... -- 7,000
---------- ----------
Net cash provided by financing activities................................................. -- 7,000
---------- ----------
Net increase (decrease) in cash and cash equivalents...................................... (11,346) 7,357
Cash and cash equivalents at beginning of period.......................................... 34,202 30,535
---------- ----------
Cash and cash equivalents at end of period................................................ $ 22,856 $ 37,892
---------- ----------
---------- ----------
Supplemental cash flow information:
Cash paid for interest.................................................................. $ 11,910 $ 11,955
Cash paid for income taxes.............................................................. $ -- $ 154
</TABLE>
See notes to condensed consolidated financial statements.
F-29
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. GENERAL
Rexene Corporation manufactures and markets thermoplastic and petrochemical
products, including low density polyethylene and polypropylene resins, plastic
films and styrene, which are integral elements in the manufacture of a wide
variety of industrial and consumer products. Rexene Corporation and its
subsidiaries are hereinafter sometimes collectively or separately referred to as
the "Company".
The accompanying condensed consolidated financial statements are unaudited;
however, in management's opinion, all adjustments, consisting only of normal
recurring adjustments necessary for a fair presentation of the results of
operations, financial position, and cash flows for the periods shown have been
made. Results for interim periods are not necessarily indicative of those to be
expected for the full year. The interim condensed consolidated financial
statements should be read in conjunction with the Consolidated Financial
Statements and Notes thereto included elsewhere in this Prospectus.
2. INCOME TAXES
The income tax benefit (expense) is composed of (in thousands):
<TABLE>
<CAPTION>
SIX MONTHS ENDED
JUNE 30,
--------------------
1993 1994
--------- ---------
<S> <C> <C>
Current:
State............................................................................ $ (31) $ (140)
Federal.......................................................................... 79 (1,949)
Deferred income taxes.............................................................. 4,391 2,266
--------- ---------
$ 4,439 $ 177
--------- ---------
--------- ---------
</TABLE>
3. INVENTORIES
Inventories consist of the following (in thousands):
<TABLE>
<CAPTION>
JUNE 30,
1994
---------
<S> <C>
Raw materials...................................................................... $ 15,116
Work in progress................................................................... 7,335
Finished goods..................................................................... 30,899
---------
$ 53,350
---------
---------
</TABLE>
F-30
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(UNAUDITED)
4. NONCURRENT ASSETS
The cost and accumulated depreciation of property, plant and equipment and
cost and accumulated amortization of reorganization value in excess of amounts
allocable to identifiable assets and intangible assets are as follows (in
thousands):
<TABLE>
<CAPTION>
JUNE 30,
1994
----------
<S> <C>
Property, plant and equipment..................................................... $ 279,514
Accumulated depreciation.......................................................... (28,207)
----------
$ 251,307
----------
----------
Reorganization value in excess of amounts allocable to identifiable assets........ $ 4,298
Accumulated amortization.......................................................... (771)
----------
$ 3,527
----------
----------
Intangible assets................................................................. $ 5,598
Accumulated amortization.......................................................... (1,960)
----------
$ 3,638
----------
----------
</TABLE>
5. LONG-TERM DEBT
Long-term debt consists of the following (in thousands):
<TABLE>
<CAPTION>
JUNE 30,
1994
----------
<S> <C>
Old Senior Notes.................................................................. $ 253,000
Old Subordinated Notes............................................................ 99,629
Less: unamortized discount........................................................ (63,606)
----------
289,023
Bank borrowings under the Old Credit Agreement.................................... 9,000
----------
$ 298,023
----------
----------
</TABLE>
6. CONTINGENCIES
The Company is subject to extensive environmental laws and regulations
concerning, for example, emissions to the air, discharges to surface and
subsurface waters and the generation, handling, storage, transportation,
treatment and disposal of waste and other materials. The Company believes that,
in light of its historical expenditures, it will have adequate resources to
conduct its operations in compliance with currently applicable environmental and
health and safety laws and regulations. However, in order to comply with
changing licensing and regulatory standards, the Company may be required to make
additional significant site or operational modifications. Further, the Company
has incurred and may in the future incur liability to clean up waste or
contamination at its current or former facilities, or which it may have disposed
of at facilities operated by third parties. On the basis of reasonable
investigation and analysis, management believes that the approximately $23.3
million accrued in the June 30, 1994 balance sheet is adequate for the total
potential environmental remediation liability with respect of contaminated
sites. However, no assurance can be given that all potential liabilities arising
out of the Company's present or past operations have been identified or that the
amounts that might be required to remediate such conditions will not be
significant to the Company. The Company continually reviews its estimates of
potential environmental liabilities.
F-31
<PAGE>
REXENE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(UNAUDITED)
6. CONTINGENCIES (CONTINUED)
The Company is a party to various lawsuits arising in the ordinary course of
business and to certain other lawsuits which are set forth in Note 19 to the
Consolidated Financial Statements included in this Prospectus. There have been
no material changes to the certain other lawsuits described in the
aforementioned Note 19, except as described in the Litigation section of this
Prospectus.
With respect to each of the litigation matters filed against the Company,
the Company believes that, based upon its current knowledge of the facts of each
case, the Company has meritorious defenses to the various claims made and
intends to defend each such suit vigorously. Although there can be no assurance
of the final resolution of any of these litigation matters, the Company does not
believe that the outcome of any of these lawsuits will have a material adverse
effect on the Company's financial position or results of operations.
F-32
<PAGE>
[Inside Back Cover]
[Photos of Odessa, Texas facility and Scunthorpe, England plant to come]
<PAGE>
- -------------------------------------------
-------------------------------------------
- -------------------------------------------
-------------------------------------------
NO PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY
REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS PROSPECTUS, AND,
IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON AS
HAVING BEEN AUTHORIZED BY THE COMPANY OR ANY OF THE UNDERWRITERS. THIS
PROSPECTUS DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER
TO BUY ANY SECURITIES OTHER THAN THE SECURITIES TO WHICH IT RELATES OR AN OFFER
TO SELL OR A SOLICITATION OF AN OFFER TO BUY SUCH SECURITIES IN ANY
CIRCUMSTANCES OR IN ANY JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION IS
UNLAWFUL. NEITHER THE DELIVERY OF THIS PROSPECTUS NOR ANY SALE MADE HEREUNDER
SHALL, UNDER ANY CIRCUMSTANCES, CREATE ANY IMPLICATION THAT THERE HAS BEEN NO
CHANGE IN THE AFFAIRS OF THE COMPANY SINCE THE DATE HEREOF OR THAT THE
INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT TO ITS DATE.
--------------
TABLE OF CONTENTS
<TABLE>
<CAPTION>
PAGE
------
<S> <C>
Prospectus Summary.................................................... 3
Investment Considerations............................................. 10
The Recapitalization.................................................. 14
Use of Proceeds....................................................... 15
Capitalization........................................................ 16
Selected Historical Consolidated Financial Data....................... 17
Pro Forma Unaudited Condensed Consolidated Financial Data............. 19
Management's Discussion and Analysis of Financial Condition and
Results of Operations................................................ 22
Business.............................................................. 30
Management............................................................ 47
Security Ownership of Certain Beneficial Owners and Management........ 49
Description of New Credit Agreement................................... 51
Description of Senior Notes........................................... 51
Description of Capital Stock.......................................... 73
Underwriting.......................................................... 76
Legal Opinions........................................................ 76
Experts............................................................... 76
Available Information................................................. 76
Incorporation of Certain Documents by Reference....................... 77
Index to Consolidated Financial Statements............................ F-1
</TABLE>
$175,000,000
[LOGO]
% SENIOR NOTES
DUE 2004
---------
P R O S P E C T U S
NOVEMBER , 1994
---------
SMITH BARNEY INC.
WERTHEIM SCHRODER & CO.
INCORPORATED
- -------------------------------------------
-------------------------------------------
- -------------------------------------------
-------------------------------------------
<PAGE>
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
The following table sets forth the costs and expenses, other than
underwriting discounts and commissions, incurred or to be incurred in connection
with the sale of the Senior Notes being registered (all amounts are being
estimated except the SEC Registration Fee and the NASD Filing Fee), all of which
will be paid by the Registrant:
<TABLE>
<S> <C>
SEC Registration Fee...................................................... $ 60,345
NASD Filing Fee........................................................... 18,000
Printing and Engraving Expenses........................................... *
Fees and Expenses of Counsel.............................................. *
Accounting Fees........................................................... *
Blue Sky Qualification Fees and Expenses.................................. *
Trustee's Fees and Expenses............................................... *
Rating Agencies' Fees..................................................... *
Miscellaneous............................................................. *
---------
Total................................................................. $ *
---------
---------
<FN>
- ------------------------
* To be provided by amendment.
</TABLE>
ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS
STATUTORY PROVISIONS
Section 102(b)(7) of the Delaware General Corporation Law enables a
corporation to include in its certification of incorporation a provision
eliminating or limiting the personal liability of members of its board of
directors to the corporation or its stockholders for monetary damages for
violations of a director's fiduciary duty as a director. Such a provision does
not have any effect on the availability of equitable remedies, such as an
injunction or rescission, for breach of fiduciary duty. In addition, such a
provision may not eliminate or limit the liability of a director for breaching
his duty of loyalty to the corporation or its stockholders, failing to act in
good faith, engaging in intentional misconduct or knowingly violating a law,
paying an unlawful dividend or approving an illegal stock repurchase, or
executing any transaction from which the director obtained an improper personal
benefit.
Section 145 of the Delaware General Corporation Law empowers a corporation
to indemnify any person who was or is a party to or is threatened to be made a
party to any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (other than an action
by or in the right of the corporation), by reason of the fact that he is or was
a director, officer, employee or agent of the corporation, or is or was serving
at the request of the corporation as a director, officer, employee or agent of
another corporation, partnership, joint venture, trust or other enterprise,
against expenses (including attorney's fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred by him in connection with such
action, suit or proceeding if he acted in good faith and in a manner he
reasonably believed to be in or not opposed to the best interests of the
corporation, and, with respect to any criminal action or proceeding, had no
reasonable cause to believe his conduct was unlawful and except that no
indemnification may be made in respect of any claim, issue or matter as to which
such person has been adjudged to be liable to the corporation unless and only to
the extent that the Delaware Court of Chancery or the court in which such action
or suit was brought shall determine upon application that, despite the
adjudication of liability but in view of all the circumstances of the case, such
person is fairly and reasonably entitled to indemnity for such expenses as the
court deems proper. With respect to actions or suits by or in the right of the
corporation, such indemnification is limited to expenses (including attorney's
fees) actually and reasonably incurred by such person in connection with the
defense or settlement of such action or suit. To the extent that such directors
or officers have been successful on the merits or otherwise in defense of any
II-1
<PAGE>
action, suit or proceeding referred to above or in defense of any claim, issue
or matter therein a corporation is required to indemnify its directors and
officers against expenses (including attorneys fees) actually and reasonably
incurred by such officers and directors in connection therewith.
Indemnification can be made by the corporation only upon a determination
made in the manner prescribed by the statute that indemnification is proper in
the circumstances because the party seeking indemnification has met the
applicable standard of conduct as set forth in the Delaware General Corporation
Law. The indemnification provided by the Delaware General Corporation Law is not
exclusive of any other rights to which those seeking indemnification may be
entitled under any bylaw, agreement, vote of stockholders or disinterested
directors, or otherwise. Unless otherwise provided when authorized or ratified,
the indemnification provided by the Delaware General Corporation Law continues
as to a person who has ceased to be a director, officer, employee or agent and
inures to the benefit of the heirs, executors and administrators of such a
person.
A corporation also has the power to purchase and maintain insurance on
behalf of any person covering any liability incurred by such person in his
capacity as a director, officer, employee or agent of the corporation, or
arising out of his status as such, whether or not the corporation has the power
to indemnify him against such liability.
THE REGISTRANT'S CHARTER AND BYLAW PROVISIONS
Article VI, Section 6.1 of the Registrant's Amended and Restated Bylaws
provides that the Registrant shall indemnify all directors and officers of the
Company to the fullest extent now or hereafter permitted by the Delaware General
Corporation Law. Under such provisions, any director or officer, who in his
capacity as such, is made or threatened to be made a party to any suit or
proceeding, shall be indemnified if such director or officer acted in good faith
and in a manner he reasonably believed to be in or not opposed to the best
interests of the Registrant and, with respect to any criminal proceeding, had no
reasonable cause to believe his conduct was unlawful. The Amended and Restated
Bylaws and the Delaware General Corporation Law further provide that such
indemnification is not exclusive of any other rights to which such individuals
may be entitled under any bylaws, agreement, vote of stockholders or
disinterested directors or otherwise.
In addition, Article VII of the Registrant's Restated Certificate of
Incorporation provides that to the fullest extent now or hereafter permitted by
Delaware law, the Registrant's directors will not be liable to the Registrant
and its stockholders for monetary damages for breach of fiduciary duty as a
director.
UNDERWRITING AGREEMENT PROVISIONS
The form of Underwriting Agreement contained in Exhibit 1.1 provides for
indemnification of the directors and officers signing the Registration Statement
and certain controlling persons of the Company against certain liabilities,
including certain liabilities under the Securities Act of 1933, in certain
instances by the Underwriters.
ITEM 16. EXHIBITS
<TABLE>
<CAPTION>
NUMBER EXHIBIT
- --------- -----------------------------------------------------------------------------------------------------
<C> <C> <S>
1.1* -- Form of Underwriting Agreement.
2.1 -- First Amended Plan of Reorganization of Rexene Products Company, et al., dated April 29, 1992 (filed
as Exhibit 2.1 to the Registrant's Form 8-K Current Report dated July 7, 1992 and incorporated herein
by reference).
2.2 -- Order Confirming First Amended Plan of Reorganization dated April 29, 1992 (filed as Exhibit 2.2 to
the Registrant's Form 10-K for the fiscal year ended December 31, 1992 and incorporated herein by
reference).
2.3 -- Plan and Agreement of Merger between the Registrant and Rexene Products Company dated as of September
11, 1992 (filed as Exhibit 2.3 to the Registrant's Form 10-K for the fiscal year ended December 31,
1992 and incorporated herein by reference.)
</TABLE>
II-2
<PAGE>
<TABLE>
<CAPTION>
NUMBER EXHIBIT
- --------- -----------------------------------------------------------------------------------------------------
<C> <C> <S>
3.1.1 -- Restated Certificate of Incorporation of Rexene Products Company (a/k/a Rexene Corporation) dated
September 11, 1992 (filed as Exhibit 3.1 to the Registrant's Form 10-K for the fiscal year ended
December 31, 1992 and incorporated herein by reference.)
3.1.2 -- Amendment to Certificate of Incorporation dated June 9, 1993 (filed as Exhibit 3.1.2 to the
Registrant's Annual Report on Form 10-K for the year ended December 31, 1993 and incorporated herein
by reference).
3.2.1 -- Amendments to By-Laws adopted May 24, 1994, together with a restatement of the Registrant's By-Laws
incorporating all amendments through May 24, 1994 (filed as Exhibit 3.2.3 to the Registrant's Form
10-Q Quarterly Report for the three months ended June 30, 1994 and incorporated herein by reference).
4.1* -- Form of Indenture governing the Senior Notes (including form of Senior Notes).
4.2 -- Indenture dated as of September 18, 1992 between the Registrant, as Issuer, and Chemical Bank, as
Trustee, for Increasing Rate First Priority Notes Due 1999 (filed as Exhibit 4.1 to the Registrant's
Form 10-Q Quarterly Report for the three months ended September 30, 1992 and incorporated herein by
reference).
4.3 -- Indenture dated as of September 18, 1992 between the Registrant, as Issuer, and United States Trust
Company of New York, as Trustee, for Increasing Rate Second Priority Notes Due 2002 (filed as Exhibit
4.2 to the Registrant's Form 10-Q Quarterly Report for the three months ended September 30, 1992 and
incorporated herein by reference).
4.4 -- Intercreditor and Collateral Trust Agreement dated as of September 18, 1992 by and among the
Registrant and Poly-Pac, Inc. as Grantors, Chemical Bank as Collateral Agent, Chemical Bank as
Trustee, and United States Trust Company, as Trustee (filed as Exhibit 4.3 to the Registrant's Form
10-Q Quarterly Report for the three months ended September 30, 1992 and incorporated herein by
reference).
4.5 -- Company First Priority Security and Pledge Agreement dated as of September 18, 1992 made by the
Registrant, as Grantor, in favor of Chemical Bank, as Collateral Agent (filed as Exhibit 4.4 to the
Registrant's Form 10-Q Quarterly Report for the three months ended September 30, 1992 and
incorporated herein by reference).
4.6 -- Company Second Priority Security and Pledge Agreement dated as of September 18, 1992 made by the
Registrant, as Grantor, in favor of Chemical Bank, as Collateral Agent (filed as Exhibit 4.5 to the
Registrant's Form 10-Q Quarterly Report for the three months ended September 30, 1992 and
incorporated herein by reference).
4.7 -- Subsidiary First Priority Security and Pledge Agreement dated as of September 18, 1992 made by
Poly-Pac, Inc., as Grantor, in favor of Chemical Bank, as Collateral Agent (filed as Exhibit 4.6 to
the Registrant's Form 10-Q Quarterly Report for the three months ended September 30, 1992 and
incorporated herein by reference).
4.8 -- Subsidiary Second Priority Security and Pledge Agreement dated as of September 18, 1992 made by
Poly-Pac, Inc., as Grantor, in favor of Chemical Bank, as Collateral Agent (filed as Exhibit 4.7 to
the Registrant's Form 10-Q Quarterly Report for the three months ended September 30, 1992 and
incorporated herein by reference).
4.9 -- First Priority Deed of Trust and Security Agreement dated as of September 18, 1992 from the
Registrant, as Grantor, to Phillip D. Weller, as Trustee for the benefit of Chemical Bank, as
Beneficiary, for certain property located in Odessa, Texas (filed as Exhibit 4.8 to the Registrant's
Form 10-Q Quarterly Report for the three months ended September 30, 1992 and incorporated herein by
reference).
</TABLE>
II-3
<PAGE>
<TABLE>
<CAPTION>
NUMBER EXHIBIT
- --------- -----------------------------------------------------------------------------------------------------
<C> <C> <S>
4.10 -- Second Priority Deed of Trust and Security Agreement dated as of September 18, 1992 from the
Registrant, as Grantor, to Phillip D. Weller, as Trustee for the benefit of Chemical Bank, as
Beneficiary, for certain property located in Odessa, Texas (filed as Exhibit 4.9 to the Registrant's
Form 10-Q Quarterly Report for the three months ended September 30, 1992 and incorporated herein by
reference).
4.11 -- First Priority Deed of Trust and Security Agreement dated as of September 18, 1992 from the
Registrant, as Grantor, to Phillip D. Weller, as Trustee for the benefit of Chemical Bank, as
Beneficiary, for certain property located in Pasadena, Texas (filed as Exhibit 4.10 to the
Registrant's Form 10-Q Quarterly Report for the three months ended September 30, 1992 and
incorporated herein by reference).
4.12 -- Second Priority Deed of Trust and Security Agreement dated as of September 18, 1992 from the
Registrant, as Grantor, to Phillip D. Weller, as Trustee for the benefit of Chemical Bank, as
Beneficiary, for certain property located in Pasadena, Texas (filed as Exhibit 4.11 to the
Registrant's Form 10-Q Quarterly Report for the three months ended September 30, 1992 and
incorporated herein by reference).
4.13 -- First Priority Mortgage, Fixture Filing and Security Agreement dated as of September 18, 1992 from
the Registrant, as Mortgagor, to Chemical Bank, as Collateral Agent, Mortgagee, for certain property
located in Chippewa Falls, Wisconsin (filed as Exhibit 4.12 to the Registrant's Form 10-Q Quarterly
Report for the three months ended September 30, 1992 and incorporated herein by reference).
4.14 -- Second Priority Mortgage, Fixture Filing and Security Agreement dated as of September 18, 1992 from
the Registrant, as Mortgagor, to Chemical Bank, as Collateral Agent, Mortgagee, for certain property
located in Chippewa Falls, Wisconsin (filed as Exhibit 4.13 to the Registrant's Form 10-Q Quarterly
Report for the three months ended September 30, 1992 and incorporated herein by reference).
4.15 -- First Priority Mortgage and Security Agreement dated as of September 18, 1992 from the Registrant, as
Mortgagor, to Chemical Bank, as Collateral Agent, Mortgagee, for certain property located in
Harrington, Delaware (filed as Exhibit 4.14 to the Registrant's Form 10-Q Quarterly Report for the
three months ended September 30, 1992 and incorporated herein by reference).
4.16 -- Second Priority Mortgage and Security Agreement dated as of September 18, 1992 from the Registrant,
as Mortgagor, to Chemical Bank, as Collateral Agent, Mortgagee, for certain property located in
Harrington, Delaware (filed as Exhibit 4.15 to the Registrant's Form 10-Q Quarterly Report for the
three months ended September 30, 1992 and incorporated herein by reference).
4.17 -- First Priority Leasehold Deed of Trust, Fixture Filing and Security Agreement dated as of September
18, 1992 from the Registrant, Trustor, to Founders Title Company, Trustee for the use and benefit of
Chemical Bank, as Collateral Agent, Beneficiary, for certain property located in Clearfield, Utah
(filed as Exhibit 4.16 to the Registrant's Form 10-Q Quarterly Report for the three months ended
September 30, 1992 and incorporated herein by reference).
4.18 -- Second Priority Leasehold Deed of Trust, Fixture Filing and Security Agreement dated as of September
18, 1992 from the Registrant, Trustor, to Founders Title Company, Trustee for the use and benefit of
Chemical Bank, as Collateral Agent, Beneficiary, for certain property located in Clearfield, Utah
(filed as Exhibit 4.17 to the Registrant's Form 10-Q Quarterly Report for the three months ended
September 30, 1992 and incorporated herein by reference).
4.19 -- First Priority Deed to Secure Debt and Security Agreement dated as of September 18, 1992 from
Poly-Pac, Inc., Grantor, to Chemical Bank, as Collateral Agent, Grantee, for certain property located
in Dalton, Georgia (filed as Exhibit 4.18 to the Registrant's Form 10-Q Quarterly Report for the
three months ended September 30, 1992 and incorporated herein by reference).
</TABLE>
II-4
<PAGE>
<TABLE>
<CAPTION>
NUMBER EXHIBIT
- --------- -----------------------------------------------------------------------------------------------------
<C> <C> <S>
4.20 -- Second Priority Deed to Secure Debt and Security Agreement dated as of September 18, 1992 from
Poly-Pac, Inc., Grantor, to Chemical Bank, as Collateral Agent, Grantee, for certain property located
in Dalton, Georgia (filed as Exhibit 4.19 to the Registrant's Form 10-Q Quarterly Report for the
three months ended September 30, 1992 and incorporated herein by reference).
4.21 -- Stockholder Rights Agreement between the Registrant and American Stock Transfer & Trust Company, as
Rights Agent, dated as of January 26, 1993 (filed as Exhibit 4.20 to the Registrant's Form 10-K for
the fiscal year ended December 31, 1992 and incorporated herein by reference).
5.1* -- Opinion of Thompson & Knight, A Professional Corporation.
10.1.1 -- Loan Agreement dated as of September 18, 1992 between the Registrant and Transamerica Business Credit
Corporation (filed as Exhibit 28 to the Registrant's Form 10-Q Quarterly Report for the quarter ended
September 30, 1992 and incorporated herein by reference).
10.1.2 -- First Amendment to Loan Agreement dated as of February 10, 1993 between the Registrant and
Transamerica Business Credit Corporation (filed as Exhibit 28.2 to the Registrant's Form 10-K for the
fiscal year ended December 31, 1992 and incorporated herein by reference).
10.1.3 -- Fourth Amendment to Loan Agreement dated as of December 22, 1993 between Rexene Corporation and
Transamerica Business Credit Corporation (filed as Exhibit 10.17.3 to the Registrant's Form 10-K for
the fiscal year ended December 31, 1993 and incorporated herein by reference).
12.1 -- Statement of Computation of Ratio of Earnings to Fixed Charges (filed as Exhibit 12.1 to the
Registrant's Registration Statement on Form S-3 (SEC File No. 33-55507) as filed on September 16,
1994).
23.1 -- Consent of Price Waterhouse LLP (contained on page II-9 of this Registration Statement).
24.1 -- Power of Attorney (included on the signature page of this Registration Statement).
25.1* -- Statement of Eligibility and Qualification of Trustee under the Trust Indenture Act of 1939 on Form
T-1.
27 -- Financial Data Schedule (filed as Exhibit 27 to the Registrant's Registration Statement on Form S-3
(SEC File No. 33-55507) as filed on September 16, 1994).
<FN>
- ------------------------
* To be filed by amendment.
</TABLE>
Financial Statement Schedules:
Consolidated Schedules for the year ended December 31, 1991, the nine months
ended September 30, 1992, the three months ended December 31, 1992 and the year
ended December 31, 1993:
<TABLE>
<S> <C> <C> <C>
V -- Property, Plant and Equipment................................................ S-1
VI -- Accumulated Depreciation of Property, Plant and Equipment.................... S-2
VIII -- Valuation and Qualifying Accounts............................................ S-3
</TABLE>
All other schedules have been omitted since the required information is not
present in amounts sufficient to require submission of the schedule, or because
the information required is included in the Consolidated Financial Statements or
the notes thereto.
ITEM. 17 UNDERTAKINGS
A. The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each filing of the
Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
Securities Exchange Act of 1934 that is incorporated by reference in the
Registration Statement shall be deemed to be a new registration statement
relating to the securities offerer therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
II-5
<PAGE>
B. Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the provisions described in Item 14 of this Registration
Statement, or otherwise, the Registrant certifies that it has reasonable grounds
to believe that it meets all of the requirements for filing on Form S-3 and has
been advised that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
C. The undersigned Registrant hereby undertakes that:
(1) For purposes of determining any liability under the Securities Act,
the information omitted from the form of prospectus filed as part of this
registration statement in reliance upon Rule 430A and contained in a form of
prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4) or
497(h) under the Securities Act shall be deemed to be part of this
registration statement as of the time it was declared effective.
(2) For the purpose of determining any liability under the Securities
Act, each post-effective amendment that contains a form of prospectus shall
be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be
deemed to be the initial BONA FIDE offering thereof.
II-6
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Dallas, State of Texas, on September 23, 1994.
REXENE CORPORATION
By: /s/ KEVIN W. MCALEER
-----------------------------------
Kevin W. McAleer
EXECUTIVE VICE PRESIDENT AND
CHIEF FINANCIAL OFFICER
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated. Each person whose signature appears below
constitutes and appoints Andrew J. Smith, Lavon N. Anderson and Kevin W.
McAleer, and each of them (with full power to act alone), his true and lawful
attorney-in-fact and agent with full power of substitution and resubstitution,
for him and in his name, place and stead, in any and all capacities, to sign on
his behalf individually and in each capacity stated below any amendment,
including post-effective amendments, to this Registration Statement, and to file
the same, with all exhibits thereto and other documents in connection therewith
with the Securities and Exchange Commission, granting unto said
attorneys-in-fact and agents, and each of them, full power and authority to do
and perform each and every act and thing requisite and necessary to be done in
and about the premises, as fully to all intents and purposes as he might or
could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents or any of them, or their substitute or substitutes,
may lawfully do or cause to be done by virtue hereof.
SIGNATURE TITLE DATE
- -------------------------------- ----------------------- ------------------
/s/ ARTHUR L. GOESCHEL
- -------------------------------- Chairman of the Board September 23, 1994
Arthur L. Goeschel
/s/ ANDREW J. SMITH
- -------------------------------- Chief Executive Officer September 23, 1994
Andrew J. Smith and Director
/s/ LAVON N. ANDERSON President, Chief
- -------------------------------- Operating Officer and September 23, 1994
Lavon N. Anderson Director
/s/ KEVIN W. MCALEER Executive Vice
- -------------------------------- President and Chief September 23, 1994
Kevin W. McAleer Financial Officer
/s/ GEFF PERERA
- -------------------------------- Vice President and September 23, 1994
Geff Perera Controller
II-7
<PAGE>
SIGNATURE TITLE DATE
- ----------------------------------- ----------------------- ------------------
/s/ KEVIN N. CLOWE
- ----------------------------------- Director September 23, 1994
Kevin N. Clowe
/s/ WILLIAM B. HEWITT
- ----------------------------------- Director September 23, 1994
William B. Hewitt
/s/ ILAN KAUFTHAL
- ----------------------------------- Director September 23, 1994
Ilan Kaufthal
/s/ FRED P. RULLO, JR.
- ----------------------------------- Director September 23, 1994
Fred P. Rullo, Jr.
/s/ PHILLIP SIEGEL
- ----------------------------------- Director September 23, 1994
Phillip Siegel
/s/ HEINN F. TOMFOHRDE, III
- ----------------------------------- Director September 23, 1994
Heinn F. Tomfohrde, III
II-8
<PAGE>
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the use in the Prospectus constituting part of this
Registration Statement on Form S-3 of our reports dated February 10, 1994 and
April 12, 1993 relating to the consolidated financial statements of Rexene
Corporation, which appear in such Prospectus. We also consent to the
incorporation by reference of our reports dated February 10, 1994 and April 12,
1993 appearing on pages F-2 and F-3 of Rexene Corporation's Annual Report on
Form 10-K for the year ended December 31, 1993. We also consent to the reference
to us under the heading "Experts" in such Prospectus.
PRICE WATERHOUSE LLP
Dallas, Texas
September 23, 1994
II-9
<PAGE>
SCHEDULE V
REXENE CORPORATION AND SUBSIDIARIES
PROPERTY, PLANT AND EQUIPMENT
(IN THOUSANDS)
<TABLE>
<CAPTION>
BALANCE AT BALANCE AT
BEGINNING ADDITIONS RETIREMENTS END OF
DESCRIPTION OF PERIOD AT COST OR SALE OTHER CHARGES PERIOD
- ------------------------------------------------- ---------- ----------- ----------- ------------- ----------
<S> <C> <C> <C> <C> <C>
PRE-EMERGENCE
Year ended December 31, 1991:
Land......................................... $ 3,536 $ -- $ (1,194) $ -- $ 2,342
Buildings.................................... 20,316 1,965 (1,707) -- 20,574
Plant and equipment.......................... 190,832 30,301 (183) -- 220,950
Construction in progress..................... 19,916 1,198 (34) -- 21,080
---------- ----------- ----------- ------------- ----------
$ 234,600 $ 33,464 $ (3,118) $ -- $ 264,946
---------- ----------- ----------- ------------- ----------
---------- ----------- ----------- ------------- ----------
Nine months ended September 30, 1992:
Land......................................... $ 2,342 $ -- $ -- $ 2,934(A) $ 5,276
Buildings.................................... 20,574 57 -- (6,758)(A) 13,873
Plant and equipment.......................... 220,950 18,846 -- (28,760)(A) 211,036
Construction in progress..................... 21,080 (7,767) -- -- 13,313
---------- ----------- ----------- ------------- ----------
$ 264,946 $ 11,136 $ -- $ (32,584) $ 243,498
---------- ----------- ----------- ------------- ----------
---------- ----------- ----------- ------------- ----------
POST-EMERGENCE
Three months ended December 31, 1992:
Land......................................... $ 5,276 $ -- $ -- $ -- $ 5,276
Buildings.................................... 13,873 32 (64) -- 13,841
Plant and equipment.......................... 211,036 5,514 (110) -- 216,440
Construction in progress..................... 13,313 (1,585) -- -- 11,728
---------- ----------- ----------- ------------- ----------
$ 243,498 $ 3,961 $ (174) $ -- $ 247,285
---------- ----------- ----------- ------------- ----------
---------- ----------- ----------- ------------- ----------
Year ended December 31, 1993:
Land......................................... $ 5,276 $ 462 $ -- $ -- $ 5,738
Buildings.................................... 13,841 3,917 -- -- 17,758
Plant and equipment.......................... 216,440 13,827 (241) -- 230,026
Construction in progress..................... 11,728 (1,198) -- -- 10,530
---------- ----------- ----------- ------------- ----------
$ 247,285 $ 17,008 $ (241) $ -- $ 264,052
---------- ----------- ----------- ------------- ----------
---------- ----------- ----------- ------------- ----------
<FN>
- ------------------------
(A) Other charges reflect the effect of fresh start reporting (see note 3 to
the consolidated financial statements).
</TABLE>
S-1
<PAGE>
SCHEDULE VI
REXENE CORPORATION AND SUBSIDIARIES
ACCUMULATED DEPRECIATION OF PROPERTY, PLANT AND EQUIPMENT
(IN THOUSANDS)
<TABLE>
<CAPTION>
ADDITIONS
BALANCE AT CHARGED TO BALANCE
BEGINNING COSTS AND AT END OF
DESCRIPTION OF PERIOD EXPENSES RETIREMENTS OTHER CHARGES PERIOD
- ------------------------------------------------ ----------- ----------- ------------- -------------- ---------
<S> <C> <C> <C> <C> <C>
PRE-EMERGENCE
Year ended December 31, 1991:
Buildings................................... $ 1,793 $ 1,013 $ (288) $ -- $ 2,518
Plant and equipment......................... 43,322 19,643 (53) -- 62,912
----------- ----------- ----- -------------- ---------
$ 45,115 $ 20,656 $ (341) $ -- $ 65,430
----------- ----------- ----- -------------- ---------
----------- ----------- ----- -------------- ---------
Nine months ended September 30, 1992:
Buildings................................... $ 2,518 $ 779 $ -- $ (3,297 )(A) $ --
Plant and equipment......................... 62,912 16,910 -- (79,822 )(A) --
----------- ----------- ----- -------------- ---------
$ 65,430 $ 17,689 $ -- $ (83,119 ) $ --
----------- ----------- ----- -------------- ---------
----------- ----------- ----- -------------- ---------
POST-EMERGENCE
Three months ended December 31, 1992:
Buildings................................... $ -- $ 216 $ -- $ -- $ 216
Plant and equipment......................... -- 3,448 -- -- 3,448
----------- ----------- ----- -------------- ---------
$ -- $ 3,664 $ -- $ -- $ 3,664
----------- ----------- ----- -------------- ---------
----------- ----------- ----- -------------- ---------
Year ended December 31, 1993:
Buildings................................... $ 216 $ 883 $ -- $ -- $ 1,099
Plant and equipment......................... 3,448 15,176 (17) -- 18,607
----------- ----------- ----- -------------- ---------
$ 3,664 $ 16,059 $ (17) $ -- $ 19,706
----------- ----------- ----- -------------- ---------
----------- ----------- ----- -------------- ---------
<FN>
- ------------------------
(A) Other charges reflect the effect of fresh start reporting (see note 3 to
the consolidated financial statements).
</TABLE>
S-2
<PAGE>
SCHEDULE VIII
REXENE CORPORATION AND SUBSIDIARIES
VALUATION AND QUALIFYING ACCOUNTS
(IN THOUSANDS)
<TABLE>
<CAPTION>
ADDITIONS
BALANCE AT CHARGED TO UNCOLLECTIBLE BALANCE
BEGINNING COSTS AND ACCOUNTS AT END OF
OF PERIOD EXPENSES WRITTEN OFF PERIOD
----------- ----------- ------------ -----------
<S> <C> <C> <C> <C>
PRE-EMERGENCE
Year ended December 31, 1991:
Allowance for doubtful accounts............................. $ 4,703 $ 1,175 $ (1,778) $ 4,100
Nine months ended September 30, 1992:
Allowance for doubtful accounts............................. $ 4,100 $ 327 $ -- $ 4,427
POST-EMERGENCE
Three months ended December 31, 1992:
Allowance for doubtful accounts............................. $ 4,427 $ 300 $ (218) $ 4,509
Year ended December 31, 1993:
Allowance for doubtful accounts............................. $ 4,509 $ 223 $ (925) $ 3,807
</TABLE>
S-3
<PAGE>
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
SEQUENTIALLY
NUMBER EXHIBIT NUMBERED PAGE
- --------- ----------------------------------------------------------------------------------------- ---------------
<C> <C> <S> <C>
1.1* -- Form of Underwriting Agreement.
2.1 -- First Amended Plan of Reorganization of Rexene Products Company, et al., dated April 29,
1992 (filed as Exhibit 2.1 to the Registrant's Form 8-K Current Report dated July 7, 1992
and incorporated herein by reference).
2.2 -- Order Confirming First Amended Plan of Reorganization dated April 29, 1992 (filed as
Exhibit 2.2 to the Registrant's Form 10-K for the fiscal year ended December 31, 1992 and
incorporated herein by reference).
2.3 -- Plan and Agreement of Merger between the Registrant and Rexene Products Company dated as
of September 11, 1992 (filed as Exhibit 2.3 to the Registrant's Form 10-K for the fiscal
year ended December 31, 1992 and incorporated herein by reference.)
3.1.1 -- Restated Certificate of Incorporation of Rexene Products Company (a/k/a Rexene
Corporation) dated September 11, 1992 (filed as Exhibit 3.1 to the Registrant's Form 10-K
for the fiscal year ended December 31, 1992 and incorporated herein by reference.)
3.1.2 -- Amendment to Certificate of Incorporation dated June 9, 1993 (filed as Exhibit 3.1.2 to
the Registrant's Annual Report on Form 10-K for the year ended December 31, 1993 and
incorporated herein by reference).
3.2.1 -- Amendments to By-Laws adopted May 24, 1994, together with a restatement of the
Registrant's By-Laws incorporating all amendments through May 24, 1994 (filed as Exhibit
3.2.3 to the Registrant's Form 10-Q Quarterly Report for the three months ended June 30,
1994 and incorporated herein by reference).
4.1* -- Form of Indenture governing the Senior Notes (including form of Senior Notes).
4.2 -- Indenture dated as of September 18, 1992 between the Registrant, as Issuer, and Chemical
Bank, as Trustee, for Increasing Rate First Priority Notes Due 1999 (filed as Exhibit 4.1
to the Registrant's Form 10-Q Quarterly Report for the three months ended September 30,
1992 and incorporated herein by reference).
4.3 -- Indenture dated as of September 18, 1992 between the Registrant, as Issuer, and United
States Trust Company of New York, as Trustee, for Increasing Rate Second Priority Notes
Due 2002 (filed as Exhibit 4.2 to the Registrant's Form 10-Q Quarterly Report for the
three months ended September 30, 1992 and incorporated herein by reference).
4.4 -- Intercreditor and Collateral Trust Agreement dated as of September 18, 1992 by and among
the Registrant and Poly-Pac, Inc. as Grantors, Chemical Bank as Collateral Agent,
Chemical Bank as Trustee, and United States Trust Company, as Trustee (filed as Exhibit
4.3 to the Registrant's Form 10-Q Quarterly Report for the three months ended September
30, 1992 and incorporated herein by reference).
4.5 -- Company First Priority Security and Pledge Agreement dated as of September 18, 1992 made
by the Registrant, as Grantor, in favor of Chemical Bank, as Collateral Agent (filed as
Exhibit 4.4 to the Registrant's Form 10-Q Quarterly Report for the three months ended
September 30, 1992 and incorporated herein by reference).
4.6 -- Company Second Priority Security and Pledge Agreement dated as of September 18, 1992 made
by the Registrant, as Grantor, in favor of Chemical Bank, as Collateral Agent (filed as
Exhibit 4.5 to the Registrant's Form 10-Q Quarterly Report for the three months ended
September 30, 1992 and incorporated herein by reference).
4.7 -- Subsidiary First Priority Security and Pledge Agreement dated as of September 18, 1992
made by Poly-Pac, Inc., as Grantor, in favor of Chemical Bank, as Collateral Agent (filed
as Exhibit 4.6 to the Registrant's Form 10-Q Quarterly Report for the three months ended
September 30, 1992 and incorporated herein by reference).
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
SEQUENTIALLY
NUMBER EXHIBIT NUMBERED PAGE
- --------- ----------------------------------------------------------------------------------------- ---------------
<C> <C> <S> <C>
4.8 -- Subsidiary Second Priority Security and Pledge Agreement dated as of September 18, 1992
made by Poly-Pac, Inc., as Grantor, in favor of Chemical Bank, as Collateral Agent (filed
as Exhibit 4.7 to the Registrant's Form 10-Q Quarterly Report for the three months ended
September 30, 1992 and incorporated herein by reference).
4.9 -- First Priority Deed of Trust and Security Agreement dated as of September 18, 1992 from
the Registrant, as Grantor, to Phillip D. Weller, as Trustee for the benefit of Chemical
Bank, as Beneficiary, for certain property located in Odessa, Texas (filed as Exhibit 4.8
to the Registrant's Form 10-Q Quarterly Report for the three months ended September 30,
1992 and incorporated herein by reference).
4.10 -- Second Priority Deed of Trust and Security Agreement dated as of September 18, 1992 from
the Registrant, as Grantor, to Phillip D. Weller, as Trustee for the benefit of Chemical
Bank, as Beneficiary, for certain property located in Odessa, Texas (filed as Exhibit 4.9
to the Registrant's Form 10-Q Quarterly Report for the three months ended September 30,
1992 and incorporated herein by reference).
4.11 -- First Priority Deed of Trust and Security Agreement dated as of September 18, 1992 from
the Registrant, as Grantor, to Phillip D. Weller, as Trustee for the benefit of Chemical
Bank, as Beneficiary, for certain property located in Pasadena, Texas (filed as Exhibit
4.10 to the Registrant's Form 10-Q Quarterly Report for the three months ended September
30, 1992 and incorporated herein by reference).
4.12 -- Second Priority Deed of Trust and Security Agreement dated as of September 18, 1992 from
the Registrant, as Grantor, to Phillip D. Weller, as Trustee for the benefit of Chemical
Bank, as Beneficiary, for certain property located in Pasadena, Texas (filed as Exhibit
4.11 to the Registrant's Form 10-Q Quarterly Report for the three months ended September
30, 1992 and incorporated herein by reference).
4.13 -- First Priority Mortgage, Fixture Filing and Security Agreement dated as of September 18,
1992 from the Registrant, as Mortgagor, to Chemical Bank, as Collateral Agent, Mortgagee,
for certain property located in Chippewa Falls, Wisconsin (filed as Exhibit 4.12 to the
Registrant's Form 10-Q Quarterly Report for the three months ended September 30, 1992 and
incorporated herein by reference).
4.14 -- Second Priority Mortgage, Fixture Filing and Security Agreement dated as of September 18,
1992 from the Registrant, as Mortgagor, to Chemical Bank, as Collateral Agent, Mortgagee,
for certain property located in Chippewa Falls, Wisconsin (filed as Exhibit 4.13 to the
Registrant's Form 10-Q Quarterly Report for the three months ended September 30, 1992 and
incorporated herein by reference).
4.15 -- First Priority Mortgage and Security Agreement dated as of September 18, 1992 from the
Registrant, as Mortgagor, to Chemical Bank, as Collateral Agent, Mortgagee, for certain
property located in Harrington, Delaware (filed as Exhibit 4.14 to the Registrant's Form
10-Q Quarterly Report for the three months ended September 30, 1992 and incorporated
herein by reference).
4.16 -- Second Priority Mortgage and Security Agreement dated as of September 18, 1992 from the
Registrant, as Mortgagor, to Chemical Bank, as Collateral Agent, Mortgagee, for certain
property located in Harrington, Delaware (filed as Exhibit 4.15 to the Registrant's Form
10-Q Quarterly Report for the three months ended September 30, 1992 and incorporated
herein by reference).
4.17 -- First Priority Leasehold Deed of Trust, Fixture Filing and Security Agreement dated as of
September 18, 1992 from the Registrant, Trustor, to Founders Title Company, Trustee for
the use and benefit of Chemical Bank, as Collateral Agent, Beneficiary, for certain
property located in Clearfield, Utah (filed as Exhibit 4.16 to the Registrant's Form 10-Q
Quarterly Report for the three months ended September 30, 1992 and incorporated herein by
reference).
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
SEQUENTIALLY
NUMBER EXHIBIT NUMBERED PAGE
- --------- ----------------------------------------------------------------------------------------- ---------------
<C> <C> <S> <C>
4.18 -- Second Priority Leasehold Deed of Trust, Fixture Filing and Security Agreement dated as
of September 18, 1992 from the Registrant, Trustor, to Founders Title Company, Trustee
for the use and benefit of Chemical Bank, as Collateral Agent, Beneficiary, for certain
property located in Clearfield, Utah (filed as Exhibit 4.17 to the Registrant's Form 10-Q
Quarterly Report for the three months ended September 30, 1992 and incorporated herein by
reference).
4.19 -- First Priority Deed to Secure Debt and Security Agreement dated as of September 18, 1992
from Poly-Pac, Inc., Grantor, to Chemical Bank, as Collateral Agent, Grantee, for certain
property located in Dalton, Georgia (filed as Exhibit 4.18 to the Registrant's Form 10-Q
Quarterly Report for the three months ended September 30, 1992 and incorporated herein by
reference).
4.20 -- Second Priority Deed to Secure Debt and Security Agreement dated as of September 18, 1992
from Poly-Pac, Inc., Grantor, to Chemical Bank, as Collateral Agent, Grantee, for certain
property located in Dalton, Georgia (filed as Exhibit 4.19 to the Registrant's Form 10-Q
Quarterly Report for the three months ended September 30, 1992 and incorporated herein by
reference).
4.21 -- Stockholder Rights Agreement between the Registrant and American Stock Transfer & Trust
Company, as Rights Agent, dated as of January 26, 1993 (filed as Exhibit 4.20 to the
Registrant's Form 10-K for the fiscal year ended December 31, 1992 and incorporated
herein by reference).
5.1* -- Opinion of Thompson & Knight, A Professional Corporation.
10.1.1 -- Loan Agreement dated as of September 18, 1992 between the Registrant and Transamerica
Business Credit Corporation (filed as Exhibit 28 to the Registrant's Form 10-Q Quarterly
Report for the quarter ended September 30, 1992 and incorporated herein by reference).
10.1.2 -- First Amendment to Loan Agreement dated as of February 10, 1993 between the Registrant
and Transamerica Business Credit Corporation (filed as Exhibit 28.2 to the Registrant's
Form 10-K for the fiscal year ended December 31, 1992 and incorporated herein by
reference).
10.1.3 -- Fourth Amendment to Loan Agreement dated as of December 22, 1993 between Rexene
Corporation and Transamerica Business Credit Corporation (filed as Exhibit 10.17.3 to the
Registrant's Form 10-K for the fiscal year ended December 31, 1993 and incorporated
herein by reference).
12.1 -- Statement of Computation of Ratio of Earnings to Fixed Charges (filed as Exhibit 12.1 to
the Registrant's Registration Statement on Form S-3 (SEC File No. 33-55507) as filed on
September 16, 1994).
23.1 -- Consent of Price Waterhouse LLP (contained on page II-9 of this Registration Statement).
24.1 -- Power of Attorney (included on the signature page of this Registration Statement).
25.1* -- Statement of Eligibility and Qualification of Trustee under the Trust Indenture Act of
1939 on Form T-1.
27 -- Financial Data Schedule (filed as Exhibit 27 to the Registrant's Registration Statement
on Form S-3 (SEC File No. 33-55507) as filed on September 16, 1994).
<FN>
- ------------------------
* To be filed by amendment.
</TABLE>
